{"text": "Somatic cell selection is a major determinant of the blood cell phenotype in heterozygotes for glucose 6 phosphate dehydrogenase mutations causing severe [E1] enzyme deficiency [/E1] X chromosome inactivation in mammals is regarded as an essentially random process but the resulting somatic cell mosaicism creates the opportunity for cell selection In most people with red blood cell glucose 6 phosphate dehydrogenase G6PD deficiency the enzyme", "mention_data": [{"mention": "enzyme deficiency", "kb_id": "D008661", "start": 22, "end": 25}]}
{"text": "glucose 6 phosphate dehydrogenase mutations causing severe enzyme deficiency X chromosome inactivation in mammals is regarded as an essentially random process but the resulting somatic cell mosaicism creates the opportunity for cell selection In most people with red blood cell [E1] glucose 6 phosphate dehydrogenase G6PD deficiency [/E1] the enzyme deficient phenotype is only moderately expressed in nucleated cells However in a small subset of hemizygous males who suffer from chronic nonspherocytic hemolytic anemia the underlying mutations designated class I cause more severe G6PD deficiency and this", "mention_data": [{"mention": "glucose 6 phosphate dehydrogenase G6PD deficiency", "kb_id": "D005955", "start": 55, "end": 62}]}
{"text": "the opportunity for cell selection In most people with red blood cell glucose 6 phosphate dehydrogenase G6PD deficiency the enzyme deficient phenotype is only moderately expressed in nucleated cells However in a small subset of hemizygous males who suffer from [E1] chronic nonspherocytic hemolytic anemia [/E1] the underlying mutations designated class I cause more severe G6PD deficiency and this might provide an opportunity for selection in heterozygous females during development In order to test this possibility we have analyzed four heterozygotes for class I G6PD", "mention_data": [{"mention": "chronic nonspherocytic hemolytic anemia", "kb_id": "D000746", "start": 83, "end": 88}]}
{"text": "6 phosphate dehydrogenase G6PD deficiency the enzyme deficient phenotype is only moderately expressed in nucleated cells However in a small subset of hemizygous males who suffer from chronic nonspherocytic hemolytic anemia the underlying mutations designated class I cause more severe [E1] G6PD deficiency [/E1] and this might provide an opportunity for selection in heterozygous females during development In order to test this possibility we have analyzed four heterozygotes for class I G6PD mutations two with G6PD Portici 1178G A and two with G6PD", "mention_data": [{"mention": "G6PD deficiency", "kb_id": "D005955", "start": 96, "end": 99}]}
{"text": "The significant concordance that we have observed in the degree of imbalance in the different blood cell lineages indicates that a selective mechanism is likely to operate at the level of pluripotent blood stem cells Thus it appears that severe [E1] G6PD deficiency [/E1] affects adversely the proliferation or the survival of nucleated blood cells and that this phenotypic characteristic is critical during hematopoiesis", "mention_data": [{"mention": "G6PD deficiency", "kb_id": "D005955", "start": 204, "end": 207}]}
{"text": "The [E1] ataxia telangiectasia [/E1] gene product a constitutively expressed nuclear protein that is not up regulated following genome damage The product of the ataxia telangiectasia gene ATM was identified by using an antiserum developed to a peptide corresponding to the deduced amino acid", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 1, "end": 4}]}
{"text": "The ataxia telangiectasia gene product a constitutively expressed nuclear protein that is not up regulated following genome damage The product of the [E1] ataxia telangiectasia [/E1] gene ATM was identified by using an antiserum developed to a peptide corresponding to the deduced amino acid sequence The ATM protein is a single high molecular weight protein predominantly confined to the nucleus of human fibroblasts but is", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 22, "end": 25}]}
{"text": "but is present in both nuclear and microsomal fractions from human lymphoblast cells and peripheral blood lymphocytes ATM protein levels and localization remain constant throughout all stages of the cell cycle Truncated ATM protein was not detected in lymphoblasts from [E1] ataxia telangiectasia [/E1] patients homozygous for mutations leading to premature protein termination Exposure of normal human cells to gamma irradiation and the radiomimetic drug neocarzinostatin had no effect on ATM protein levels in contrast to a noted rise in p53 levels over", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 101, "end": 104}]}
{"text": "Molecular basis for [E1] Duarte and Los Angeles variant galactosemia [/E1] Human orythrocytes that are homozygous for the Duarte enzyme variant of galactosemia D/D have a characteristic isoform on isoelectric focusing and 50 reduction in galactose 1 phosphate uridyltransferase GALT enzyme activity The Duarte biochemical phenotype has a molecular genotype", "mention_data": [{"mention": "Duarte and Los Angeles variant galactosemia", "kb_id": "D005693", "start": 3, "end": 10}]}
{"text": "Molecular basis for Duarte and Los Angeles variant galactosemia Human orythrocytes that are homozygous for the [E1] Duarte enzyme variant of galactosemia [/E1] D/D have a characteristic isoform on isoelectric focusing and 50 reduction in galactose 1 phosphate uridyltransferase GALT enzyme activity The Duarte biochemical phenotype has a molecular genotype of N314D/N314D The characteristic Duarte isoform is also associated with a variant", "mention_data": [{"mention": "Duarte enzyme variant of galactosemia", "kb_id": "D005693", "start": 16, "end": 22}]}
{"text": "in GALT activity in the wild type N/N after exposure at identical initial enzyme activity to 50 degrees C for 15 min We conclude that the codon change N314D in cis with the base pair transition 1721C T produces the [E1] LA variant of galactosemia [/E1] and that this nucleotide change increases GALT activity by increasing GALT protein abundance without increasing transcription or decreasing thermal lability A favorable codon bias for the mutated codon with consequently increased translation rates is postulated as the mechanism", "mention_data": [{"mention": "LA variant of galactosemia", "kb_id": "D005693", "start": 269, "end": 274}]}
{"text": "An intronic mutation in a lariat branchpoint sequence is a direct cause of an [E1] inherited human disorder [/E1] fish eye disease The first step in the splicing of an intron from nuclear precursors of mRNA results in the formation of a lariat structure A distinct intronic nucleotide sequence known as the branchpoint region plays a central role", "mention_data": [{"mention": "inherited human disorder", "kb_id": "D030342", "start": 14, "end": 18}]}
{"text": "An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder [E1] fish eye disease [/E1] The first step in the splicing of an intron from nuclear precursors of mRNA results in the formation of a lariat structure A distinct intronic nucleotide sequence known as the branchpoint region plays a central role in this process", "mention_data": [{"mention": "fish eye disease", "kb_id": "D007863", "start": 17, "end": 21}]}
{"text": "the formation of a lariat structure A distinct intronic nucleotide sequence known as the branchpoint region plays a central role in this process We here describe a point mutation in such a sequence Three sisters were shown to suffer from [E1] fish eye disease [/E1] FED a disorder which is caused by mutations in the gene coding for lecithin cholesterol acyltransferase LCAT Sequencing of the LCAT gene of all three probands revealed compound heterozygosity for a missense mutation in exon 4 which is reported", "mention_data": [{"mention": "fish eye disease", "kb_id": "D007863", "start": 76, "end": 80}]}
{"text": "a lariat structure A distinct intronic nucleotide sequence known as the branchpoint region plays a central role in this process We here describe a point mutation in such a sequence Three sisters were shown to suffer from fish eye disease [E1] FED [/E1] a disorder which is caused by mutations in the gene coding for lecithin cholesterol acyltransferase LCAT Sequencing of the LCAT gene of all three probands revealed compound heterozygosity for a missense mutation in exon 4 which is reported to", "mention_data": [{"mention": "FED", "kb_id": "D007863", "start": 79, "end": 81}]}
{"text": "disorder which is caused by mutations in the gene coding for lecithin cholesterol acyltransferase LCAT Sequencing of the LCAT gene of all three probands revealed compound heterozygosity for a missense mutation in exon 4 which is reported to underlie the [E1] FED [/E1] phenotype and a point mutation located in intron 4 IVS4 T 22C By performing in vitro expression of LCAT minigenes and reverse transcriptase PCR on mRNA isolated from leukocytes of the patient this gene defect was shown to cause", "mention_data": [{"mention": "FED", "kb_id": "D007863", "start": 121, "end": 123}]}
{"text": "patient this gene defect was shown to cause a null allele as the result of complete intron retention In conclusion we demonstrated that a point mutation in a lariat branchpoint consensus sequence causes a null allele in a patient with [E1] FED [/E1] In addition our finding illustrates the importance of this sequence for normal human mRNA processing Finally this report provides a widely applicable strategy which ensures fast and effective screening for intronic defects that underlie differential gene expression", "mention_data": [{"mention": "FED", "kb_id": "D007863", "start": 193, "end": 195}]}
{"text": "Genetic heterogeneity in [E1] hereditary breast cancer [/E1] role of BRCA1 and BRCA2 The common hereditary forms of breast cancer have been largely attributed to the inheritance of mutations in the BRCA1 or BRCA2 genes However it is not yet clear what proportion of hereditary breast cancer", "mention_data": [{"mention": "hereditary breast cancer", "kb_id": "D061325", "start": 3, "end": 7}]}
{"text": "Genetic heterogeneity in hereditary breast cancer role of BRCA1 and BRCA2 The common hereditary forms of [E1] breast cancer [/E1] have been largely attributed to the inheritance of mutations in the BRCA1 or BRCA2 genes However it is not yet clear what proportion of hereditary breast cancer is explained by BRCA1 and BRCA2 or by some other unidentified susceptibility", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 16, "end": 19}]}
{"text": "in hereditary breast cancer role of BRCA1 and BRCA2 The common hereditary forms of breast cancer have been largely attributed to the inheritance of mutations in the BRCA1 or BRCA2 genes However it is not yet clear what proportion of [E1] hereditary breast cancer [/E1] is explained by BRCA1 and BRCA2 or by some other unidentified susceptibility gene s We describe the proportion of hereditary breast cancer explained by BRCA1 or BRCA2 in a sample of North American hereditary breast cancers and assess the", "mention_data": [{"mention": "hereditary breast cancer", "kb_id": "D061325", "start": 42, "end": 46}]}
{"text": "inheritance of mutations in the BRCA1 or BRCA2 genes However it is not yet clear what proportion of hereditary breast cancer is explained by BRCA1 and BRCA2 or by some other unidentified susceptibility gene s We describe the proportion of [E1] hereditary breast cancer [/E1] explained by BRCA1 or BRCA2 in a sample of North American hereditary breast cancers and assess the evidence for additional susceptibility genes that may confer hereditary breast or ovarian cancer risk Twenty three families were identified through two high", "mention_data": [{"mention": "hereditary breast cancer", "kb_id": "D061325", "start": 64, "end": 68}]}
{"text": "clear what proportion of hereditary breast cancer is explained by BRCA1 and BRCA2 or by some other unidentified susceptibility gene s We describe the proportion of hereditary breast cancer explained by BRCA1 or BRCA2 in a sample of North American [E1] hereditary breast cancers [/E1] and assess the evidence for additional susceptibility genes that may confer hereditary breast or ovarian cancer risk Twenty three families were identified through two high risk breast cancer research programs Genetic analysis was undertaken to establish linkage between the", "mention_data": [{"mention": "hereditary breast cancers", "kb_id": "D061325", "start": 78, "end": 82}]}
{"text": "by some other unidentified susceptibility gene s We describe the proportion of hereditary breast cancer explained by BRCA1 or BRCA2 in a sample of North American hereditary breast cancers and assess the evidence for additional susceptibility genes that may confer [E1] hereditary breast or ovarian cancer [/E1] risk Twenty three families were identified through two high risk breast cancer research programs Genetic analysis was undertaken to establish linkage between the breast or ovarian cancer cases and markers on chromosomes 17q BRCA1 and 13q BRCA2 Mutation analysis", "mention_data": [{"mention": "hereditary breast or ovarian cancer", "kb_id": "D061325", "start": 92, "end": 98}]}
{"text": "explained by BRCA1 or BRCA2 in a sample of North American hereditary breast cancers and assess the evidence for additional susceptibility genes that may confer hereditary breast or ovarian cancer risk Twenty three families were identified through two high risk [E1] breast cancer [/E1] research programs Genetic analysis was undertaken to establish linkage between the breast or ovarian cancer cases and markers on chromosomes 17q BRCA1 and 13q BRCA2 Mutation analysis in the BRCA1 and BRCA2 genes was also undertaken in all families", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 107, "end": 110}]}
{"text": "cancers and assess the evidence for additional susceptibility genes that may confer hereditary breast or ovarian cancer risk Twenty three families were identified through two high risk breast cancer research programs Genetic analysis was undertaken to establish linkage between the [E1] breast or ovarian cancer [/E1] cases and markers on chromosomes 17q BRCA1 and 13q BRCA2 Mutation analysis in the BRCA1 and BRCA2 genes was also undertaken in all families The pattern of hereditary cancer in 14 61 of the 23 families studied was attributed", "mention_data": [{"mention": "breast or ovarian cancer", "kb_id": "D001943|D010051", "start": 120, "end": 125}]}
{"text": "Genetic analysis was undertaken to establish linkage between the breast or ovarian cancer cases and markers on chromosomes 17q BRCA1 and 13q BRCA2 Mutation analysis in the BRCA1 and BRCA2 genes was also undertaken in all families The pattern of [E1] hereditary cancer [/E1] in 14 61 of the 23 families studied was attributed to BRCA1 by a combination of linkage and mutation analyses No families were attributed to BRCA2 Five families 22 provided evidence against linkage to both BRCA1 and BRCA2 No", "mention_data": [{"mention": "hereditary cancer", "kb_id": "D009386", "start": 151, "end": 154}]}
{"text": "evidence against linkage to both BRCA1 and BRCA2 No BRCA1 or BRCA2 mutations were detected in these five families The BRCA1 or BRCA2 status of four families 17 could not be determined BRCA1 and BRCA2 probably explain the majority of [E1] hereditary breast cancer [/E1] that exists in the North American population However one or more additional genes may yet be found that explain some proportion of hereditary breast cancer", "mention_data": [{"mention": "hereditary breast cancer", "kb_id": "D061325", "start": 223, "end": 227}]}
{"text": "four families 17 could not be determined BRCA1 and BRCA2 probably explain the majority of hereditary breast cancer that exists in the North American population However one or more additional genes may yet be found that explain some proportion of [E1] hereditary breast cancer [/E1]", "mention_data": [{"mention": "hereditary breast cancer", "kb_id": "D061325", "start": 248, "end": 252}]}
{"text": "The [E1] tumor [/E1] suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse Mutations of the BRCA1 gone in humans are associated with predisposition to breast and ovarian cancers We show here that Brca1 / mice are normal and fertile", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 1, "end": 3}]}
{"text": "The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse Mutations of the BRCA1 gone in humans are associated with predisposition to [E1] breast and ovarian cancers [/E1] We show here that Brca1 / mice are normal and fertile and lack tumors by age eleven months Homozygous Brca1 5 6 mutant mice die before day 7 5 of embryogenesis Mutant embryos are poorly developed with no evidence", "mention_data": [{"mention": "breast and ovarian cancers", "kb_id": "D001943|D010051", "start": 26, "end": 31}]}
{"text": "gene Brca1 is required for embryonic cellular proliferation in the mouse Mutations of the BRCA1 gone in humans are associated with predisposition to breast and ovarian cancers We show here that Brca1 / mice are normal and fertile and lack [E1] tumors [/E1] by age eleven months Homozygous Brca1 5 6 mutant mice die before day 7 5 of embryogenesis Mutant embryos are poorly developed with no evidence of mesoderm formation The extraembryonic region is abnormal but aggregation with wild type tetraploid", "mention_data": [{"mention": "tumors", "kb_id": "D009369", "start": 43, "end": 45}]}
{"text": "Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene specific mechanisms in [E1] alveolar rhabdomyosarcoma [/E1] Chromosomal translocations identified in hematopoietic and solid tumors result in deregulated expression of protooncogenes or creation of chimeric proteins with tumorigenic potential In the pediatric solid tumor alveolar rhabdomyosarcoma a consistent t 2 13 q35 q14 or variant t", "mention_data": [{"mention": "alveolar rhabdomyosarcoma", "kb_id": "D018232", "start": 14, "end": 17}]}
{"text": "Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene specific mechanisms in alveolar rhabdomyosarcoma Chromosomal translocations identified in [E1] hematopoietic and solid tumors [/E1] result in deregulated expression of protooncogenes or creation of chimeric proteins with tumorigenic potential In the pediatric solid tumor alveolar rhabdomyosarcoma a consistent t 2 13 q35 q14 or variant t 1 13 p36 q14 translocation generates PAX3 FKHR", "mention_data": [{"mention": "hematopoietic and solid tumors", "kb_id": "D019337", "start": 20, "end": 25}]}
{"text": "genes resulting from alternative chromosomal translocations are overexpressed by gene specific mechanisms in alveolar rhabdomyosarcoma Chromosomal translocations identified in hematopoietic and solid tumors result in deregulated expression of protooncogenes or creation of chimeric proteins with tumorigenic potential In the pediatric [E1] solid tumor [/E1] alveolar rhabdomyosarcoma a consistent t 2 13 q35 q14 or variant t 1 13 p36 q14 translocation generates PAX3 FKHR or PAX7 FKHR fusion proteins respectively In this report we demonstrate that in addition to functional alterations these translocations", "mention_data": [{"mention": "solid tumor", "kb_id": "D009369", "start": 41, "end": 44}]}
{"text": "from alternative chromosomal translocations are overexpressed by gene specific mechanisms in alveolar rhabdomyosarcoma Chromosomal translocations identified in hematopoietic and solid tumors result in deregulated expression of protooncogenes or creation of chimeric proteins with tumorigenic potential In the pediatric solid tumor [E1] alveolar rhabdomyosarcoma [/E1] a consistent t 2 13 q35 q14 or variant t 1 13 p36 q14 translocation generates PAX3 FKHR or PAX7 FKHR fusion proteins respectively In this report we demonstrate that in addition to functional alterations these translocations are associated", "mention_data": [{"mention": "alveolar rhabdomyosarcoma", "kb_id": "D018232", "start": 43, "end": 46}]}
{"text": "of PAX3 FKHR is increased relative to wild type PAX3 by a copy number independent process In contrast PAX7 FKHR overexpression results from fusion gene amplification Thus gene specific mechanisms were selected to overexpress PAX3 FKHR and PAX7 FKHR in [E1] alveolar rhabdomyosarcoma [/E1] presumably due to differences in regulation between the wild type loci We postulate that these overexpression mechanisms ensure a critical level of gene product for the oncogenic effects of these fusions", "mention_data": [{"mention": "alveolar rhabdomyosarcoma", "kb_id": "D018232", "start": 140, "end": 143}]}
{"text": "Pleiotropic defects in [E1] ataxia telangiectasia [/E1] protein deficient mice We have generated a mouse model for ataxia telangiectasia by using gene targeting to generate mice that do not express the Atm protein Atm deficient mice are retarded in growth do not produce mature sperm and", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 3, "end": 6}]}
{"text": "Pleiotropic defects in ataxia telangiectasia protein deficient mice We have generated a mouse model for [E1] ataxia telangiectasia [/E1] by using gene targeting to generate mice that do not express the Atm protein Atm deficient mice are retarded in growth do not produce mature sperm and exhibit severe defects in T cell maturation while going on to develop", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 15, "end": 18}]}
{"text": "telangiectasia by using gene targeting to generate mice that do not express the Atm protein Atm deficient mice are retarded in growth do not produce mature sperm and exhibit severe defects in T cell maturation while going on to develop [E1] thymomas [/E1] Atm deficient fibroblasts grow poorly in culture and display a high level of double stranded chromosome breaks Atm deficient thymocytes undergo spontaneous apoptosis in vitro significantly more than controls Atm deficient mice then exhibit many of the same symptoms", "mention_data": [{"mention": "thymomas", "kb_id": "D013945", "start": 56, "end": 58}]}
{"text": "deficient fibroblasts grow poorly in culture and display a high level of double stranded chromosome breaks Atm deficient thymocytes undergo spontaneous apoptosis in vitro significantly more than controls Atm deficient mice then exhibit many of the same symptoms found in [E1] ataxia telangiectasia [/E1] patients and in cells derived from them Furthermore we demonstrate that the Atm protein exists as two discrete molecular species and that loss of one or of both of these can lead to the development of the disease", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 98, "end": 101}]}
{"text": "Muscle expression of [E1] glucose 6 phosphate dehydrogenase deficiency [/E1] in different variants Muscle expression of G6PD deficiency has been investigated in Mediterranean Seattle like and A variants G6PD activity was detected in samples obtained from biopsies on the quadriceps muscle of seven males and one female The type", "mention_data": [{"mention": "glucose 6 phosphate dehydrogenase deficiency", "kb_id": "D005955", "start": 3, "end": 9}]}
{"text": "Muscle expression of glucose 6 phosphate dehydrogenase deficiency in different variants Muscle expression of [E1] G6PD deficiency [/E1] has been investigated in Mediterranean Seattle like and A variants G6PD activity was detected in samples obtained from biopsies on the quadriceps muscle of seven males and one female The type of genetic variant was determined by molecular analysis", "mention_data": [{"mention": "G6PD deficiency", "kb_id": "D005955", "start": 14, "end": 17}]}
{"text": "PTEN a putative protein tyrosine phosphatase gene mutated in human [E1] brain breast and prostate cancer [/E1] Mapping of homozygous deletions on human chromosome 10q23 has led to the isolation of a candidate tumor suppressor gene PTEN that appears to be mutated at considerable frequency in human cancers In preliminary screens mutations of PTEN were detected", "mention_data": [{"mention": "brain breast and prostate cancer", "kb_id": "D001932|D001943|D011471", "start": 10, "end": 16}]}
{"text": "PTEN a putative protein tyrosine phosphatase gene mutated in human brain breast and prostate cancer Mapping of homozygous deletions on human chromosome 10q23 has led to the isolation of a candidate [E1] tumor [/E1] suppressor gene PTEN that appears to be mutated at considerable frequency in human cancers In preliminary screens mutations of PTEN were detected in 31 13/42 of glioblastoma cell lines and xenografts 100 4/4 of prostate cancer cell lines 6", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 31, "end": 33}]}
{"text": "phosphatase gene mutated in human brain breast and prostate cancer Mapping of homozygous deletions on human chromosome 10q23 has led to the isolation of a candidate tumor suppressor gene PTEN that appears to be mutated at considerable frequency in human [E1] cancers [/E1] In preliminary screens mutations of PTEN were detected in 31 13/42 of glioblastoma cell lines and xenografts 100 4/4 of prostate cancer cell lines 6 4/65 of breast cancer cell lines and xenografts and 17 3/18 of primary glioblastomas", "mention_data": [{"mention": "cancers", "kb_id": "D009369", "start": 45, "end": 47}]}
{"text": "deletions on human chromosome 10q23 has led to the isolation of a candidate tumor suppressor gene PTEN that appears to be mutated at considerable frequency in human cancers In preliminary screens mutations of PTEN were detected in 31 13/42 of [E1] glioblastoma [/E1] cell lines and xenografts 100 4/4 of prostate cancer cell lines 6 4/65 of breast cancer cell lines and xenografts and 17 3/18 of primary glioblastomas The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homology", "mention_data": [{"mention": "glioblastoma", "kb_id": "D005909", "start": 58, "end": 60}]}
{"text": "the isolation of a candidate tumor suppressor gene PTEN that appears to be mutated at considerable frequency in human cancers In preliminary screens mutations of PTEN were detected in 31 13/42 of glioblastoma cell lines and xenografts 100 4/4 of [E1] prostate cancer [/E1] cell lines 6 4/65 of breast cancer cell lines and xenografts and 17 3/18 of primary glioblastomas The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homology to tensin a protein that interacts with actin filaments", "mention_data": [{"mention": "prostate cancer", "kb_id": "D011471", "start": 66, "end": 69}]}
{"text": "gene PTEN that appears to be mutated at considerable frequency in human cancers In preliminary screens mutations of PTEN were detected in 31 13/42 of glioblastoma cell lines and xenografts 100 4/4 of prostate cancer cell lines 6 4/65 of [E1] breast cancer [/E1] cell lines and xenografts and 17 3/18 of primary glioblastomas The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homology to tensin a protein that interacts with actin filaments at focal adhesions These homologies suggest that", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 73, "end": 76}]}
{"text": "in human cancers In preliminary screens mutations of PTEN were detected in 31 13/42 of glioblastoma cell lines and xenografts 100 4/4 of prostate cancer cell lines 6 4/65 of breast cancer cell lines and xenografts and 17 3/18 of [E1] primary glioblastomas [/E1] The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homology to tensin a protein that interacts with actin filaments at focal adhesions These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine", "mention_data": [{"mention": "primary glioblastomas", "kb_id": "D005909", "start": 83, "end": 86}]}
{"text": "and xenografts and 17 3/18 of primary glioblastomas The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homology to tensin a protein that interacts with actin filaments at focal adhesions These homologies suggest that PTEN may suppress [E1] tumor [/E1] cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 117, "end": 119}]}
{"text": "product has a protein tyrosine phosphatase domain and extensive homology to tensin a protein that interacts with actin filaments at focal adhesions These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate [E1] tumor [/E1] cell invasion and metastasis through interactions at focal adhesions", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 128, "end": 130}]}
{"text": "tyrosine phosphatase domain and extensive homology to tensin a protein that interacts with actin filaments at focal adhesions These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and [E1] metastasis [/E1] through interactions at focal adhesions", "mention_data": [{"mention": "metastasis", "kb_id": "D009362", "start": 132, "end": 134}]}
{"text": "Somatic alterations of the DPC4 gene in human [E1] colorectal cancers [/E1] in vivo BACKGROUND AIMS The chromosome region 18q21 has been shown to be frequently deleted in colorectal cancers and such frequent allelic loss is a hallmark of the presence of a tumor suppressor gene The DPC4 gene which is", "mention_data": [{"mention": "colorectal cancers", "kb_id": "D015179", "start": 8, "end": 11}]}
{"text": "Somatic alterations of the DPC4 gene in human colorectal cancers in vivo BACKGROUND AIMS The chromosome region 18q21 has been shown to be frequently deleted in [E1] colorectal cancers [/E1] and such frequent allelic loss is a hallmark of the presence of a tumor suppressor gene The DPC4 gene which is located at 18q21 has been identified as a tumor suppressor gene from examination of pancreatic cancers The aim", "mention_data": [{"mention": "colorectal cancers", "kb_id": "D015179", "start": 26, "end": 29}]}
{"text": "frequently deleted in colorectal cancers and such frequent allelic loss is a hallmark of the presence of a tumor suppressor gene The DPC4 gene which is located at 18q21 has been identified as a tumor suppressor gene from examination of [E1] pancreatic cancers [/E1] The aim of the present study was to determine if it might also be altered in colorectal cancers METHODS Mutation analyses of the DPC4 gene were performed on complementary DNA samples from 31 primary colorectal cancer specimens using a", "mention_data": [{"mention": "pancreatic cancers", "kb_id": "D010190", "start": 63, "end": 66}]}
{"text": "tumor suppressor gene The DPC4 gene which is located at 18q21 has been identified as a tumor suppressor gene from examination of pancreatic cancers The aim of the present study was to determine if it might also be altered in [E1] colorectal cancers [/E1] METHODS Mutation analyses of the DPC4 gene were performed on complementary DNA samples from 31 primary colorectal cancer specimens using a combination of polymerase chain reaction single strand conformation polymorphism and DNA sequencing RESULTS Four missense mutations producing amino", "mention_data": [{"mention": "colorectal cancers", "kb_id": "D015179", "start": 81, "end": 84}]}
{"text": "gene from examination of pancreatic cancers The aim of the present study was to determine if it might also be altered in colorectal cancers METHODS Mutation analyses of the DPC4 gene were performed on complementary DNA samples from 31 primary [E1] colorectal cancer [/E1] specimens using a combination of polymerase chain reaction single strand conformation polymorphism and DNA sequencing RESULTS Four missense mutations producing amino acid substitutions and a somatic 12 base pair deletion in the coding region of the DPC4 gene were", "mention_data": [{"mention": "colorectal cancer", "kb_id": "D015179", "start": 99, "end": 102}]}
{"text": "combination of polymerase chain reaction single strand conformation polymorphism and DNA sequencing RESULTS Four missense mutations producing amino acid substitutions and a somatic 12 base pair deletion in the coding region of the DPC4 gene were detected in the 31 [E1] cancers [/E1] 16 5 of 31 CONCLUSIONS The DPC4 gene may play a role as a tumor suppressor gene in a fraction of colorectal cancers however while allelic loss at 18q21 is very often seen in colorectal cancers only a minority", "mention_data": [{"mention": "cancers", "kb_id": "D009369", "start": 144, "end": 146}]}
{"text": "somatic 12 base pair deletion in the coding region of the DPC4 gene were detected in the 31 cancers 16 5 of 31 CONCLUSIONS The DPC4 gene may play a role as a tumor suppressor gene in a fraction of [E1] colorectal cancers [/E1] however while allelic loss at 18q21 is very often seen in colorectal cancers only a minority show DPC4 mutations suggesting that there might be another tumor suppressor gene in this chromosome region", "mention_data": [{"mention": "colorectal cancers", "kb_id": "D015179", "start": 166, "end": 169}]}
{"text": "were detected in the 31 cancers 16 5 of 31 CONCLUSIONS The DPC4 gene may play a role as a tumor suppressor gene in a fraction of colorectal cancers however while allelic loss at 18q21 is very often seen in [E1] colorectal cancers [/E1] only a minority show DPC4 mutations suggesting that there might be another tumor suppressor gene in this chromosome region", "mention_data": [{"mention": "colorectal cancers", "kb_id": "D015179", "start": 179, "end": 182}]}
{"text": "Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1 Over 100 distinct disease associated mutations have been identified in the [E1] breast ovarian cancer [/E1] susceptibility gene BRCA1 Loss of the wild type allele in 90 of tumors from patients with inherited BRCA1 mutations indicates tumor suppressive function The low incidence of somatic mutations suggests that BRCA1 inactivation in sporadic tumors occurs by alternative", "mention_data": [{"mention": "breast ovarian cancer", "kb_id": "D061325", "start": 26, "end": 30}]}
{"text": "genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1 Over 100 distinct disease associated mutations have been identified in the breast ovarian cancer susceptibility gene BRCA1 Loss of the wild type allele in 90 of [E1] tumors [/E1] from patients with inherited BRCA1 mutations indicates tumor suppressive function The low incidence of somatic mutations suggests that BRCA1 inactivation in sporadic tumors occurs by alternative mechanisms such as interstitial chromosomal deletion or reduced transcription To identify possible features", "mention_data": [{"mention": "tumors", "kb_id": "D009369", "start": 41, "end": 43}]}
{"text": "human DNA containing the gene BRCA1 Over 100 distinct disease associated mutations have been identified in the breast ovarian cancer susceptibility gene BRCA1 Loss of the wild type allele in 90 of tumors from patients with inherited BRCA1 mutations indicates [E1] tumor [/E1] suppressive function The low incidence of somatic mutations suggests that BRCA1 inactivation in sporadic tumors occurs by alternative mechanisms such as interstitial chromosomal deletion or reduced transcription To identify possible features of the BRCA1 genomic region that may contribute", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 49, "end": 51}]}
{"text": "in the breast ovarian cancer susceptibility gene BRCA1 Loss of the wild type allele in 90 of tumors from patients with inherited BRCA1 mutations indicates tumor suppressive function The low incidence of somatic mutations suggests that BRCA1 inactivation in sporadic [E1] tumors [/E1] occurs by alternative mechanisms such as interstitial chromosomal deletion or reduced transcription To identify possible features of the BRCA1 genomic region that may contribute to chromosomal instability as well as potential transcriptional regulatory elements a 117 143 bp DNA", "mention_data": [{"mention": "tumors", "kb_id": "D009369", "start": 64, "end": 66}]}
{"text": "[E1] Type II human complement C2 deficiency [/E1] Allele specific amino acid substitutions Ser189 Phe Gly444 Arg cause impaired C2 secretion Type II complement protein C2 deficiency is characterized by a selective block in C2 secretion The Type II C2 null allele C2Q0 is linked to two", "mention_data": [{"mention": "Type II human complement C2 deficiency", "kb_id": "217000", "start": 0, "end": 7}]}
{"text": "Type II human complement C2 deficiency Allele specific amino acid substitutions Ser189 Phe Gly444 Arg cause impaired C2 secretion [E1] Type II complement protein C2 deficiency [/E1] is characterized by a selective block in C2 secretion The Type II C2 null allele C2Q0 is linked to two major histocompatibility haplotypes MHC that differ from the MHC of the more common Type I C2 deficiency To determine", "mention_data": [{"mention": "Type II complement protein C2 deficiency", "kb_id": "217000", "start": 19, "end": 26}]}
{"text": "secretion Type II complement protein C2 deficiency is characterized by a selective block in C2 secretion The Type II C2 null allele C2Q0 is linked to two major histocompatibility haplotypes MHC that differ from the MHC of the more common [E1] Type I C2 deficiency [/E1] To determine the molecular basis of Type II deficiency the two Type II C2Q0 genes were isolated and transfected separately into L cells Subsequent molecular biology biosynthetic and immunofluorescence studies demonstrated that C2 secretion is impaired in Type II", "mention_data": [{"mention": "Type I C2 deficiency", "kb_id": "217000", "start": 58, "end": 63}]}
{"text": "a selective block in C2 secretion The Type II C2 null allele C2Q0 is linked to two major histocompatibility haplotypes MHC that differ from the MHC of the more common Type I C2 deficiency To determine the molecular basis of [E1] Type II deficiency [/E1] the two Type II C2Q0 genes were isolated and transfected separately into L cells Subsequent molecular biology biosynthetic and immunofluorescence studies demonstrated that C2 secretion is impaired in Type II C2 deficiency because of different missense mutations at highly", "mention_data": [{"mention": "Type II deficiency", "kb_id": "217000", "start": 68, "end": 72}]}
{"text": "I C2 deficiency To determine the molecular basis of Type II deficiency the two Type II C2Q0 genes were isolated and transfected separately into L cells Subsequent molecular biology biosynthetic and immunofluorescence studies demonstrated that C2 secretion is impaired in [E1] Type II C2 deficiency [/E1] because of different missense mutations at highly conserved residues in each of the C2Q0 alleles One is in exon 5 nucleotide C566 T Ser189 Phe of the C2Q0 gene linked to the MHC haplotype A11 B35 DRw1 BFS C4A0B1", "mention_data": [{"mention": "Type II C2 deficiency", "kb_id": "217000", "start": 99, "end": 104}]}
{"text": "Targeted disruption of ATM leads to [E1] growth retardation [/E1] chromosomal fragmentation during meiosis immune defects and thymic lymphoma ATM the gene mutated in the inherited human disease ataxia telangiectasia is a member of a family of kinases involved in DNA metabolism and cell cycle checkpoint control To help", "mention_data": [{"mention": "growth retardation", "kb_id": "D006130", "start": 6, "end": 9}]}
{"text": "Targeted disruption of ATM leads to growth retardation [E1] chromosomal fragmentation during meiosis [/E1] immune defects and thymic lymphoma ATM the gene mutated in the inherited human disease ataxia telangiectasia is a member of a family of kinases involved in DNA metabolism and cell cycle checkpoint control To help clarify the physiological roles", "mention_data": [{"mention": "chromosomal fragmentation during meiosis", "kb_id": "D048629", "start": 8, "end": 13}]}
{"text": "Targeted disruption of ATM leads to growth retardation chromosomal fragmentation during meiosis [E1] immune defects [/E1] and thymic lymphoma ATM the gene mutated in the inherited human disease ataxia telangiectasia is a member of a family of kinases involved in DNA metabolism and cell cycle checkpoint control To help clarify the physiological roles of the", "mention_data": [{"mention": "immune defects", "kb_id": "D007154", "start": 12, "end": 15}]}
{"text": "Targeted disruption of ATM leads to growth retardation chromosomal fragmentation during meiosis immune defects and [E1] thymic lymphoma [/E1] ATM the gene mutated in the inherited human disease ataxia telangiectasia is a member of a family of kinases involved in DNA metabolism and cell cycle checkpoint control To help clarify the physiological roles of the ATM protein we", "mention_data": [{"mention": "thymic lymphoma", "kb_id": "D013953", "start": 15, "end": 18}]}
{"text": "Targeted disruption of ATM leads to growth retardation chromosomal fragmentation during meiosis immune defects and thymic lymphoma ATM the gene mutated in the [E1] inherited human disease [/E1] ataxia telangiectasia is a member of a family of kinases involved in DNA metabolism and cell cycle checkpoint control To help clarify the physiological roles of the ATM protein we disrupted the ATM gene in mice through homologous recombination", "mention_data": [{"mention": "inherited human disease", "kb_id": "D030342", "start": 23, "end": 27}]}
{"text": "Targeted disruption of ATM leads to growth retardation chromosomal fragmentation during meiosis immune defects and thymic lymphoma ATM the gene mutated in the inherited human disease [E1] ataxia telangiectasia [/E1] is a member of a family of kinases involved in DNA metabolism and cell cycle checkpoint control To help clarify the physiological roles of the ATM protein we disrupted the ATM gene in mice through homologous recombination Initial evaluation", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 26, "end": 29}]}
{"text": "help clarify the physiological roles of the ATM protein we disrupted the ATM gene in mice through homologous recombination Initial evaluation of the ATM knockout animals indicates that inactivation of the mouse ATM gene recreates much of the phenotype of [E1] ataxia telangiectasia [/E1] The homozygous mutant ATM / mice are viable growth retarded and infertile The infertility of ATM / mice results from meiotic failure Meiosis is arrested at the zygotene/pachytene stage of prophase I as a result of abnormal chromosomal synapsis", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 86, "end": 89}]}
{"text": "mice through homologous recombination Initial evaluation of the ATM knockout animals indicates that inactivation of the mouse ATM gene recreates much of the phenotype of ataxia telangiectasia The homozygous mutant ATM / mice are viable growth retarded and infertile The [E1] infertility [/E1] of ATM / mice results from meiotic failure Meiosis is arrested at the zygotene/pachytene stage of prophase I as a result of abnormal chromosomal synapsis and subsequent chromosome fragmentation Immune defects also are evident in ATM / mice including", "mention_data": [{"mention": "infertility", "kb_id": "D007246", "start": 101, "end": 103}]}
{"text": "ATM / mice are viable growth retarded and infertile The infertility of ATM / mice results from meiotic failure Meiosis is arrested at the zygotene/pachytene stage of prophase I as a result of abnormal chromosomal synapsis and subsequent chromosome fragmentation [E1] Immune defects [/E1] also are evident in ATM / mice including reduced numbers of B220 CD43 pre B cells thymocytes and peripheral T cells as well as functional impairment of T cell dependent immune responses The cerebella of ATM / mice appear", "mention_data": [{"mention": "Immune defects", "kb_id": "D007154", "start": 131, "end": 134}]}
{"text": "B cells thymocytes and peripheral T cells as well as functional impairment of T cell dependent immune responses The cerebella of ATM / mice appear normal by histologic examination at 3 to 4 months and the mice have no gross [E1] behavioral abnormalities [/E1] The majority of mutant mice rapidly develop thymic lymphomas and die before 4 months of age These findings indicate that the ATM gene product plays an essential role in a diverse group of cellular processes including meiosis the normal", "mention_data": [{"mention": "behavioral abnormalities", "kb_id": "D001523", "start": 187, "end": 190}]}
{"text": "as functional impairment of T cell dependent immune responses The cerebella of ATM / mice appear normal by histologic examination at 3 to 4 months and the mice have no gross behavioral abnormalities The majority of mutant mice rapidly develop [E1] thymic lymphomas [/E1] and die before 4 months of age These findings indicate that the ATM gene product plays an essential role in a diverse group of cellular processes including meiosis the normal growth of somatic tissues immune development and tumor suppression", "mention_data": [{"mention": "thymic lymphomas", "kb_id": "D008223", "start": 196, "end": 199}]}
{"text": "develop thymic lymphomas and die before 4 months of age These findings indicate that the ATM gene product plays an essential role in a diverse group of cellular processes including meiosis the normal growth of somatic tissues immune development and [E1] tumor [/E1] suppression", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 235, "end": 237}]}
{"text": "The 5 end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21 To begin to address the hypothesis that abnormal regulation of the [E1] breast/ovarian cancer [/E1] susceptibility gene BRCA1 is a critical step in sporadic breast/ovarian tumorigenesis we have determined the detailed structure of the BRCA1 genomic region We show that this region of the genome contains a tandem duplication of approximately 30 kilobases which", "mention_data": [{"mention": "breast/ovarian cancer", "kb_id": "D061325", "start": 27, "end": 30}]}
{"text": "atm and p53 cooperate in apoptosis and suppression of tumorigenesis but not in resistance to [E1] acute radiation toxicity [/E1] Mutations in atm and p53 cause the human cancer associated diseases ataxia telangiectasia and Li Fraumeni syndrome respectively The two genes are believed to interact in a number of pathways including regulation of DNA damage induced cell cycle checkpoints", "mention_data": [{"mention": "acute radiation toxicity", "kb_id": "D054508", "start": 15, "end": 19}]}
{"text": "atm and p53 cooperate in apoptosis and suppression of tumorigenesis but not in resistance to acute radiation toxicity Mutations in atm and p53 cause the human [E1] cancer associated diseases [/E1] ataxia telangiectasia and Li Fraumeni syndrome respectively The two genes are believed to interact in a number of pathways including regulation of DNA damage induced cell cycle checkpoints apoptosis and radiation sensitivity and cellular proliferation Atm null mice as", "mention_data": [{"mention": "cancer associated diseases", "kb_id": "D009369", "start": 26, "end": 30}]}
{"text": "atm and p53 cooperate in apoptosis and suppression of tumorigenesis but not in resistance to acute radiation toxicity Mutations in atm and p53 cause the human cancer associated diseases [E1] ataxia telangiectasia [/E1] and Li Fraumeni syndrome respectively The two genes are believed to interact in a number of pathways including regulation of DNA damage induced cell cycle checkpoints apoptosis and radiation sensitivity and cellular proliferation Atm null mice as well as", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 29, "end": 32}]}
{"text": "atm and p53 cooperate in apoptosis and suppression of tumorigenesis but not in resistance to acute radiation toxicity Mutations in atm and p53 cause the human cancer associated diseases ataxia telangiectasia and [E1] Li Fraumeni syndrome [/E1] respectively The two genes are believed to interact in a number of pathways including regulation of DNA damage induced cell cycle checkpoints apoptosis and radiation sensitivity and cellular proliferation Atm null mice as well as those null for p53", "mention_data": [{"mention": "Li Fraumeni syndrome", "kb_id": "D016864", "start": 32, "end": 36}]}
{"text": "The two genes are believed to interact in a number of pathways including regulation of DNA damage induced cell cycle checkpoints apoptosis and radiation sensitivity and cellular proliferation Atm null mice as well as those null for p53 develop mainly [E1] T cell lymphomas [/E1] supporting the view that these genes have similar roles in thymocyte development To study the interactions of these two genes on an organismal level we bred mice heterozygous for null alleles of both atm and p53 to produce all", "mention_data": [{"mention": "T cell lymphomas", "kb_id": "D016399", "start": 76, "end": 80}]}
{"text": "study the interactions of these two genes on an organismal level we bred mice heterozygous for null alleles of both atm and p53 to produce all genotypic combinations Mice doubly null for atm and p53 exhibited a dramatic acceleration of [E1] tumour [/E1] formation relative to singly null mice indicating that both genes collaborate in a significant manner to prevent tumorigenesis With respect to their roles in apoptosis loss of atm rendered thymocytes only partly resistant to irradiation induced apoptosis whereas additional", "mention_data": [{"mention": "tumour", "kb_id": "D009369", "start": 132, "end": 134}]}
{"text": "apoptosis whereas additional loss of p53 engendered complete resistance This implies that the irradiation induced atm and p53 apoptotic pathways are not completely congruent Finally and in contrast to prior predictions atm and p53 do not appear to interact in [E1] acute radiation toxicity [/E1] suggesting a separate atm effector pathway for this DNA damage response and having implications for the prognosis and treatment of human tumours", "mention_data": [{"mention": "acute radiation toxicity", "kb_id": "D054508", "start": 209, "end": 213}]}
{"text": "Finally and in contrast to prior predictions atm and p53 do not appear to interact in acute radiation toxicity suggesting a separate atm effector pathway for this DNA damage response and having implications for the prognosis and treatment of human [E1] tumours [/E1]", "mention_data": [{"mention": "tumours", "kb_id": "D009369", "start": 233, "end": 235}]}
{"text": "Molecular bases of [E1] C7 deficiency [/E1] three different defects The molecular basis of C7 deficiency has been investigated in two Irish families and a number of Israeli families of Moroccan Sephardic Jewish origin Exon PCR and sequencing revealed a heterozygous point mutation at the 3", "mention_data": [{"mention": "C7 deficiency", "kb_id": "610102", "start": 3, "end": 6}]}
{"text": "Molecular bases of C7 deficiency three different defects The molecular basis of [E1] C7 deficiency [/E1] has been investigated in two Irish families and a number of Israeli families of Moroccan Sephardic Jewish origin Exon PCR and sequencing revealed a heterozygous point mutation at the 3 splice acceptor site of intron 1 in one Irish", "mention_data": [{"mention": "C7 deficiency", "kb_id": "610102", "start": 12, "end": 15}]}
{"text": "shown to be deleted Marker haplotype studies of the C6 and C7 gene region and Southern blots show that the Irish family with the splice defect also segregate for the deletion which is not easily detected in heterozygotes The Israeli [E1] C7 deficient [/E1] cases all share a C7 haplotype and are homozygous for a mis sense mutation in exon 9 However one individual is heterozygous for markers at adjacent C6 loci showing that there has been an intergenic recombination and suggesting that", "mention_data": [{"mention": "C7 deficient", "kb_id": "610102", "start": 109, "end": 112}]}
{"text": "Identification of WASP mutations mutation hotspots and genotype phenotype disparities in 24 patients with the [E1] Wiskott Aldrich syndrome [/E1] The Wiskott Aldrich syndrome WAS an X linked immunodeficiency disease caused by mutation in the recently isolated gene encoding WAS protein WASP is known to be associated with extensive clinical heterogeneity Cumulative mutation data have revealed that WASP genotypes", "mention_data": [{"mention": "Wiskott Aldrich syndrome", "kb_id": "D014923", "start": 15, "end": 19}]}
{"text": "Identification of WASP mutations mutation hotspots and genotype phenotype disparities in 24 patients with the Wiskott Aldrich syndrome The [E1] Wiskott Aldrich syndrome [/E1] WAS an X linked immunodeficiency disease caused by mutation in the recently isolated gene encoding WAS protein WASP is known to be associated with extensive clinical heterogeneity Cumulative mutation data have revealed that WASP genotypes are also highly variable", "mention_data": [{"mention": "Wiskott Aldrich syndrome", "kb_id": "D014923", "start": 19, "end": 23}]}
{"text": "Identification of WASP mutations mutation hotspots and genotype phenotype disparities in 24 patients with the Wiskott Aldrich syndrome The Wiskott Aldrich syndrome [E1] WAS [/E1] an X linked immunodeficiency disease caused by mutation in the recently isolated gene encoding WAS protein WASP is known to be associated with extensive clinical heterogeneity Cumulative mutation data have revealed that WASP genotypes are also highly variable among", "mention_data": [{"mention": "WAS", "kb_id": "D014923", "start": 22, "end": 24}]}
{"text": "Identification of WASP mutations mutation hotspots and genotype phenotype disparities in 24 patients with the Wiskott Aldrich syndrome The Wiskott Aldrich syndrome WAS an [E1] X linked immunodeficiency disease [/E1] caused by mutation in the recently isolated gene encoding WAS protein WASP is known to be associated with extensive clinical heterogeneity Cumulative mutation data have revealed that WASP genotypes are also highly variable among WAS patients but the relationship", "mention_data": [{"mention": "X linked immunodeficiency disease", "kb_id": "D007153|D040181", "start": 24, "end": 29}]}
{"text": "Identification of WASP mutations mutation hotspots and genotype phenotype disparities in 24 patients with the Wiskott Aldrich syndrome The Wiskott Aldrich syndrome WAS an X linked immunodeficiency disease caused by mutation in the recently isolated gene encoding [E1] WAS [/E1] protein WASP is known to be associated with extensive clinical heterogeneity Cumulative mutation data have revealed that WASP genotypes are also highly variable among WAS patients but the relationship of phenotype with genotype in this disease remains unclear To", "mention_data": [{"mention": "WAS", "kb_id": "D014923", "start": 37, "end": 39}]}
{"text": "WAS an X linked immunodeficiency disease caused by mutation in the recently isolated gene encoding WAS protein WASP is known to be associated with extensive clinical heterogeneity Cumulative mutation data have revealed that WASP genotypes are also highly variable among [E1] WAS [/E1] patients but the relationship of phenotype with genotype in this disease remains unclear To address this issue we characterized WASP mutations in 24 unrelated WAS patients including 18 boys with severe classical WAS and 6 boys expressing mild forms", "mention_data": [{"mention": "WAS", "kb_id": "D014923", "start": 62, "end": 64}]}
{"text": "clinical heterogeneity Cumulative mutation data have revealed that WASP genotypes are also highly variable among WAS patients but the relationship of phenotype with genotype in this disease remains unclear To address this issue we characterized WASP mutations in 24 unrelated [E1] WAS [/E1] patients including 18 boys with severe classical WAS and 6 boys expressing mild forms of the disease and then examined the degree of correlation of these as well as all previously published WASP mutations with disease severity By analysis", "mention_data": [{"mention": "WAS", "kb_id": "D014923", "start": 87, "end": 89}]}
{"text": "WASP genotypes are also highly variable among WAS patients but the relationship of phenotype with genotype in this disease remains unclear To address this issue we characterized WASP mutations in 24 unrelated WAS patients including 18 boys with severe classical [E1] WAS [/E1] and 6 boys expressing mild forms of the disease and then examined the degree of correlation of these as well as all previously published WASP mutations with disease severity By analysis of these compiled mutation data we demonstrated clustering", "mention_data": [{"mention": "WAS", "kb_id": "D014923", "start": 95, "end": 97}]}
{"text": "region as hotspots for WASP mutation These characteristics were observed however in both severe and mild cases of the disease Similarly while the cumulative data revealed a predominance of missense mutations among the WASP gene lesions observed in boys with [E1] isolated thrombocytopenia [/E1] missense mutations were not exclusively associated with milder WAS phenotypes but also comprised a substantial portion 38 of the WASP gene defects found in patients with severe disease These findings as well as the detection of identical WASP mutations", "mention_data": [{"mention": "isolated thrombocytopenia", "kb_id": "D013921", "start": 195, "end": 198}]}
{"text": "however in both severe and mild cases of the disease Similarly while the cumulative data revealed a predominance of missense mutations among the WASP gene lesions observed in boys with isolated thrombocytopenia missense mutations were not exclusively associated with milder [E1] WAS [/E1] phenotypes but also comprised a substantial portion 38 of the WASP gene defects found in patients with severe disease These findings as well as the detection of identical WASP mutations in patients with disparate phenotypes reveal a lack of", "mention_data": [{"mention": "WAS", "kb_id": "D014923", "start": 205, "end": 207}]}
{"text": "a substantial portion 38 of the WASP gene defects found in patients with severe disease These findings as well as the detection of identical WASP mutations in patients with disparate phenotypes reveal a lack of phenotype concordance with genotype in [E1] WAS [/E1] and thus imply that phenotypic outcome in this disease cannot be reliably predicted solely on the basis of WASP genotypes", "mention_data": [{"mention": "WAS", "kb_id": "D014923", "start": 250, "end": 252}]}
{"text": "Identification and chromosomal localization of Atm the mouse homolog of the [E1] ataxia telangiectasia [/E1] gene Atm the mouse homolog of the human ATM gene defective in ataxia telangiectasia A T has been identified The entire coding sequence of the Atm transcript was cloned and found to contain an open reading frame encoding a", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 11, "end": 14}]}
{"text": "Identification and chromosomal localization of Atm the mouse homolog of the ataxia telangiectasia gene Atm the mouse homolog of the human ATM gene defective in [E1] ataxia telangiectasia [/E1] A T has been identified The entire coding sequence of the Atm transcript was cloned and found to contain an open reading frame encoding a protein of 3066 amino acids with 84 overall identity and 91 similarity to the", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 25, "end": 28}]}
{"text": "Identification and chromosomal localization of Atm the mouse homolog of the ataxia telangiectasia gene Atm the mouse homolog of the human ATM gene defective in ataxia telangiectasia [E1] A T [/E1] has been identified The entire coding sequence of the Atm transcript was cloned and found to contain an open reading frame encoding a protein of 3066 amino acids with 84 overall identity and 91 similarity to the human ATM", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 27, "end": 30}]}
{"text": "Mutation of MSH3 in [E1] endometrial cancer [/E1] and evidence for its functional role in heteroduplex repair Many human tumours have length alterations in repetitive sequence elements Although this microsatellite instability has been attributed to mutations in four DNA mismatch repair genes in hereditary nonpolyposis colorectal cancer", "mention_data": [{"mention": "endometrial cancer", "kb_id": "D016889", "start": 4, "end": 7}]}
{"text": "Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair Many human [E1] tumours [/E1] have length alterations in repetitive sequence elements Although this microsatellite instability has been attributed to mutations in four DNA mismatch repair genes in hereditary nonpolyposis colorectal cancer HNPCC kindreds many sporadic tumours exhibit instability but no detectable mutations in", "mention_data": [{"mention": "tumours", "kb_id": "D009369", "start": 17, "end": 19}]}
{"text": "Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair Many human tumours have length alterations in repetitive sequence elements Although this [E1] microsatellite instability [/E1] has been attributed to mutations in four DNA mismatch repair genes in hereditary nonpolyposis colorectal cancer HNPCC kindreds many sporadic tumours exhibit instability but no detectable mutations in these genes It is therefore of interest to identify other genes", "mention_data": [{"mention": "microsatellite instability", "kb_id": "D053842", "start": 27, "end": 30}]}
{"text": "of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair Many human tumours have length alterations in repetitive sequence elements Although this microsatellite instability has been attributed to mutations in four DNA mismatch repair genes in [E1] hereditary nonpolyposis colorectal cancer [/E1] HNPCC kindreds many sporadic tumours exhibit instability but no detectable mutations in these genes It is therefore of interest to identify other genes that contribute to this instability In yeast mutations in several genes including RTH and MSH3 cause", "mention_data": [{"mention": "hereditary nonpolyposis colorectal cancer", "kb_id": "D003123", "start": 41, "end": 46}]}
{"text": "cancer and evidence for its functional role in heteroduplex repair Many human tumours have length alterations in repetitive sequence elements Although this microsatellite instability has been attributed to mutations in four DNA mismatch repair genes in hereditary nonpolyposis colorectal cancer [E1] HNPCC [/E1] kindreds many sporadic tumours exhibit instability but no detectable mutations in these genes It is therefore of interest to identify other genes that contribute to this instability In yeast mutations in several genes including RTH and MSH3 cause microsatellite", "mention_data": [{"mention": "HNPCC", "kb_id": "D003123", "start": 45, "end": 47}]}
{"text": "for its functional role in heteroduplex repair Many human tumours have length alterations in repetitive sequence elements Although this microsatellite instability has been attributed to mutations in four DNA mismatch repair genes in hereditary nonpolyposis colorectal cancer HNPCC kindreds many [E1] sporadic tumours [/E1] exhibit instability but no detectable mutations in these genes It is therefore of interest to identify other genes that contribute to this instability In yeast mutations in several genes including RTH and MSH3 cause microsatellite instability Thus we screened", "mention_data": [{"mention": "sporadic tumours", "kb_id": "D009369", "start": 48, "end": 51}]}
{"text": "exhibit instability but no detectable mutations in these genes It is therefore of interest to identify other genes that contribute to this instability In yeast mutations in several genes including RTH and MSH3 cause microsatellite instability Thus we screened 16 [E1] endometrial carcinomas [/E1] with microsatellite instability for alterations in FEN1 the human homolog of RTH and in MSH3 refs 12 14 Although we found no FEN1 mutations a frameshift mutation in MSH3 was observed in an endometrial carcinoma and in an endometrial", "mention_data": [{"mention": "endometrial carcinomas", "kb_id": "D016889", "start": 90, "end": 93}]}
{"text": "instability Thus we screened 16 endometrial carcinomas with microsatellite instability for alterations in FEN1 the human homolog of RTH and in MSH3 refs 12 14 Although we found no FEN1 mutations a frameshift mutation in MSH3 was observed in an [E1] endometrial carcinoma [/E1] and in an endometrial carcinoma cell line Extracts of the cell line were deficient in repair of DNA substrates containing mismatches or extra nucleotides Introducing chromosome 5 encoding the MSH3 gene into the mutant cell line increased the stability", "mention_data": [{"mention": "endometrial carcinoma", "kb_id": "D016889", "start": 125, "end": 128}]}
{"text": "endometrial carcinomas with microsatellite instability for alterations in FEN1 the human homolog of RTH and in MSH3 refs 12 14 Although we found no FEN1 mutations a frameshift mutation in MSH3 was observed in an endometrial carcinoma and in an [E1] endometrial carcinoma [/E1] cell line Extracts of the cell line were deficient in repair of DNA substrates containing mismatches or extra nucleotides Introducing chromosome 5 encoding the MSH3 gene into the mutant cell line increased the stability of some but not all", "mention_data": [{"mention": "endometrial carcinoma", "kb_id": "D016889", "start": 130, "end": 133}]}
{"text": "a second gene mutation in HHUA cells a missense mutation in the MSH6 gene Together the data suggest that the MSH3 gene encodes a product that functions in repair of some but not all pre mutational intermediates its mutation in [E1] tumours [/E1] can result in genomic instability and as in yeast MSH3 and MSH6 are partially redundant for mismatch repair", "mention_data": [{"mention": "tumours", "kb_id": "D009369", "start": 239, "end": 241}]}
{"text": "[E1] Kniest dysplasia [/E1] Dr W Kniest his patient the molecular defect Kniest dysplasia is a severe chondrodysplasia caused by the defective formation of type II collagen We report about Dr Kniest who first described the condition in 1952 and his patient who", "mention_data": [{"mention": "Kniest dysplasia", "kb_id": "C537207", "start": 0, "end": 3}]}
{"text": "Kniest dysplasia Dr W Kniest his patient the molecular defect [E1] Kniest dysplasia [/E1] is a severe chondrodysplasia caused by the defective formation of type II collagen We report about Dr Kniest who first described the condition in 1952 and his patient who at the age of 50 years is severely handicapped with", "mention_data": [{"mention": "Kniest dysplasia", "kb_id": "C537207", "start": 10, "end": 13}]}
{"text": "Kniest dysplasia Dr W Kniest his patient the molecular defect Kniest dysplasia is a severe [E1] chondrodysplasia [/E1] caused by the defective formation of type II collagen We report about Dr Kniest who first described the condition in 1952 and his patient who at the age of 50 years is severely handicapped with short stature restricted joint", "mention_data": [{"mention": "chondrodysplasia", "kb_id": "D010009", "start": 15, "end": 17}]}
{"text": "Kniest dysplasia Dr W Kniest his patient the molecular defect Kniest dysplasia is a severe chondrodysplasia caused by the [E1] defective formation of type II collagen [/E1] We report about Dr Kniest who first described the condition in 1952 and his patient who at the age of 50 years is severely handicapped with short stature restricted joint mobility and blindness but is mentally alert and leads", "mention_data": [{"mention": "defective formation of type II collagen", "kb_id": "D003095", "start": 19, "end": 26}]}
{"text": "molecular defect Kniest dysplasia is a severe chondrodysplasia caused by the defective formation of type II collagen We report about Dr Kniest who first described the condition in 1952 and his patient who at the age of 50 years is [E1] severely handicapped [/E1] with short stature restricted joint mobility and blindness but is mentally alert and leads an active life Molecular analysis of the patients DNA showed a single base G deletion involving the GT dinucleotide at the start of intron 18", "mention_data": [{"mention": "severely handicapped", "kb_id": "D008607", "start": 48, "end": 51}]}
{"text": "dysplasia is a severe chondrodysplasia caused by the defective formation of type II collagen We report about Dr Kniest who first described the condition in 1952 and his patient who at the age of 50 years is severely handicapped with [E1] short stature [/E1] restricted joint mobility and blindness but is mentally alert and leads an active life Molecular analysis of the patients DNA showed a single base G deletion involving the GT dinucleotide at the start of intron 18 destroying a splice", "mention_data": [{"mention": "short stature", "kb_id": "D006130", "start": 51, "end": 54}]}
{"text": "a severe chondrodysplasia caused by the defective formation of type II collagen We report about Dr Kniest who first described the condition in 1952 and his patient who at the age of 50 years is severely handicapped with short stature [E1] restricted joint mobility [/E1] and blindness but is mentally alert and leads an active life Molecular analysis of the patients DNA showed a single base G deletion involving the GT dinucleotide at the start of intron 18 destroying a splice site of the", "mention_data": [{"mention": "restricted joint mobility", "kb_id": "D007592", "start": 53, "end": 57}]}
{"text": "by the defective formation of type II collagen We report about Dr Kniest who first described the condition in 1952 and his patient who at the age of 50 years is severely handicapped with short stature restricted joint mobility and [E1] blindness [/E1] but is mentally alert and leads an active life Molecular analysis of the patients DNA showed a single base G deletion involving the GT dinucleotide at the start of intron 18 destroying a splice site of the COL2A1 gene", "mention_data": [{"mention": "blindness", "kb_id": "D001766", "start": 57, "end": 59}]}
{"text": "analysis of the patients DNA showed a single base G deletion involving the GT dinucleotide at the start of intron 18 destroying a splice site of the COL2A1 gene This is in accordance with molecular findings in other patients with [E1] Kniest dysplasia [/E1] and confirms in the original patient that the disorder is caused by small inframe deletions often due to exon skipping as a result of COL2A1 splice site mutations", "mention_data": [{"mention": "Kniest dysplasia", "kb_id": "C537207", "start": 108, "end": 111}]}
{"text": "Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 BRCA1 and BRCA2 are the two major identified causes of [E1] inherited breast cancer [/E1] with mutations in either gene conferring up to 80 90 lifetime risk of breast cancer in carrier females Mutations in BRCA1 account for approximately 45 of familial breast cancer and 90 of inherited breast/ovarian cancer whereas mutations in BRCA2", "mention_data": [{"mention": "inherited breast cancer", "kb_id": "D001943", "start": 21, "end": 25}]}
{"text": "Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 BRCA1 and BRCA2 are the two major identified causes of inherited breast cancer with mutations in either gene conferring up to 80 90 lifetime risk of [E1] breast cancer [/E1] in carrier females Mutations in BRCA1 account for approximately 45 of familial breast cancer and 90 of inherited breast/ovarian cancer whereas mutations in BRCA2 account for a comparable percentage of inherited breast cancer cases Over 85 distinct BRCA1 mutations", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 37, "end": 40}]}
{"text": "BRCA2 BRCA1 and BRCA2 are the two major identified causes of inherited breast cancer with mutations in either gene conferring up to 80 90 lifetime risk of breast cancer in carrier females Mutations in BRCA1 account for approximately 45 of [E1] familial breast cancer [/E1] and 90 of inherited breast/ovarian cancer whereas mutations in BRCA2 account for a comparable percentage of inherited breast cancer cases Over 85 distinct BRCA1 mutations and a growing list of BRCA2 mutations have been identified with the majority resulting", "mention_data": [{"mention": "familial breast cancer", "kb_id": "D001943", "start": 50, "end": 54}]}
{"text": "two major identified causes of inherited breast cancer with mutations in either gene conferring up to 80 90 lifetime risk of breast cancer in carrier females Mutations in BRCA1 account for approximately 45 of familial breast cancer and 90 of [E1] inherited breast/ovarian cancer [/E1] whereas mutations in BRCA2 account for a comparable percentage of inherited breast cancer cases Over 85 distinct BRCA1 mutations and a growing list of BRCA2 mutations have been identified with the majority resulting in protein truncation A specific BRCA1", "mention_data": [{"mention": "inherited breast/ovarian cancer", "kb_id": "D061325", "start": 56, "end": 60}]}
{"text": "conferring up to 80 90 lifetime risk of breast cancer in carrier females Mutations in BRCA1 account for approximately 45 of familial breast cancer and 90 of inherited breast/ovarian cancer whereas mutations in BRCA2 account for a comparable percentage of [E1] inherited breast cancer [/E1] cases Over 85 distinct BRCA1 mutations and a growing list of BRCA2 mutations have been identified with the majority resulting in protein truncation A specific BRCA1 mutation 185delAG has a reported increased carrier frequency of approximately 0 9 in", "mention_data": [{"mention": "inherited breast cancer", "kb_id": "D001943", "start": 69, "end": 73}]}
{"text": "in the Ashkenazi Jewish population but is also found in rare non Jewish patients with a different haplotype The 6174delT mutation in BRCA2 was recently identified as a frequent mutation in 8 out of 107 Ashkenazi Jewish women diagnosed with [E1] breast cancer [/E1] by age 50 ref 8 as well as in three Ashkenazi male breast cancer patients We have conducted a large scale population study to investigate the prevalence of specific BRCA1 and BRCA2 mutations in Ashkenazi Jewish individuals who were", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 150, "end": 153}]}
{"text": "patients with a different haplotype The 6174delT mutation in BRCA2 was recently identified as a frequent mutation in 8 out of 107 Ashkenazi Jewish women diagnosed with breast cancer by age 50 ref 8 as well as in three Ashkenazi [E1] male breast cancer [/E1] patients We have conducted a large scale population study to investigate the prevalence of specific BRCA1 and BRCA2 mutations in Ashkenazi Jewish individuals who were unselected for breast cancer BRCA1 mutation screening on approximately 3 000 Ashkenazi Jewish samples", "mention_data": [{"mention": "male breast cancer", "kb_id": "D018567", "start": 163, "end": 167}]}
{"text": "age 50 ref 8 as well as in three Ashkenazi male breast cancer patients We have conducted a large scale population study to investigate the prevalence of specific BRCA1 and BRCA2 mutations in Ashkenazi Jewish individuals who were unselected for [E1] breast cancer [/E1] BRCA1 mutation screening on approximately 3 000 Ashkenazi Jewish samples determined a carrier frequency of 1 09 for the 185delAG mutation and 0 13 for the 5382insC mutation BRCA2 analysis on 3 085 individuals from the same population showed", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 193, "end": 196}]}
{"text": "from the same population showed a carrier frequency of 1 52 for the 6174delT mutation This expanded population based study confirms that the BRCA1 185delAG mutation and the BRCA2 6174delT mutation constitute the two most frequent mutation alleles predisposing to [E1] hereditary breast cancer [/E1] among the Ashkenazim and suggests a relatively lower penetrance for the 6174delT mutation in BRCA2", "mention_data": [{"mention": "hereditary breast cancer", "kb_id": "D001943", "start": 269, "end": 273}]}
{"text": "Mapping the homolog of the human Rb1 gene to chromosome 14 of higher primates The Rb1 gene has been implicated with [E1] retinoblastoma [/E1] and is located on human Chromosome Chr 13q14 2 2 A unique sequence human Rb1 cosmid DNA probe has been used to localize this region on apes Chr 14 by the FISH technique The conservation of the Rb1 gene", "mention_data": [{"mention": "retinoblastoma", "kb_id": "D012175", "start": 21, "end": 23}]}
{"text": "Difficulties in the ascertainment of [E1] C9 deficiency [/E1] lessons to be drawn from a compound heterozygote C9 deficient subject A group of patients with long surviving mismatched kidney allografts were investigated for complement function using haemolytic assays in agarose gels One patient was found to have no", "mention_data": [{"mention": "C9 deficiency", "kb_id": "613825", "start": 5, "end": 8}]}
{"text": "Difficulties in the ascertainment of C9 deficiency lessons to be drawn from a compound heterozygote [E1] C9 deficient [/E1] subject A group of patients with long surviving mismatched kidney allografts were investigated for complement function using haemolytic assays in agarose gels One patient was found to have no alternative pathway activity but a low normal classical pathway Surprisingly", "mention_data": [{"mention": "C9 deficient", "kb_id": "613825", "start": 15, "end": 18}]}
{"text": "for all components except C9 which was functionally absent The patient was shown to be heterozygous for DNA markers in the C6 C7 and C9 region of chromosome 5 and therefore appears to be a compound heterozygote for two uncharacterized [E1] C9 deficiency [/E1] genes Serological analysis by ELISA revealed that he has trace concentrations of a non functional C9 molecule Western blot analysis was not sufficiently sensitive to permit detection of this molecule We hypothesize that the patient is heterozygous for a", "mention_data": [{"mention": "C9 deficiency", "kb_id": "613825", "start": 104, "end": 107}]}
{"text": "deficiency genes Serological analysis by ELISA revealed that he has trace concentrations of a non functional C9 molecule Western blot analysis was not sufficiently sensitive to permit detection of this molecule We hypothesize that the patient is heterozygous for a [E1] complete deficiency of C9 [/E1] and for a gene directing hyposynthesis of a defective C9 We also suggest that C9 deficiency may be more common among Caucasians than has been reported", "mention_data": [{"mention": "complete deficiency of C9", "kb_id": "613825", "start": 145, "end": 150}]}
{"text": "Western blot analysis was not sufficiently sensitive to permit detection of this molecule We hypothesize that the patient is heterozygous for a complete deficiency of C9 and for a gene directing hyposynthesis of a defective C9 We also suggest that [E1] C9 deficiency [/E1] may be more common among Caucasians than has been reported", "mention_data": [{"mention": "C9 deficiency", "kb_id": "613825", "start": 163, "end": 166}]}
{"text": "Moderate intergenerational and somatic instability of a 55 CTG repeat in transgenic mice [E1] Myotonic dystrophy [/E1] DM is associated with the expansion of a CTG n trinucleotide repeat in the 3 untranslated region UTR of the DM protein kinase gene DMPK The CTG n repeat is polymorphic and varies in size between 5 and 37", "mention_data": [{"mention": "Myotonic dystrophy", "kb_id": "D009223", "start": 13, "end": 16}]}
{"text": "Moderate intergenerational and somatic instability of a 55 CTG repeat in transgenic mice Myotonic dystrophy [E1] DM [/E1] is associated with the expansion of a CTG n trinucleotide repeat in the 3 untranslated region UTR of the DM protein kinase gene DMPK The CTG n repeat is polymorphic and varies in size between 5 and 37 repeats", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 15, "end": 17}]}
{"text": "Moderate intergenerational and somatic instability of a 55 CTG repeat in transgenic mice Myotonic dystrophy DM is associated with the expansion of a CTG n trinucleotide repeat in the 3 untranslated region UTR of the [E1] DM [/E1] protein kinase gene DMPK The CTG n repeat is polymorphic and varies in size between 5 and 37 repeats in unaffected individuals whereas in affected patients there are between 50 and 4 000 CTGs The size of the CTG", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 35, "end": 37}]}
{"text": "through generations generally correlates with clinical severity and age of onset The instability of the CTG repeat appears to depend on its size as well as on the sex of the transmitting parent Moreover mitotic instability analysis of different human [E1] DM [/E1] tissues shows length mosaicism between different cell lineages The molecular mechanisms of triplet instability remain elusive To investigate the role of genomic sequences in instability we produced transgenic mice containing a 45 kb genomic segment with a 55 CTG", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 119, "end": 121}]}
{"text": "Mutations in the arginine rich protein gene ARP in [E1] pancreatic cancer [/E1] The ARP gene encodes a highly conserved arginine rich protein from chromosomal band 3p21 1 1 At the cytogenetic level this region is frequently deleted in a variety of different solid tumors although not in pancreatic cancer We have", "mention_data": [{"mention": "pancreatic cancer", "kb_id": "D010190", "start": 9, "end": 12}]}
{"text": "in the arginine rich protein gene ARP in pancreatic cancer The ARP gene encodes a highly conserved arginine rich protein from chromosomal band 3p21 1 1 At the cytogenetic level this region is frequently deleted in a variety of different [E1] solid tumors [/E1] although not in pancreatic cancer We have reported the presence of a specific mutation ATG50 AGG or deletion of codon 50 of the ARP gene in different tumor types Shridhar et al 1996 1996a In the present study we", "mention_data": [{"mention": "solid tumors", "kb_id": "D009369", "start": 41, "end": 44}]}
{"text": "gene ARP in pancreatic cancer The ARP gene encodes a highly conserved arginine rich protein from chromosomal band 3p21 1 1 At the cytogenetic level this region is frequently deleted in a variety of different solid tumors although not in [E1] pancreatic cancer [/E1] We have reported the presence of a specific mutation ATG50 AGG or deletion of codon 50 of the ARP gene in different tumor types Shridhar et al 1996 1996a In the present study we have observed mutations involving codon", "mention_data": [{"mention": "pancreatic cancer", "kb_id": "D010190", "start": 46, "end": 49}]}
{"text": "level this region is frequently deleted in a variety of different solid tumors although not in pancreatic cancer We have reported the presence of a specific mutation ATG50 AGG or deletion of codon 50 of the ARP gene in different [E1] tumor types [/E1] Shridhar et al 1996 1996a In the present study we have observed mutations involving codon 50 in 11 of 37 pancreatic tumors The frequency of codon 50 mutation is roughly the same in pancreatic tumors as in the other", "mention_data": [{"mention": "tumor types", "kb_id": "D009369", "start": 70, "end": 73}]}
{"text": "presence of a specific mutation ATG50 AGG or deletion of codon 50 of the ARP gene in different tumor types Shridhar et al 1996 1996a In the present study we have observed mutations involving codon 50 in 11 of 37 [E1] pancreatic tumors [/E1] The frequency of codon 50 mutation is roughly the same in pancreatic tumors as in the other types of tumors previously examined In addition we have detected mutations at codon 51 in multiple PCR subclones in two other pancreatic", "mention_data": [{"mention": "pancreatic tumors", "kb_id": "D010190", "start": 92, "end": 95}]}
{"text": "the ARP gene in different tumor types Shridhar et al 1996 1996a In the present study we have observed mutations involving codon 50 in 11 of 37 pancreatic tumors The frequency of codon 50 mutation is roughly the same in [E1] pancreatic tumors [/E1] as in the other types of tumors previously examined In addition we have detected mutations at codon 51 in multiple PCR subclones in two other pancreatic tumors Mutations in the ARP gene are thus commonly observed in pancreatic cancer", "mention_data": [{"mention": "pancreatic tumors", "kb_id": "D010190", "start": 105, "end": 108}]}
{"text": "et al 1996 1996a In the present study we have observed mutations involving codon 50 in 11 of 37 pancreatic tumors The frequency of codon 50 mutation is roughly the same in pancreatic tumors as in the other types of [E1] tumors [/E1] previously examined In addition we have detected mutations at codon 51 in multiple PCR subclones in two other pancreatic tumors Mutations in the ARP gene are thus commonly observed in pancreatic cancer as well as many other cancers", "mention_data": [{"mention": "tumors", "kb_id": "D009369", "start": 113, "end": 115}]}
{"text": "pancreatic tumors The frequency of codon 50 mutation is roughly the same in pancreatic tumors as in the other types of tumors previously examined In addition we have detected mutations at codon 51 in multiple PCR subclones in two other [E1] pancreatic tumors [/E1] Mutations in the ARP gene are thus commonly observed in pancreatic cancer as well as many other cancers", "mention_data": [{"mention": "pancreatic tumors", "kb_id": "D010190", "start": 132, "end": 135}]}
{"text": "in pancreatic tumors as in the other types of tumors previously examined In addition we have detected mutations at codon 51 in multiple PCR subclones in two other pancreatic tumors Mutations in the ARP gene are thus commonly observed in [E1] pancreatic cancer [/E1] as well as many other cancers", "mention_data": [{"mention": "pancreatic cancer", "kb_id": "D010190", "start": 144, "end": 147}]}
{"text": "types of tumors previously examined In addition we have detected mutations at codon 51 in multiple PCR subclones in two other pancreatic tumors Mutations in the ARP gene are thus commonly observed in pancreatic cancer as well as many other [E1] cancers [/E1]", "mention_data": [{"mention": "cancers", "kb_id": "D009369", "start": 151, "end": 153}]}
{"text": "Heterogeneity in [E1] Schwartz Jampel chondrodystrophic myotonia [/E1] The Schwartz Jampel syndrome SJS chondrodystrophic myotonia McK 255 800 is a recessively inherited condition defined by myotonia short stature and bone dysplasia Genetic linkage between SJS and chromosomal region 1q36 34 has been observed in several families but", "mention_data": [{"mention": "Schwartz Jampel chondrodystrophic myotonia", "kb_id": "255800", "start": 2, "end": 7}]}
{"text": "Heterogeneity in Schwartz Jampel chondrodystrophic myotonia The [E1] Schwartz Jampel syndrome [/E1] SJS chondrodystrophic myotonia McK 255 800 is a recessively inherited condition defined by myotonia short stature and bone dysplasia Genetic linkage between SJS and chromosomal region 1q36 34 has been observed in several families but the gene has not", "mention_data": [{"mention": "Schwartz Jampel syndrome", "kb_id": "255800", "start": 7, "end": 11}]}
{"text": "Heterogeneity in Schwartz Jampel chondrodystrophic myotonia The Schwartz Jampel syndrome [E1] SJS [/E1] chondrodystrophic myotonia McK 255 800 is a recessively inherited condition defined by myotonia short stature and bone dysplasia Genetic linkage between SJS and chromosomal region 1q36 34 has been observed in several families but the gene has not yet", "mention_data": [{"mention": "SJS", "kb_id": "255800", "start": 10, "end": 12}]}
{"text": "Heterogeneity in Schwartz Jampel chondrodystrophic myotonia The Schwartz Jampel syndrome SJS [E1] chondrodystrophic myotonia [/E1] McK 255 800 is a recessively inherited condition defined by myotonia short stature and bone dysplasia Genetic linkage between SJS and chromosomal region 1q36 34 has been observed in several families but the gene has not yet been identified", "mention_data": [{"mention": "chondrodystrophic myotonia", "kb_id": "255800", "start": 11, "end": 14}]}
{"text": "Heterogeneity in Schwartz Jampel chondrodystrophic myotonia The Schwartz Jampel syndrome SJS chondrodystrophic myotonia McK 255 800 is a [E1] recessively inherited condition [/E1] defined by myotonia short stature and bone dysplasia Genetic linkage between SJS and chromosomal region 1q36 34 has been observed in several families but the gene has not yet been identified We studied the clinical and radiological features in", "mention_data": [{"mention": "recessively inherited condition", "kb_id": "D030342", "start": 18, "end": 22}]}
{"text": "Heterogeneity in Schwartz Jampel chondrodystrophic myotonia The Schwartz Jampel syndrome SJS chondrodystrophic myotonia McK 255 800 is a recessively inherited condition defined by [E1] myotonia [/E1] short stature and bone dysplasia Genetic linkage between SJS and chromosomal region 1q36 34 has been observed in several families but the gene has not yet been identified We studied the clinical and radiological features in 81 patients from", "mention_data": [{"mention": "myotonia", "kb_id": "D009222", "start": 23, "end": 25}]}
{"text": "Heterogeneity in Schwartz Jampel chondrodystrophic myotonia The Schwartz Jampel syndrome SJS chondrodystrophic myotonia McK 255 800 is a recessively inherited condition defined by myotonia [E1] short stature [/E1] and bone dysplasia Genetic linkage between SJS and chromosomal region 1q36 34 has been observed in several families but the gene has not yet been identified We studied the clinical and radiological features in 81 patients from the literature", "mention_data": [{"mention": "short stature", "kb_id": "D006130", "start": 24, "end": 27}]}
{"text": "Heterogeneity in Schwartz Jampel chondrodystrophic myotonia The Schwartz Jampel syndrome SJS chondrodystrophic myotonia McK 255 800 is a recessively inherited condition defined by myotonia short stature and [E1] bone dysplasia [/E1] Genetic linkage between SJS and chromosomal region 1q36 34 has been observed in several families but the gene has not yet been identified We studied the clinical and radiological features in 81 patients from the literature and 5 own", "mention_data": [{"mention": "bone dysplasia", "kb_id": "D001848", "start": 27, "end": 30}]}
{"text": "Heterogeneity in Schwartz Jampel chondrodystrophic myotonia The Schwartz Jampel syndrome SJS chondrodystrophic myotonia McK 255 800 is a recessively inherited condition defined by myotonia short stature and bone dysplasia Genetic linkage between [E1] SJS [/E1] and chromosomal region 1q36 34 has been observed in several families but the gene has not yet been identified We studied the clinical and radiological features in 81 patients from the literature and 5 own patients trying to identify", "mention_data": [{"mention": "SJS", "kb_id": "255800", "start": 32, "end": 34}]}
{"text": "several families but the gene has not yet been identified We studied the clinical and radiological features in 81 patients from the literature and 5 own patients trying to identify distinct subgroups In addition we tested genetic linkage to the [E1] SJS [/E1] locus on chromosome 1 in one family with two affected sibs We found that a group of patients have mild skeletal changes which may be secondary consequences of myotonia while another group of patients appear to have primary bone", "mention_data": [{"mention": "SJS", "kb_id": "255800", "start": 82, "end": 84}]}
{"text": "identify distinct subgroups In addition we tested genetic linkage to the SJS locus on chromosome 1 in one family with two affected sibs We found that a group of patients have mild skeletal changes which may be secondary consequences of [E1] myotonia [/E1] while another group of patients appear to have primary bone dysplasia with myotonia Within this latter group there are differences in age of manifestation clinical course and pattern of bone changes We tentatively isolate three different types of SJS", "mention_data": [{"mention": "myotonia", "kb_id": "D009222", "start": 111, "end": 113}]}
{"text": "the SJS locus on chromosome 1 in one family with two affected sibs We found that a group of patients have mild skeletal changes which may be secondary consequences of myotonia while another group of patients appear to have primary [E1] bone dysplasia [/E1] with myotonia Within this latter group there are differences in age of manifestation clinical course and pattern of bone changes We tentatively isolate three different types of SJS type 1A usually recognized in childhood with moderate bone dysplasia corresponding", "mention_data": [{"mention": "bone dysplasia", "kb_id": "D001848", "start": 121, "end": 124}]}
{"text": "on chromosome 1 in one family with two affected sibs We found that a group of patients have mild skeletal changes which may be secondary consequences of myotonia while another group of patients appear to have primary bone dysplasia with [E1] myotonia [/E1] Within this latter group there are differences in age of manifestation clinical course and pattern of bone changes We tentatively isolate three different types of SJS type 1A usually recognized in childhood with moderate bone dysplasia corresponding to the", "mention_data": [{"mention": "myotonia", "kb_id": "D009222", "start": 124, "end": 126}]}
{"text": "of myotonia while another group of patients appear to have primary bone dysplasia with myotonia Within this latter group there are differences in age of manifestation clinical course and pattern of bone changes We tentatively isolate three different types of [E1] SJS type 1A [/E1] usually recognized in childhood with moderate bone dysplasia corresponding to the original descriptions of Schwartz Jampel and Aberfeld type 1B similar to type 1A but recognizable at birth with more pronounced bone dysplasia resembling Kniest dysplasia and type 2", "mention_data": [{"mention": "SJS type 1A", "kb_id": "255800", "start": 150, "end": 154}]}
{"text": "have primary bone dysplasia with myotonia Within this latter group there are differences in age of manifestation clinical course and pattern of bone changes We tentatively isolate three different types of SJS type 1A usually recognized in childhood with moderate [E1] bone dysplasia [/E1] corresponding to the original descriptions of Schwartz Jampel and Aberfeld type 1B similar to type 1A but recognizable at birth with more pronounced bone dysplasia resembling Kniest dysplasia and type 2 manifest at birth with increased mortality and bone", "mention_data": [{"mention": "bone dysplasia", "kb_id": "D001848", "start": 159, "end": 162}]}
{"text": "tentatively isolate three different types of SJS type 1A usually recognized in childhood with moderate bone dysplasia corresponding to the original descriptions of Schwartz Jampel and Aberfeld type 1B similar to type 1A but recognizable at birth with more pronounced [E1] bone dysplasia [/E1] resembling Kniest dysplasia and type 2 manifest at birth with increased mortality and bone dysplasia resembling Pyle disease Genetic analysis of the family with two sibs affected by SJS type 2 showed evidence against linkage to chromosome 1p36 34", "mention_data": [{"mention": "bone dysplasia", "kb_id": "D001848", "start": 184, "end": 187}]}
{"text": "different types of SJS type 1A usually recognized in childhood with moderate bone dysplasia corresponding to the original descriptions of Schwartz Jampel and Aberfeld type 1B similar to type 1A but recognizable at birth with more pronounced bone dysplasia resembling [E1] Kniest dysplasia [/E1] and type 2 manifest at birth with increased mortality and bone dysplasia resembling Pyle disease Genetic analysis of the family with two sibs affected by SJS type 2 showed evidence against linkage to chromosome 1p36 34 CONCLUSIONS SJS is", "mention_data": [{"mention": "Kniest dysplasia", "kb_id": "C537207", "start": 187, "end": 190}]}
{"text": "bone dysplasia corresponding to the original descriptions of Schwartz Jampel and Aberfeld type 1B similar to type 1A but recognizable at birth with more pronounced bone dysplasia resembling Kniest dysplasia and type 2 manifest at birth with increased mortality and [E1] bone dysplasia [/E1] resembling Pyle disease Genetic analysis of the family with two sibs affected by SJS type 2 showed evidence against linkage to chromosome 1p36 34 CONCLUSIONS SJS is clinically and radiologically heterogeneous The causes of heterogeneity are not known yet", "mention_data": [{"mention": "bone dysplasia", "kb_id": "D001848", "start": 199, "end": 202}]}
{"text": "to the original descriptions of Schwartz Jampel and Aberfeld type 1B similar to type 1A but recognizable at birth with more pronounced bone dysplasia resembling Kniest dysplasia and type 2 manifest at birth with increased mortality and bone dysplasia resembling [E1] Pyle disease [/E1] Genetic analysis of the family with two sibs affected by SJS type 2 showed evidence against linkage to chromosome 1p36 34 CONCLUSIONS SJS is clinically and radiologically heterogeneous The causes of heterogeneity are not known yet but are likely", "mention_data": [{"mention": "Pyle disease", "kb_id": "C536252", "start": 202, "end": 205}]}
{"text": "to type 1A but recognizable at birth with more pronounced bone dysplasia resembling Kniest dysplasia and type 2 manifest at birth with increased mortality and bone dysplasia resembling Pyle disease Genetic analysis of the family with two sibs affected by [E1] SJS type 2 [/E1] showed evidence against linkage to chromosome 1p36 34 CONCLUSIONS SJS is clinically and radiologically heterogeneous The causes of heterogeneity are not known yet but are likely to include both different mutations at the SJS locus on chromosome 1 and", "mention_data": [{"mention": "SJS type 2", "kb_id": "C537502", "start": 214, "end": 218}]}
{"text": "resembling Kniest dysplasia and type 2 manifest at birth with increased mortality and bone dysplasia resembling Pyle disease Genetic analysis of the family with two sibs affected by SJS type 2 showed evidence against linkage to chromosome 1p36 34 CONCLUSIONS [E1] SJS [/E1] is clinically and radiologically heterogeneous The causes of heterogeneity are not known yet but are likely to include both different mutations at the SJS locus on chromosome 1 and the presence of a second SJS locus A tentative clinico", "mention_data": [{"mention": "SJS", "kb_id": "255800", "start": 226, "end": 228}]}
{"text": "two sibs affected by SJS type 2 showed evidence against linkage to chromosome 1p36 34 CONCLUSIONS SJS is clinically and radiologically heterogeneous The causes of heterogeneity are not known yet but are likely to include both different mutations at the [E1] SJS [/E1] locus on chromosome 1 and the presence of a second SJS locus A tentative clinico radiological classification can be useful for the characterization of patients and the development of genotype phenotype correlations", "mention_data": [{"mention": "SJS", "kb_id": "255800", "start": 250, "end": 252}]}
{"text": "to chromosome 1p36 34 CONCLUSIONS SJS is clinically and radiologically heterogeneous The causes of heterogeneity are not known yet but are likely to include both different mutations at the SJS locus on chromosome 1 and the presence of a second [E1] SJS [/E1] locus A tentative clinico radiological classification can be useful for the characterization of patients and the development of genotype phenotype correlations", "mention_data": [{"mention": "SJS", "kb_id": "255800", "start": 261, "end": 263}]}
{"text": "[E1] X linked adrenoleukodystrophy [/E1] is a frequent cause of idiopathic Addison s disease in young adult male patients X Linked adrenoleukodystrophy ALD is a genetic disease associated with demyelination of the central nervous system adrenal insufficiency and accumulation of very long chain fatty", "mention_data": [{"mention": "X linked adrenoleukodystrophy", "kb_id": "D000326", "start": 0, "end": 4}]}
{"text": "X linked adrenoleukodystrophy is a frequent cause of idiopathic [E1] Addison s disease [/E1] in young adult male patients X Linked adrenoleukodystrophy ALD is a genetic disease associated with demyelination of the central nervous system adrenal insufficiency and accumulation of very long chain fatty acids in tissue and body fluids ALD is due", "mention_data": [{"mention": "Addison s disease", "kb_id": "D000224", "start": 9, "end": 13}]}
{"text": "X linked adrenoleukodystrophy is a frequent cause of idiopathic Addison s disease in young adult male patients [E1] X Linked adrenoleukodystrophy [/E1] ALD is a genetic disease associated with demyelination of the central nervous system adrenal insufficiency and accumulation of very long chain fatty acids in tissue and body fluids ALD is due to mutation of a gene located in Xq28", "mention_data": [{"mention": "X Linked adrenoleukodystrophy", "kb_id": "D000326", "start": 17, "end": 21}]}
{"text": "X linked adrenoleukodystrophy is a frequent cause of idiopathic Addison s disease in young adult male patients X Linked adrenoleukodystrophy [E1] ALD [/E1] is a genetic disease associated with demyelination of the central nervous system adrenal insufficiency and accumulation of very long chain fatty acids in tissue and body fluids ALD is due to mutation of a gene located in Xq28 that", "mention_data": [{"mention": "ALD", "kb_id": "D000326", "start": 20, "end": 22}]}
{"text": "X linked adrenoleukodystrophy is a frequent cause of idiopathic Addison s disease in young adult male patients X Linked adrenoleukodystrophy ALD is a [E1] genetic disease [/E1] associated with demyelination of the central nervous system adrenal insufficiency and accumulation of very long chain fatty acids in tissue and body fluids ALD is due to mutation of a gene located in Xq28 that encodes a peroxisomal transporter", "mention_data": [{"mention": "genetic disease", "kb_id": "D030342", "start": 23, "end": 26}]}
{"text": "X linked adrenoleukodystrophy is a frequent cause of idiopathic Addison s disease in young adult male patients X Linked adrenoleukodystrophy ALD is a genetic disease associated with [E1] demyelination of the central nervous system [/E1] adrenal insufficiency and accumulation of very long chain fatty acids in tissue and body fluids ALD is due to mutation of a gene located in Xq28 that encodes a peroxisomal transporter protein of unknown function The most common phenotype", "mention_data": [{"mention": "demyelination of the central nervous system", "kb_id": "D020279", "start": 27, "end": 34}]}
{"text": "X linked adrenoleukodystrophy is a frequent cause of idiopathic Addison s disease in young adult male patients X Linked adrenoleukodystrophy ALD is a genetic disease associated with demyelination of the central nervous system [E1] adrenal insufficiency [/E1] and accumulation of very long chain fatty acids in tissue and body fluids ALD is due to mutation of a gene located in Xq28 that encodes a peroxisomal transporter protein of unknown function The most common phenotype of ALD", "mention_data": [{"mention": "adrenal insufficiency", "kb_id": "D000309", "start": 33, "end": 36}]}
{"text": "idiopathic Addison s disease in young adult male patients X Linked adrenoleukodystrophy ALD is a genetic disease associated with demyelination of the central nervous system adrenal insufficiency and accumulation of very long chain fatty acids in tissue and body fluids [E1] ALD [/E1] is due to mutation of a gene located in Xq28 that encodes a peroxisomal transporter protein of unknown function The most common phenotype of ALD is the cerebral form 45 that develops in boys between 5 12 yr Adrenomyeloneuropathy", "mention_data": [{"mention": "ALD", "kb_id": "D000326", "start": 48, "end": 50}]}
{"text": "adrenal insufficiency and accumulation of very long chain fatty acids in tissue and body fluids ALD is due to mutation of a gene located in Xq28 that encodes a peroxisomal transporter protein of unknown function The most common phenotype of [E1] ALD [/E1] is the cerebral form 45 that develops in boys between 5 12 yr Adrenomyeloneuropathy AMN involves the spinal cord and peripheral nerves in young adults 35 Adrenal insufficiency Addisons disease is frequently associated with AMN or cerebral ALD and", "mention_data": [{"mention": "ALD", "kb_id": "D000326", "start": 73, "end": 75}]}
{"text": "fluids ALD is due to mutation of a gene located in Xq28 that encodes a peroxisomal transporter protein of unknown function The most common phenotype of ALD is the cerebral form 45 that develops in boys between 5 12 yr [E1] Adrenomyeloneuropathy [/E1] AMN involves the spinal cord and peripheral nerves in young adults 35 Adrenal insufficiency Addisons disease is frequently associated with AMN or cerebral ALD and may remain the only clinical expression of ALD 8 of cases The prevalence of", "mention_data": [{"mention": "Adrenomyeloneuropathy", "kb_id": "D000326", "start": 87, "end": 89}]}
{"text": "ALD is due to mutation of a gene located in Xq28 that encodes a peroxisomal transporter protein of unknown function The most common phenotype of ALD is the cerebral form 45 that develops in boys between 5 12 yr Adrenomyeloneuropathy [E1] AMN [/E1] involves the spinal cord and peripheral nerves in young adults 35 Adrenal insufficiency Addisons disease is frequently associated with AMN or cerebral ALD and may remain the only clinical expression of ALD 8 of cases The prevalence of ALD", "mention_data": [{"mention": "AMN", "kb_id": "D000326", "start": 88, "end": 90}]}
{"text": "encodes a peroxisomal transporter protein of unknown function The most common phenotype of ALD is the cerebral form 45 that develops in boys between 5 12 yr Adrenomyeloneuropathy AMN involves the spinal cord and peripheral nerves in young adults 35 [E1] Adrenal insufficiency [/E1] Addisons disease is frequently associated with AMN or cerebral ALD and may remain the only clinical expression of ALD 8 of cases The prevalence of ALD among adults with Addisons disease remains unknown To evaluate this prevalence we performed", "mention_data": [{"mention": "Adrenal insufficiency", "kb_id": "D000309", "start": 100, "end": 103}]}
{"text": "peroxisomal transporter protein of unknown function The most common phenotype of ALD is the cerebral form 45 that develops in boys between 5 12 yr Adrenomyeloneuropathy AMN involves the spinal cord and peripheral nerves in young adults 35 Adrenal insufficiency [E1] Addisons disease [/E1] is frequently associated with AMN or cerebral ALD and may remain the only clinical expression of ALD 8 of cases The prevalence of ALD among adults with Addisons disease remains unknown To evaluate this prevalence we performed biochemical analysis", "mention_data": [{"mention": "Addisons disease", "kb_id": "D000224", "start": 102, "end": 105}]}
{"text": "The most common phenotype of ALD is the cerebral form 45 that develops in boys between 5 12 yr Adrenomyeloneuropathy AMN involves the spinal cord and peripheral nerves in young adults 35 Adrenal insufficiency Addisons disease is frequently associated with [E1] AMN [/E1] or cerebral ALD and may remain the only clinical expression of ALD 8 of cases The prevalence of ALD among adults with Addisons disease remains unknown To evaluate this prevalence we performed biochemical analysis of very long chain fatty", "mention_data": [{"mention": "AMN", "kb_id": "D000326", "start": 108, "end": 110}]}
{"text": "common phenotype of ALD is the cerebral form 45 that develops in boys between 5 12 yr Adrenomyeloneuropathy AMN involves the spinal cord and peripheral nerves in young adults 35 Adrenal insufficiency Addisons disease is frequently associated with AMN or [E1] cerebral ALD [/E1] and may remain the only clinical expression of ALD 8 of cases The prevalence of ALD among adults with Addisons disease remains unknown To evaluate this prevalence we performed biochemical analysis of very long chain fatty acids in 14", "mention_data": [{"mention": "cerebral ALD", "kb_id": "D000326", "start": 110, "end": 113}]}
{"text": "develops in boys between 5 12 yr Adrenomyeloneuropathy AMN involves the spinal cord and peripheral nerves in young adults 35 Adrenal insufficiency Addisons disease is frequently associated with AMN or cerebral ALD and may remain the only clinical expression of [E1] ALD [/E1] 8 of cases The prevalence of ALD among adults with Addisons disease remains unknown To evaluate this prevalence we performed biochemical analysis of very long chain fatty acids in 14 male patients age ranging from 12 45 yr at", "mention_data": [{"mention": "ALD", "kb_id": "D000326", "start": 120, "end": 122}]}
{"text": "Adrenomyeloneuropathy AMN involves the spinal cord and peripheral nerves in young adults 35 Adrenal insufficiency Addisons disease is frequently associated with AMN or cerebral ALD and may remain the only clinical expression of ALD 8 of cases The prevalence of [E1] ALD [/E1] among adults with Addisons disease remains unknown To evaluate this prevalence we performed biochemical analysis of very long chain fatty acids in 14 male patients age ranging from 12 45 yr at diagnosis previously diagnosed as having primary idiopathic", "mention_data": [{"mention": "ALD", "kb_id": "D000326", "start": 127, "end": 129}]}
{"text": "spinal cord and peripheral nerves in young adults 35 Adrenal insufficiency Addisons disease is frequently associated with AMN or cerebral ALD and may remain the only clinical expression of ALD 8 of cases The prevalence of ALD among adults with [E1] Addisons disease [/E1] remains unknown To evaluate this prevalence we performed biochemical analysis of very long chain fatty acids in 14 male patients age ranging from 12 45 yr at diagnosis previously diagnosed as having primary idiopathic adrenocortical insufficiency In 5 of", "mention_data": [{"mention": "Addisons disease", "kb_id": "D000224", "start": 131, "end": 134}]}
{"text": "ALD among adults with Addisons disease remains unknown To evaluate this prevalence we performed biochemical analysis of very long chain fatty acids in 14 male patients age ranging from 12 45 yr at diagnosis previously diagnosed as having primary idiopathic [E1] adrenocortical insufficiency [/E1] In 5 of 14 patients 35 elevated plasma concentrations of very long chain fatty acids were detected None of these patients had adrenocortical antibodies By electrophysiological tests and magnetic resonance imaging it was determined that two patients had cerebral", "mention_data": [{"mention": "adrenocortical insufficiency", "kb_id": "D000224", "start": 167, "end": 170}]}
{"text": "adrenocortical insufficiency In 5 of 14 patients 35 elevated plasma concentrations of very long chain fatty acids were detected None of these patients had adrenocortical antibodies By electrophysiological tests and magnetic resonance imaging it was determined that two patients had [E1] cerebral ALD [/E1] one had adrenomyeloneuropathy with cerebral involvement and two had preclinical AMN Our data support the hypothesis that ALD is a frequent cause of idiopathic Addisons disease in children and adults", "mention_data": [{"mention": "cerebral ALD", "kb_id": "D000326", "start": 207, "end": 210}]}
{"text": "of 14 patients 35 elevated plasma concentrations of very long chain fatty acids were detected None of these patients had adrenocortical antibodies By electrophysiological tests and magnetic resonance imaging it was determined that two patients had cerebral ALD one had [E1] adrenomyeloneuropathy [/E1] with cerebral involvement and two had preclinical AMN Our data support the hypothesis that ALD is a frequent cause of idiopathic Addisons disease in children and adults", "mention_data": [{"mention": "adrenomyeloneuropathy", "kb_id": "D000326", "start": 211, "end": 213}]}
{"text": "very long chain fatty acids were detected None of these patients had adrenocortical antibodies By electrophysiological tests and magnetic resonance imaging it was determined that two patients had cerebral ALD one had adrenomyeloneuropathy with cerebral involvement and two had preclinical [E1] AMN [/E1] Our data support the hypothesis that ALD is a frequent cause of idiopathic Addisons disease in children and adults", "mention_data": [{"mention": "AMN", "kb_id": "D000326", "start": 219, "end": 221}]}
{"text": "None of these patients had adrenocortical antibodies By electrophysiological tests and magnetic resonance imaging it was determined that two patients had cerebral ALD one had adrenomyeloneuropathy with cerebral involvement and two had preclinical AMN Our data support the hypothesis that [E1] ALD [/E1] is a frequent cause of idiopathic Addisons disease in children and adults", "mention_data": [{"mention": "ALD", "kb_id": "D000326", "start": 226, "end": 228}]}
{"text": "By electrophysiological tests and magnetic resonance imaging it was determined that two patients had cerebral ALD one had adrenomyeloneuropathy with cerebral involvement and two had preclinical AMN Our data support the hypothesis that ALD is a frequent cause of idiopathic [E1] Addisons disease [/E1] in children and adults", "mention_data": [{"mention": "Addisons disease", "kb_id": "D000224", "start": 233, "end": 236}]}
{"text": "Low incidence of BRCA2 mutations in [E1] breast carcinoma [/E1] and other cancers Inherited mutant alleles of familial tumour suppressor genes predispose individuals to particular types of cancer In addition to an involvement in inherited susceptibility to cancer these tumour suppressor genes are targets for somatic mutations in sporadic", "mention_data": [{"mention": "breast carcinoma", "kb_id": "D001943", "start": 6, "end": 9}]}
{"text": "Low incidence of BRCA2 mutations in breast carcinoma and other [E1] cancers [/E1] Inherited mutant alleles of familial tumour suppressor genes predispose individuals to particular types of cancer In addition to an involvement in inherited susceptibility to cancer these tumour suppressor genes are targets for somatic mutations in sporadic cancers of the", "mention_data": [{"mention": "cancers", "kb_id": "D009369", "start": 10, "end": 12}]}
{"text": "Low incidence of BRCA2 mutations in breast carcinoma and other cancers Inherited mutant alleles of familial [E1] tumour [/E1] suppressor genes predispose individuals to particular types of cancer In addition to an involvement in inherited susceptibility to cancer these tumour suppressor genes are targets for somatic mutations in sporadic cancers of the same type found in the familial", "mention_data": [{"mention": "tumour", "kb_id": "D009369", "start": 16, "end": 18}]}
{"text": "Low incidence of BRCA2 mutations in breast carcinoma and other cancers Inherited mutant alleles of familial tumour suppressor genes predispose individuals to particular types of [E1] cancer [/E1] In addition to an involvement in inherited susceptibility to cancer these tumour suppressor genes are targets for somatic mutations in sporadic cancers of the same type found in the familial forms An exception is BRCA1 which contributes to a", "mention_data": [{"mention": "cancer", "kb_id": "D009369", "start": 25, "end": 27}]}
{"text": "Low incidence of BRCA2 mutations in breast carcinoma and other cancers Inherited mutant alleles of familial tumour suppressor genes predispose individuals to particular types of cancer In addition to an involvement in inherited susceptibility to [E1] cancer [/E1] these tumour suppressor genes are targets for somatic mutations in sporadic cancers of the same type found in the familial forms An exception is BRCA1 which contributes to a significant fraction of familial breast and ovarian cancer but undergoes", "mention_data": [{"mention": "cancer", "kb_id": "D009369", "start": 35, "end": 37}]}
{"text": "Low incidence of BRCA2 mutations in breast carcinoma and other cancers Inherited mutant alleles of familial tumour suppressor genes predispose individuals to particular types of cancer In addition to an involvement in inherited susceptibility to cancer these [E1] tumour [/E1] suppressor genes are targets for somatic mutations in sporadic cancers of the same type found in the familial forms An exception is BRCA1 which contributes to a significant fraction of familial breast and ovarian cancer but undergoes mutation at", "mention_data": [{"mention": "tumour", "kb_id": "D009369", "start": 37, "end": 39}]}
{"text": "breast carcinoma and other cancers Inherited mutant alleles of familial tumour suppressor genes predispose individuals to particular types of cancer In addition to an involvement in inherited susceptibility to cancer these tumour suppressor genes are targets for somatic mutations in [E1] sporadic cancers [/E1] of the same type found in the familial forms An exception is BRCA1 which contributes to a significant fraction of familial breast and ovarian cancer but undergoes mutation at very low rates in sporadic breast and ovarian cancers This", "mention_data": [{"mention": "sporadic cancers", "kb_id": "D009369", "start": 46, "end": 49}]}
{"text": "to an involvement in inherited susceptibility to cancer these tumour suppressor genes are targets for somatic mutations in sporadic cancers of the same type found in the familial forms An exception is BRCA1 which contributes to a significant fraction of [E1] familial breast and ovarian cancer [/E1] but undergoes mutation at very low rates in sporadic breast and ovarian cancers This finding suggests that other genes may be the principal targets for somatic mutation in breast carcinoma A second recently identified familial breast cancer gene BRCA2", "mention_data": [{"mention": "familial breast and ovarian cancer", "kb_id": "D061325", "start": 68, "end": 74}]}
{"text": "targets for somatic mutations in sporadic cancers of the same type found in the familial forms An exception is BRCA1 which contributes to a significant fraction of familial breast and ovarian cancer but undergoes mutation at very low rates in [E1] sporadic breast and ovarian cancers [/E1] This finding suggests that other genes may be the principal targets for somatic mutation in breast carcinoma A second recently identified familial breast cancer gene BRCA2 refs 5 8 accounts for a proportion of breast cancer roughly equal to", "mention_data": [{"mention": "sporadic breast and ovarian cancers", "kb_id": "D001943|D010051", "start": 81, "end": 87}]}
{"text": "which contributes to a significant fraction of familial breast and ovarian cancer but undergoes mutation at very low rates in sporadic breast and ovarian cancers This finding suggests that other genes may be the principal targets for somatic mutation in [E1] breast carcinoma [/E1] A second recently identified familial breast cancer gene BRCA2 refs 5 8 accounts for a proportion of breast cancer roughly equal to BRCA1 Like BRCA1 BRCA2 behaves as a dominantly inherited tumour suppressor gene Individuals who inherit one mutant", "mention_data": [{"mention": "breast carcinoma", "kb_id": "D001943", "start": 101, "end": 104}]}
{"text": "of familial breast and ovarian cancer but undergoes mutation at very low rates in sporadic breast and ovarian cancers This finding suggests that other genes may be the principal targets for somatic mutation in breast carcinoma A second recently identified [E1] familial breast cancer [/E1] gene BRCA2 refs 5 8 accounts for a proportion of breast cancer roughly equal to BRCA1 Like BRCA1 BRCA2 behaves as a dominantly inherited tumour suppressor gene Individuals who inherit one mutant allele are at increased risk for breast", "mention_data": [{"mention": "familial breast cancer", "kb_id": "D001943", "start": 107, "end": 111}]}
{"text": "in sporadic breast and ovarian cancers This finding suggests that other genes may be the principal targets for somatic mutation in breast carcinoma A second recently identified familial breast cancer gene BRCA2 refs 5 8 accounts for a proportion of [E1] breast cancer [/E1] roughly equal to BRCA1 Like BRCA1 BRCA2 behaves as a dominantly inherited tumour suppressor gene Individuals who inherit one mutant allele are at increased risk for breast cancer and the tumours they develop lose the wild type allele by", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 120, "end": 123}]}
{"text": "the principal targets for somatic mutation in breast carcinoma A second recently identified familial breast cancer gene BRCA2 refs 5 8 accounts for a proportion of breast cancer roughly equal to BRCA1 Like BRCA1 BRCA2 behaves as a dominantly inherited [E1] tumour [/E1] suppressor gene Individuals who inherit one mutant allele are at increased risk for breast cancer and the tumours they develop lose the wild type allele by heterozygous deletion The BRCA2 coding sequence is huge composed of 26 exons that", "mention_data": [{"mention": "tumour", "kb_id": "D009369", "start": 134, "end": 136}]}
{"text": "breast cancer gene BRCA2 refs 5 8 accounts for a proportion of breast cancer roughly equal to BRCA1 Like BRCA1 BRCA2 behaves as a dominantly inherited tumour suppressor gene Individuals who inherit one mutant allele are at increased risk for [E1] breast cancer [/E1] and the tumours they develop lose the wild type allele by heterozygous deletion The BRCA2 coding sequence is huge composed of 26 exons that span 10 443 bp Here we investigate the rate of BRCA2 mutation in sporadic breast", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 148, "end": 151}]}
{"text": "refs 5 8 accounts for a proportion of breast cancer roughly equal to BRCA1 Like BRCA1 BRCA2 behaves as a dominantly inherited tumour suppressor gene Individuals who inherit one mutant allele are at increased risk for breast cancer and the [E1] tumours [/E1] they develop lose the wild type allele by heterozygous deletion The BRCA2 coding sequence is huge composed of 26 exons that span 10 443 bp Here we investigate the rate of BRCA2 mutation in sporadic breast cancers and in", "mention_data": [{"mention": "tumours", "kb_id": "D009369", "start": 152, "end": 154}]}
{"text": "for breast cancer and the tumours they develop lose the wild type allele by heterozygous deletion The BRCA2 coding sequence is huge composed of 26 exons that span 10 443 bp Here we investigate the rate of BRCA2 mutation in [E1] sporadic breast cancers [/E1] and in a set of cell lines that represent twelve other tumour types Surprisingly mutations in BRCA2 are infrequent in cancers including breast carcinoma However a probable germline mutation in a pancreatic tumour cell line suggests a role for", "mention_data": [{"mention": "sporadic breast cancers", "kb_id": "D001943", "start": 187, "end": 191}]}
{"text": "heterozygous deletion The BRCA2 coding sequence is huge composed of 26 exons that span 10 443 bp Here we investigate the rate of BRCA2 mutation in sporadic breast cancers and in a set of cell lines that represent twelve other [E1] tumour [/E1] types Surprisingly mutations in BRCA2 are infrequent in cancers including breast carcinoma However a probable germline mutation in a pancreatic tumour cell line suggests a role for BRCA2 in susceptibility to pancreatic cancer", "mention_data": [{"mention": "tumour", "kb_id": "D009369", "start": 201, "end": 203}]}
{"text": "of 26 exons that span 10 443 bp Here we investigate the rate of BRCA2 mutation in sporadic breast cancers and in a set of cell lines that represent twelve other tumour types Surprisingly mutations in BRCA2 are infrequent in [E1] cancers [/E1] including breast carcinoma However a probable germline mutation in a pancreatic tumour cell line suggests a role for BRCA2 in susceptibility to pancreatic cancer", "mention_data": [{"mention": "cancers", "kb_id": "D009369", "start": 210, "end": 212}]}
{"text": "exons that span 10 443 bp Here we investigate the rate of BRCA2 mutation in sporadic breast cancers and in a set of cell lines that represent twelve other tumour types Surprisingly mutations in BRCA2 are infrequent in cancers including [E1] breast carcinoma [/E1] However a probable germline mutation in a pancreatic tumour cell line suggests a role for BRCA2 in susceptibility to pancreatic cancer", "mention_data": [{"mention": "breast carcinoma", "kb_id": "D001943", "start": 212, "end": 215}]}
{"text": "the rate of BRCA2 mutation in sporadic breast cancers and in a set of cell lines that represent twelve other tumour types Surprisingly mutations in BRCA2 are infrequent in cancers including breast carcinoma However a probable germline mutation in a [E1] pancreatic tumour [/E1] cell line suggests a role for BRCA2 in susceptibility to pancreatic cancer", "mention_data": [{"mention": "pancreatic tumour", "kb_id": "D010190", "start": 221, "end": 224}]}
{"text": "set of cell lines that represent twelve other tumour types Surprisingly mutations in BRCA2 are infrequent in cancers including breast carcinoma However a probable germline mutation in a pancreatic tumour cell line suggests a role for BRCA2 in susceptibility to [E1] pancreatic cancer [/E1]", "mention_data": [{"mention": "pancreatic cancer", "kb_id": "D010190", "start": 233, "end": 236}]}
{"text": "in early embryos and throughout embryogenesis In the adult type III collagen is a major component of the extracellular matrix in a variety of internal organs and skin Mutations in the COL3A1 gene have been implicated as a cause of [E1] type IV Ehlers Danlos syndrome [/E1] a disease leading to aortic rupture in early adult life To directly study the role of Col3a1 in development and disease we have inactivated the Col3a1 gene in embryonic stem cells by homologous recombination The mutated allele was transmitted", "mention_data": [{"mention": "type IV Ehlers Danlos syndrome", "kb_id": "D004535", "start": 70, "end": 76}]}
{"text": "type III collagen is a major component of the extracellular matrix in a variety of internal organs and skin Mutations in the COL3A1 gene have been implicated as a cause of type IV Ehlers Danlos syndrome a disease leading to [E1] aortic rupture [/E1] in early adult life To directly study the role of Col3a1 in development and disease we have inactivated the Col3a1 gene in embryonic stem cells by homologous recombination The mutated allele was transmitted through the mouse germ line and", "mention_data": [{"mention": "aortic rupture", "kb_id": "D001019", "start": 79, "end": 82}]}
{"text": "10 of the homozygous mutant animals survived to adulthood but have a much shorter life span compared with wild type mice The major cause of death of mutant mice was rupture of the major blood vessels similar to patients with [E1] type IV Ehlers Danlos syndrome [/E1] Ultrastructural analysis of tissues from mutant mice revealed that type III collagen is essential for normal collagen I fibrillogenesis in the cardiovascular system and other organs", "mention_data": [{"mention": "type IV Ehlers Danlos syndrome", "kb_id": "D004535", "start": 169, "end": 175}]}
{"text": "The incidence of PAX6 mutation in patients with simple [E1] aniridia [/E1] an evaluation of mutation detection in 12 cases Twelve aniridia patients five with a family history and seven presumed to be sporadic were exhaustively screened in order to test what proportion of people with aniridia uncomplicated by associated anomalies", "mention_data": [{"mention": "aniridia", "kb_id": "D015783", "start": 9, "end": 11}]}
{"text": "The incidence of PAX6 mutation in patients with simple aniridia an evaluation of mutation detection in 12 cases Twelve [E1] aniridia [/E1] patients five with a family history and seven presumed to be sporadic were exhaustively screened in order to test what proportion of people with aniridia uncomplicated by associated anomalies carry mutations in the human PAX6 gene Mutations were detected", "mention_data": [{"mention": "aniridia", "kb_id": "D015783", "start": 19, "end": 21}]}
{"text": "mutation in patients with simple aniridia an evaluation of mutation detection in 12 cases Twelve aniridia patients five with a family history and seven presumed to be sporadic were exhaustively screened in order to test what proportion of people with [E1] aniridia [/E1] uncomplicated by associated anomalies carry mutations in the human PAX6 gene Mutations were detected in 90 of the cases Three mutation detection techniques were used to determine if one method was superior for this gene The protein truncation test", "mention_data": [{"mention": "aniridia", "kb_id": "D015783", "start": 44, "end": 46}]}
{"text": "Germline mutations in the 3 part of [E1] APC [/E1] exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli Familial adenomatous polyposis FAP is an inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal", "mention_data": [{"mention": "APC", "kb_id": "D011125", "start": 7, "end": 9}]}
{"text": "Germline mutations in the 3 part of APC exon 15 do not result in truncated proteins and are associated with attenuated [E1] adenomatous polyposis coli [/E1] Familial adenomatous polyposis FAP is an inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal region Germline mutations in the adenomatous polyposis coli APC gene are responsible for most cases of", "mention_data": [{"mention": "adenomatous polyposis coli", "kb_id": "D011125", "start": 21, "end": 25}]}
{"text": "Germline mutations in the 3 part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli [E1] Familial adenomatous polyposis [/E1] FAP is an inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal region Germline mutations in the adenomatous polyposis coli APC gene are responsible for most cases of FAP Mutations at", "mention_data": [{"mention": "Familial adenomatous polyposis", "kb_id": "D011125", "start": 24, "end": 28}]}
{"text": "Germline mutations in the 3 part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli Familial adenomatous polyposis [E1] FAP [/E1] is an inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal region Germline mutations in the adenomatous polyposis coli APC gene are responsible for most cases of FAP Mutations at the", "mention_data": [{"mention": "FAP", "kb_id": "D011125", "start": 27, "end": 29}]}
{"text": "Germline mutations in the 3 part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli Familial adenomatous polyposis FAP is an inherited predisposition to [E1] colorectal cancer [/E1] characterized by the development of numerous adenomatous polyps predominantly in the colorectal region Germline mutations in the adenomatous polyposis coli APC gene are responsible for most cases of FAP Mutations at the 5 end of APC are known to", "mention_data": [{"mention": "colorectal cancer", "kb_id": "D015179", "start": 33, "end": 36}]}
{"text": "mutations in the 3 part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli Familial adenomatous polyposis FAP is an inherited predisposition to colorectal cancer characterized by the development of numerous [E1] adenomatous polyps [/E1] predominantly in the colorectal region Germline mutations in the adenomatous polyposis coli APC gene are responsible for most cases of FAP Mutations at the 5 end of APC are known to be associated with a relatively mild form of", "mention_data": [{"mention": "adenomatous polyps", "kb_id": "D018256", "start": 41, "end": 44}]}
{"text": "result in truncated proteins and are associated with attenuated adenomatous polyposis coli Familial adenomatous polyposis FAP is an inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal region Germline mutations in the [E1] adenomatous polyposis coli [/E1] APC gene are responsible for most cases of FAP Mutations at the 5 end of APC are known to be associated with a relatively mild form of the disease called attenuated adenomatous polyposis coli AAPC We identified a frameshift", "mention_data": [{"mention": "adenomatous polyposis coli", "kb_id": "D011125", "start": 52, "end": 56}]}
{"text": "proteins and are associated with attenuated adenomatous polyposis coli Familial adenomatous polyposis FAP is an inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal region Germline mutations in the adenomatous polyposis coli [E1] APC [/E1] gene are responsible for most cases of FAP Mutations at the 5 end of APC are known to be associated with a relatively mild form of the disease called attenuated adenomatous polyposis coli AAPC We identified a frameshift mutation", "mention_data": [{"mention": "APC", "kb_id": "D011125", "start": 55, "end": 57}]}
{"text": "coli Familial adenomatous polyposis FAP is an inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal region Germline mutations in the adenomatous polyposis coli APC gene are responsible for most cases of [E1] FAP [/E1] Mutations at the 5 end of APC are known to be associated with a relatively mild form of the disease called attenuated adenomatous polyposis coli AAPC We identified a frameshift mutation in the 3 part of exon 15 resulting", "mention_data": [{"mention": "FAP", "kb_id": "D011125", "start": 63, "end": 65}]}
{"text": "inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal region Germline mutations in the adenomatous polyposis coli APC gene are responsible for most cases of FAP Mutations at the 5 end of [E1] APC [/E1] are known to be associated with a relatively mild form of the disease called attenuated adenomatous polyposis coli AAPC We identified a frameshift mutation in the 3 part of exon 15 resulting in a stop codon at 1862 in", "mention_data": [{"mention": "APC", "kb_id": "D011125", "start": 70, "end": 72}]}
{"text": "the colorectal region Germline mutations in the adenomatous polyposis coli APC gene are responsible for most cases of FAP Mutations at the 5 end of APC are known to be associated with a relatively mild form of the disease called [E1] attenuated adenomatous polyposis coli [/E1] AAPC We identified a frameshift mutation in the 3 part of exon 15 resulting in a stop codon at 1862 in a large Dutch kindred with AAPC Western blot analysis of lymphoblastoid cell lines derived from affected family members", "mention_data": [{"mention": "attenuated adenomatous polyposis coli", "kb_id": "C538265", "start": 85, "end": 90}]}
{"text": "mutations in the adenomatous polyposis coli APC gene are responsible for most cases of FAP Mutations at the 5 end of APC are known to be associated with a relatively mild form of the disease called attenuated adenomatous polyposis coli [E1] AAPC [/E1] We identified a frameshift mutation in the 3 part of exon 15 resulting in a stop codon at 1862 in a large Dutch kindred with AAPC Western blot analysis of lymphoblastoid cell lines derived from affected family members from", "mention_data": [{"mention": "AAPC", "kb_id": "C538265", "start": 89, "end": 91}]}
{"text": "associated with a relatively mild form of the disease called attenuated adenomatous polyposis coli AAPC We identified a frameshift mutation in the 3 part of exon 15 resulting in a stop codon at 1862 in a large Dutch kindred with [E1] AAPC [/E1] Western blot analysis of lymphoblastoid cell lines derived from affected family members from this kindred as well as from a previously reported Swiss family carrying a frameshift mutation at codon 1987 and displaying a similar attenuated phenotype showed only", "mention_data": [{"mention": "AAPC", "kb_id": "C538265", "start": 115, "end": 117}]}
{"text": "analysis of lymphoblastoid cell lines derived from affected family members from this kindred as well as from a previously reported Swiss family carrying a frameshift mutation at codon 1987 and displaying a similar attenuated phenotype showed only the wild type [E1] APC [/E1] protein Our study indicates that chain terminating mutations located in the 3 part of APC do not result in detectable truncated polypeptides and we hypothesize that this is likely to be the basis for the observed AAPC phenotype", "mention_data": [{"mention": "APC", "kb_id": "D011125", "start": 158, "end": 160}]}
{"text": "as from a previously reported Swiss family carrying a frameshift mutation at codon 1987 and displaying a similar attenuated phenotype showed only the wild type APC protein Our study indicates that chain terminating mutations located in the 3 part of [E1] APC [/E1] do not result in detectable truncated polypeptides and we hypothesize that this is likely to be the basis for the observed AAPC phenotype", "mention_data": [{"mention": "APC", "kb_id": "D011125", "start": 173, "end": 175}]}
{"text": "the wild type APC protein Our study indicates that chain terminating mutations located in the 3 part of APC do not result in detectable truncated polypeptides and we hypothesize that this is likely to be the basis for the observed [E1] AAPC [/E1] phenotype", "mention_data": [{"mention": "AAPC", "kb_id": "C538265", "start": 195, "end": 197}]}
{"text": "Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human [E1] Huntington disease [/E1] transcript The mutation underlying Huntington disease HD is CAG expansion in the first exon of the HD gene In order to investigate the role of CAG expansion in the pathogenesis of HD we have produced transgenic mice containing the", "mention_data": [{"mention": "Huntington disease", "kb_id": "D006816", "start": 17, "end": 20}]}
{"text": "Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript The mutation underlying [E1] Huntington disease [/E1] HD is CAG expansion in the first exon of the HD gene In order to investigate the role of CAG expansion in the pathogenesis of HD we have produced transgenic mice containing the full length human HD cDNA with", "mention_data": [{"mention": "Huntington disease", "kb_id": "D006816", "start": 23, "end": 26}]}
{"text": "Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript The mutation underlying Huntington disease [E1] HD [/E1] is CAG expansion in the first exon of the HD gene In order to investigate the role of CAG expansion in the pathogenesis of HD we have produced transgenic mice containing the full length human HD cDNA with 44", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 25, "end": 27}]}
{"text": "Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript The mutation underlying Huntington disease HD is CAG expansion in the first exon of the [E1] HD [/E1] gene In order to investigate the role of CAG expansion in the pathogenesis of HD we have produced transgenic mice containing the full length human HD cDNA with 44 CAG repeats By 1 year these mice have no behavioral", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 35, "end": 37}]}
{"text": "repeat in transgenic mice expressing the human Huntington disease transcript The mutation underlying Huntington disease HD is CAG expansion in the first exon of the HD gene In order to investigate the role of CAG expansion in the pathogenesis of [E1] HD [/E1] we have produced transgenic mice containing the full length human HD cDNA with 44 CAG repeats By 1 year these mice have no behavioral abnormalities and morphometric analysis at 6 one animal and 9 two animals months age revealed", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 50, "end": 52}]}
{"text": "mutation underlying Huntington disease HD is CAG expansion in the first exon of the HD gene In order to investigate the role of CAG expansion in the pathogenesis of HD we have produced transgenic mice containing the full length human [E1] HD [/E1] cDNA with 44 CAG repeats By 1 year these mice have no behavioral abnormalities and morphometric analysis at 6 one animal and 9 two animals months age revealed no changes Despite high levels of mRNA expression there was no", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 61, "end": 63}]}
{"text": "the HD gene In order to investigate the role of CAG expansion in the pathogenesis of HD we have produced transgenic mice containing the full length human HD cDNA with 44 CAG repeats By 1 year these mice have no [E1] behavioral abnormalities [/E1] and morphometric analysis at 6 one animal and 9 two animals months age revealed no changes Despite high levels of mRNA expression there was no evidence of the HD gene product in any of these transgenic mice In vitro", "mention_data": [{"mention": "behavioral abnormalities", "kb_id": "D001523", "start": 74, "end": 77}]}
{"text": "44 CAG repeats By 1 year these mice have no behavioral abnormalities and morphometric analysis at 6 one animal and 9 two animals months age revealed no changes Despite high levels of mRNA expression there was no evidence of the [E1] HD [/E1] gene product in any of these transgenic mice In vitro transfection studies indicated that the inclusion of 120 bp of the 5 UTR in the cDNA construct and the presence of a frameshift mutation at nucleotide 2349 prevented expression", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 104, "end": 106}]}
{"text": "product in any of these transgenic mice In vitro transfection studies indicated that the inclusion of 120 bp of the 5 UTR in the cDNA construct and the presence of a frameshift mutation at nucleotide 2349 prevented expression of the [E1] HD [/E1] cDNA These findings suggest that the pathogenesis of HD is not mediated through DNA protein interaction and that presence of the RNA transcript with an expanded CAG repeat is insufficient to cause the disease Rather translation of the CAG", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 146, "end": 148}]}
{"text": "transfection studies indicated that the inclusion of 120 bp of the 5 UTR in the cDNA construct and the presence of a frameshift mutation at nucleotide 2349 prevented expression of the HD cDNA These findings suggest that the pathogenesis of [E1] HD [/E1] is not mediated through DNA protein interaction and that presence of the RNA transcript with an expanded CAG repeat is insufficient to cause the disease Rather translation of the CAG is crucial for the pathogenesis of HD In contrast", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 155, "end": 157}]}
{"text": "the pathogenesis of HD is not mediated through DNA protein interaction and that presence of the RNA transcript with an expanded CAG repeat is insufficient to cause the disease Rather translation of the CAG is crucial for the pathogenesis of [E1] HD [/E1] In contrast to that seen in humans the CAG repeat in these mice was remarkably stable in 97 meioses This suggests that genomic sequences may play a critical role in influencing repeat instability", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 192, "end": 194}]}
{"text": "the future of medicine We have designed high density arrays consisting of over 96 600 oligonucleotides 20 nucleotides nt in length to screen for a wide range of heterozygous mutations in the 3 45 kilobases kb exon 11 of the [E1] hereditary breast and ovarian cancer [/E1] gene BRCA1 Reference and test samples were co hybridized to these arrays and differences in hybridization patterns quantitated by two colour analysis Fourteen of fifteen patient samples with known mutations were accurately diagnosed and no false positive mutations were", "mention_data": [{"mention": "hereditary breast and ovarian cancer", "kb_id": "D061325", "start": 81, "end": 87}]}
{"text": "Colchicine in breast milk of patients with [E1] familial Mediterranean fever [/E1] OBJECTIVE To clarify whether colchicine is excreted in breast milk and to compare its concentrations in the serum and breast milk of lactating women who have familial Mediterranean fever FMF METHODS Using a specific radioimmunoassay we determined colchicine concentrations", "mention_data": [{"mention": "familial Mediterranean fever", "kb_id": "D010505", "start": 7, "end": 11}]}
{"text": "Colchicine in breast milk of patients with familial Mediterranean fever OBJECTIVE To clarify whether colchicine is excreted in breast milk and to compare its concentrations in the serum and breast milk of lactating women who have [E1] familial Mediterranean fever [/E1] FMF METHODS Using a specific radioimmunoassay we determined colchicine concentrations in the serum and breast milk of 4 patients at various time points following oral administration of the drug The study evaluated 4 patients with FMF who had been", "mention_data": [{"mention": "familial Mediterranean fever", "kb_id": "D010505", "start": 36, "end": 40}]}
{"text": "Colchicine in breast milk of patients with familial Mediterranean fever OBJECTIVE To clarify whether colchicine is excreted in breast milk and to compare its concentrations in the serum and breast milk of lactating women who have familial Mediterranean fever [E1] FMF [/E1] METHODS Using a specific radioimmunoassay we determined colchicine concentrations in the serum and breast milk of 4 patients at various time points following oral administration of the drug The study evaluated 4 patients with FMF who had been taking", "mention_data": [{"mention": "FMF", "kb_id": "D010505", "start": 39, "end": 41}]}
{"text": "who have familial Mediterranean fever FMF METHODS Using a specific radioimmunoassay we determined colchicine concentrations in the serum and breast milk of 4 patients at various time points following oral administration of the drug The study evaluated 4 patients with [E1] FMF [/E1] who had been taking colchicine on a long term basis RESULTS Colchicine was found to be excreted in breast milk Its levels ranged between 1 9 and 8 6 ng/ml which were similar to those found in the serum", "mention_data": [{"mention": "FMF", "kb_id": "D010505", "start": 74, "end": 76}]}
{"text": "CONCLUSION The extensive peripheral tissue binding and relatively low concentration of colchicine in breast milk suggests that the amount ingested by the infant is small Furthermore based on our clinical experience nursing appears to be safe for lactating women with [E1] FMF [/E1] who continue to take colchicine", "mention_data": [{"mention": "FMF", "kb_id": "D010505", "start": 191, "end": 193}]}
{"text": "the gene structure The ninth component of human complement C9 is the last of the terminal complement components creating the membrane attack complex C9 is a single chain serum protein that is encoded by a gene located on chromosome 5p [E1] Deficiency of terminal complement components [/E1] is generally associated with recurrent neisseria infections We studied a previously described Swiss family with inherited C9 deficiency To identify the genetic basis of C9 deficiency we developed an approach using exon specific PCR and direct DNA sequencing As", "mention_data": [{"mention": "Deficiency of terminal complement components", "kb_id": "D007153", "start": 54, "end": 60}]}
{"text": "is the last of the terminal complement components creating the membrane attack complex C9 is a single chain serum protein that is encoded by a gene located on chromosome 5p Deficiency of terminal complement components is generally associated with recurrent [E1] neisseria infections [/E1] We studied a previously described Swiss family with inherited C9 deficiency To identify the genetic basis of C9 deficiency we developed an approach using exon specific PCR and direct DNA sequencing As a cause of C9 deficiency we found", "mention_data": [{"mention": "neisseria infections", "kb_id": "D016870", "start": 64, "end": 67}]}
{"text": "membrane attack complex C9 is a single chain serum protein that is encoded by a gene located on chromosome 5p Deficiency of terminal complement components is generally associated with recurrent neisseria infections We studied a previously described Swiss family with [E1] inherited C9 deficiency [/E1] To identify the genetic basis of C9 deficiency we developed an approach using exon specific PCR and direct DNA sequencing As a cause of C9 deficiency we found two different point mutations both generating TGA stop codons in the", "mention_data": [{"mention": "inherited C9 deficiency", "kb_id": "613825", "start": 74, "end": 78}]}
{"text": "protein that is encoded by a gene located on chromosome 5p Deficiency of terminal complement components is generally associated with recurrent neisseria infections We studied a previously described Swiss family with inherited C9 deficiency To identify the genetic basis of [E1] C9 deficiency [/E1] we developed an approach using exon specific PCR and direct DNA sequencing As a cause of C9 deficiency we found two different point mutations both generating TGA stop codons in the coding sequence One mutation a C to A", "mention_data": [{"mention": "C9 deficiency", "kb_id": "613825", "start": 83, "end": 86}]}
{"text": "associated with recurrent neisseria infections We studied a previously described Swiss family with inherited C9 deficiency To identify the genetic basis of C9 deficiency we developed an approach using exon specific PCR and direct DNA sequencing As a cause of [E1] C9 deficiency [/E1] we found two different point mutations both generating TGA stop codons in the coding sequence One mutation a C to A exchange was detected in exon 2 at cDNA position 166 the other a C to T exchange was", "mention_data": [{"mention": "C9 deficiency", "kb_id": "613825", "start": 101, "end": 104}]}
{"text": "mutation a C to A exchange was detected in exon 2 at cDNA position 166 the other a C to T exchange was located in exon 4 cDNA position 464 In family studies of three first degree relatives with heterozygous [E1] C9 deficiency [/E1] we demonstrated that the two mutations are segregating independently Therefore these mutations are sufficient to explain the complete deficiency of both the probands studied DNA sequencing of the exon intron junctions revealed a number of revisions regarding the boundaries", "mention_data": [{"mention": "C9 deficiency", "kb_id": "613825", "start": 159, "end": 162}]}
{"text": "Molecular heterogeneity of [E1] classical and Duarte galactosemia [/E1] mutation analysis by denaturing gradient gel electrophoresis Classical galactosemia is caused by one common missense mutation Q188R and by several rare mutations in the galactose 1 phosphate uridyltransferase GALT gene The most common variant of GALT the Duarte variant", "mention_data": [{"mention": "classical and Duarte galactosemia", "kb_id": "D005693", "start": 3, "end": 8}]}
{"text": "Molecular heterogeneity of classical and Duarte galactosemia mutation analysis by denaturing gradient gel electrophoresis [E1] Classical galactosemia [/E1] is caused by one common missense mutation Q188R and by several rare mutations in the galactose 1 phosphate uridyltransferase GALT gene The most common variant of GALT the Duarte variant occurs as two types Duarte 1 D 1 and", "mention_data": [{"mention": "Classical galactosemia", "kb_id": "D005693", "start": 14, "end": 17}]}
{"text": "GALT the Duarte variant occurs as two types Duarte 1 D 1 and Duarte 2 D 2 both of which carry the sequence change N314D D 1 increases whereas D 2 decreases GALT activity To study the molecular genetics of [E1] classical and Duarte galactosemia [/E1] we analyzed the GALT mutations in 30 families with classical galactosemia in 10 families with the D 2 variant and in 3 individuals carrying the D 1 allele by denaturing gradient gel electrophoresis DGGE DGGE detected 59 of the", "mention_data": [{"mention": "classical and Duarte galactosemia", "kb_id": "D005693", "start": 82, "end": 87}]}
{"text": "Duarte 2 D 2 both of which carry the sequence change N314D D 1 increases whereas D 2 decreases GALT activity To study the molecular genetics of classical and Duarte galactosemia we analyzed the GALT mutations in 30 families with [E1] classical galactosemia [/E1] in 10 families with the D 2 variant and in 3 individuals carrying the D 1 allele by denaturing gradient gel electrophoresis DGGE DGGE detected 59 of the 60 classical galactosemia alleles Q188R accounted for 60 K285N accounted for", "mention_data": [{"mention": "classical galactosemia", "kb_id": "D005693", "start": 95, "end": 98}]}
{"text": "analyzed the GALT mutations in 30 families with classical galactosemia in 10 families with the D 2 variant and in 3 individuals carrying the D 1 allele by denaturing gradient gel electrophoresis DGGE DGGE detected 59 of the 60 classical [E1] galactosemia [/E1] alleles Q188R accounted for 60 K285N accounted for 28 of these alleles Eight novel candidate galactosemia mutations were found On all D 2 alleles N314D occurred in cis with two intronic sequence changes on the D 1 alleles in", "mention_data": [{"mention": "galactosemia", "kb_id": "D005693", "start": 127, "end": 129}]}
{"text": "2 variant and in 3 individuals carrying the D 1 allele by denaturing gradient gel electrophoresis DGGE DGGE detected 59 of the 60 classical galactosemia alleles Q188R accounted for 60 K285N accounted for 28 of these alleles Eight novel candidate [E1] galactosemia [/E1] mutations were found On all D 2 alleles N314D occurred in cis with two intronic sequence changes on the D 1 alleles in cis with a neutral mutation in exon 7 We conclude that the mutations causing galactosemia are", "mention_data": [{"mention": "galactosemia", "kb_id": "D005693", "start": 143, "end": 145}]}
{"text": "novel candidate galactosemia mutations were found On all D 2 alleles N314D occurred in cis with two intronic sequence changes on the D 1 alleles in cis with a neutral mutation in exon 7 We conclude that the mutations causing [E1] galactosemia [/E1] are highly heterogeneous and that K285N is a second common galactosemia mutation in our population", "mention_data": [{"mention": "galactosemia", "kb_id": "D005693", "start": 181, "end": 183}]}
{"text": "N314D occurred in cis with two intronic sequence changes on the D 1 alleles in cis with a neutral mutation in exon 7 We conclude that the mutations causing galactosemia are highly heterogeneous and that K285N is a second common [E1] galactosemia [/E1] mutation in our population", "mention_data": [{"mention": "galactosemia", "kb_id": "D005693", "start": 192, "end": 194}]}
{"text": "Nonsense mutation in exon 3 of the proteolipid protein gene PLP in a family with an unusual form of [E1] Pelizaeus Merzbacher disease [/E1] We report a G A transition at nucleotide 431 of the proteolipid protein gene PLP results in a nonsense codon in a family with an unusual form of Pelizaeus Merzbacher disease PMD The mutation which creates a second AluI", "mention_data": [{"mention": "Pelizaeus Merzbacher disease", "kb_id": "312080", "start": 19, "end": 23}]}
{"text": "PLP in a family with an unusual form of Pelizaeus Merzbacher disease We report a G A transition at nucleotide 431 of the proteolipid protein gene PLP results in a nonsense codon in a family with an unusual form of [E1] Pelizaeus Merzbacher disease [/E1] PMD The mutation which creates a second AluI restriction site results in a nonsense mutation in PLP The clinical picture resembles somewhat that of X linked spastic paraplegia SPG It differs from this and both the classical and connatal", "mention_data": [{"mention": "Pelizaeus Merzbacher disease", "kb_id": "312080", "start": 50, "end": 54}]}
{"text": "family with an unusual form of Pelizaeus Merzbacher disease We report a G A transition at nucleotide 431 of the proteolipid protein gene PLP results in a nonsense codon in a family with an unusual form of Pelizaeus Merzbacher disease [E1] PMD [/E1] The mutation which creates a second AluI restriction site results in a nonsense mutation in PLP The clinical picture resembles somewhat that of X linked spastic paraplegia SPG It differs from this and both the classical and connatal forms", "mention_data": [{"mention": "PMD", "kb_id": "312080", "start": 53, "end": 55}]}
{"text": "results in a nonsense codon in a family with an unusual form of Pelizaeus Merzbacher disease PMD The mutation which creates a second AluI restriction site results in a nonsense mutation in PLP The clinical picture resembles somewhat that of [E1] X linked spastic paraplegia [/E1] SPG It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form onset is delayed beyond age 2 years nystagmus is absent tremors are prominent mental retardation is not", "mention_data": [{"mention": "X linked spastic paraplegia", "kb_id": "312920", "start": 77, "end": 82}]}
{"text": "codon in a family with an unusual form of Pelizaeus Merzbacher disease PMD The mutation which creates a second AluI restriction site results in a nonsense mutation in PLP The clinical picture resembles somewhat that of X linked spastic paraplegia [E1] SPG [/E1] It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form onset is delayed beyond age 2 years nystagmus is absent tremors are prominent mental retardation is not severe", "mention_data": [{"mention": "SPG", "kb_id": "312920", "start": 81, "end": 83}]}
{"text": "The mutation which creates a second AluI restriction site results in a nonsense mutation in PLP The clinical picture resembles somewhat that of X linked spastic paraplegia SPG It differs from this and both the classical and connatal forms of [E1] PMD [/E1] in that it is relatively mild in form onset is delayed beyond age 2 years nystagmus is absent tremors are prominent mental retardation is not severe some patients show dementia or personality disorders the disease is progressive rather than", "mention_data": [{"mention": "PMD", "kb_id": "312080", "start": 94, "end": 96}]}
{"text": "The clinical picture resembles somewhat that of X linked spastic paraplegia SPG It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form onset is delayed beyond age 2 years [E1] nystagmus [/E1] is absent tremors are prominent mental retardation is not severe some patients show dementia or personality disorders the disease is progressive rather than static in some and several females show signs of disease The nonsense mutation which is in", "mention_data": [{"mention": "nystagmus", "kb_id": "D020417", "start": 110, "end": 112}]}
{"text": "resembles somewhat that of X linked spastic paraplegia SPG It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form onset is delayed beyond age 2 years nystagmus is absent [E1] tremors [/E1] are prominent mental retardation is not severe some patients show dementia or personality disorders the disease is progressive rather than static in some and several females show signs of disease The nonsense mutation which is in exon 3B should", "mention_data": [{"mention": "tremors", "kb_id": "D014202", "start": 113, "end": 115}]}
{"text": "of X linked spastic paraplegia SPG It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form onset is delayed beyond age 2 years nystagmus is absent tremors are prominent [E1] mental retardation [/E1] is not severe some patients show dementia or personality disorders the disease is progressive rather than static in some and several females show signs of disease The nonsense mutation which is in exon 3B should block the synthesis of", "mention_data": [{"mention": "mental retardation", "kb_id": "D008607", "start": 116, "end": 119}]}
{"text": "from this and both the classical and connatal forms of PMD in that it is relatively mild in form onset is delayed beyond age 2 years nystagmus is absent tremors are prominent mental retardation is not severe some patients show [E1] dementia [/E1] or personality disorders the disease is progressive rather than static in some and several females show signs of disease The nonsense mutation which is in exon 3B should block the synthesis of normal PLP but spare DM20 the isoform", "mention_data": [{"mention": "dementia", "kb_id": "D003704", "start": 124, "end": 126}]}
{"text": "and both the classical and connatal forms of PMD in that it is relatively mild in form onset is delayed beyond age 2 years nystagmus is absent tremors are prominent mental retardation is not severe some patients show dementia or [E1] personality disorders [/E1] the disease is progressive rather than static in some and several females show signs of disease The nonsense mutation which is in exon 3B should block the synthesis of normal PLP but spare DM20 the isoform whose persistence has", "mention_data": [{"mention": "personality disorders", "kb_id": "D010554", "start": 126, "end": 129}]}
{"text": "than static in some and several females show signs of disease The nonsense mutation which is in exon 3B should block the synthesis of normal PLP but spare DM20 the isoform whose persistence has been associated with mild forms of [E1] PLP associated disease [/E1] in both humans and mice", "mention_data": [{"mention": "PLP associated disease", "kb_id": "312080|312920", "start": 173, "end": 177}]}
{"text": "The hybrid PAX3 FKHR fusion protein of [E1] alveolar rhabdomyosarcoma [/E1] transforms fibroblasts in culture Pediatric alveolar rhabdomyosarcoma is characterized by a chromosomal translocation that fuses parts of the PAX3 and FKHR genes PAX3 codes for a transcriptional regulator that controls developmental programs and FKHR codes for a forkhead winged", "mention_data": [{"mention": "alveolar rhabdomyosarcoma", "kb_id": "D018232", "start": 7, "end": 10}]}
{"text": "The hybrid PAX3 FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture [E1] Pediatric alveolar rhabdomyosarcoma [/E1] is characterized by a chromosomal translocation that fuses parts of the PAX3 and FKHR genes PAX3 codes for a transcriptional regulator that controls developmental programs and FKHR codes for a forkhead winged helix protein also a likely transcription factor", "mention_data": [{"mention": "Pediatric alveolar rhabdomyosarcoma", "kb_id": "D018232", "start": 13, "end": 17}]}
{"text": "A clinical overview of WT1 gene mutations Mutations in the WT1 gene were anticipated to explain the genetic basis of the childhood [E1] kidney cancer [/E1] Wilms tumour WT Six years on we review 100 reports of intragenic WT1 mutations and examine the accompanying clinical phenotypes While only 5 of sporadic Wilms tumours have intragenic WT1 mutations 90 of patients with the Denys Drash syndrome", "mention_data": [{"mention": "kidney cancer", "kb_id": "D007680", "start": 22, "end": 25}]}
{"text": "A clinical overview of WT1 gene mutations Mutations in the WT1 gene were anticipated to explain the genetic basis of the childhood kidney cancer [E1] Wilms tumour [/E1] WT Six years on we review 100 reports of intragenic WT1 mutations and examine the accompanying clinical phenotypes While only 5 of sporadic Wilms tumours have intragenic WT1 mutations 90 of patients with the Denys Drash syndrome renal nephropathy", "mention_data": [{"mention": "Wilms tumour", "kb_id": "D009396", "start": 24, "end": 27}]}
{"text": "A clinical overview of WT1 gene mutations Mutations in the WT1 gene were anticipated to explain the genetic basis of the childhood kidney cancer Wilms tumour [E1] WT [/E1] Six years on we review 100 reports of intragenic WT1 mutations and examine the accompanying clinical phenotypes While only 5 of sporadic Wilms tumours have intragenic WT1 mutations 90 of patients with the Denys Drash syndrome renal nephropathy gonadal", "mention_data": [{"mention": "WT", "kb_id": "D009396", "start": 26, "end": 28}]}
{"text": "in the WT1 gene were anticipated to explain the genetic basis of the childhood kidney cancer Wilms tumour WT Six years on we review 100 reports of intragenic WT1 mutations and examine the accompanying clinical phenotypes While only 5 of [E1] sporadic Wilms tumours [/E1] have intragenic WT1 mutations 90 of patients with the Denys Drash syndrome renal nephropathy gonadal anomaly predisposition to WT carry constitutional intragenic WT1 mutations WT1 mutations have also been reported in juvenile granulosa cell tumour non asbestos related mesothelioma", "mention_data": [{"mention": "sporadic Wilms tumours", "kb_id": "D009396", "start": 48, "end": 52}]}
{"text": "the childhood kidney cancer Wilms tumour WT Six years on we review 100 reports of intragenic WT1 mutations and examine the accompanying clinical phenotypes While only 5 of sporadic Wilms tumours have intragenic WT1 mutations 90 of patients with the [E1] Denys Drash syndrome [/E1] renal nephropathy gonadal anomaly predisposition to WT carry constitutional intragenic WT1 mutations WT1 mutations have also been reported in juvenile granulosa cell tumour non asbestos related mesothelioma desmoplastic small round cell tumour and most recently acute myeloid leukemia", "mention_data": [{"mention": "Denys Drash syndrome", "kb_id": "D030321", "start": 60, "end": 64}]}
{"text": "cancer Wilms tumour WT Six years on we review 100 reports of intragenic WT1 mutations and examine the accompanying clinical phenotypes While only 5 of sporadic Wilms tumours have intragenic WT1 mutations 90 of patients with the Denys Drash syndrome [E1] renal nephropathy [/E1] gonadal anomaly predisposition to WT carry constitutional intragenic WT1 mutations WT1 mutations have also been reported in juvenile granulosa cell tumour non asbestos related mesothelioma desmoplastic small round cell tumour and most recently acute myeloid leukemia", "mention_data": [{"mention": "renal nephropathy", "kb_id": "D007674", "start": 63, "end": 66}]}
{"text": "tumour WT Six years on we review 100 reports of intragenic WT1 mutations and examine the accompanying clinical phenotypes While only 5 of sporadic Wilms tumours have intragenic WT1 mutations 90 of patients with the Denys Drash syndrome renal nephropathy [E1] gonadal anomaly [/E1] predisposition to WT carry constitutional intragenic WT1 mutations WT1 mutations have also been reported in juvenile granulosa cell tumour non asbestos related mesothelioma desmoplastic small round cell tumour and most recently acute myeloid leukemia", "mention_data": [{"mention": "gonadal anomaly", "kb_id": "D006059", "start": 65, "end": 68}]}
{"text": "Six years on we review 100 reports of intragenic WT1 mutations and examine the accompanying clinical phenotypes While only 5 of sporadic Wilms tumours have intragenic WT1 mutations 90 of patients with the Denys Drash syndrome renal nephropathy gonadal anomaly [E1] predisposition to WT [/E1] carry constitutional intragenic WT1 mutations WT1 mutations have also been reported in juvenile granulosa cell tumour non asbestos related mesothelioma desmoplastic small round cell tumour and most recently acute myeloid leukemia", "mention_data": [{"mention": "predisposition to WT", "kb_id": "D020022", "start": 67, "end": 71}]}
{"text": "clinical phenotypes While only 5 of sporadic Wilms tumours have intragenic WT1 mutations 90 of patients with the Denys Drash syndrome renal nephropathy gonadal anomaly predisposition to WT carry constitutional intragenic WT1 mutations WT1 mutations have also been reported in [E1] juvenile granulosa cell tumour [/E1] non asbestos related mesothelioma desmoplastic small round cell tumour and most recently acute myeloid leukemia", "mention_data": [{"mention": "juvenile granulosa cell tumour", "kb_id": "D006106", "start": 82, "end": 87}]}
{"text": "5 of sporadic Wilms tumours have intragenic WT1 mutations 90 of patients with the Denys Drash syndrome renal nephropathy gonadal anomaly predisposition to WT carry constitutional intragenic WT1 mutations WT1 mutations have also been reported in juvenile granulosa cell tumour [E1] non asbestos related mesothelioma [/E1] desmoplastic small round cell tumour and most recently acute myeloid leukemia", "mention_data": [{"mention": "non asbestos related mesothelioma", "kb_id": "D008654", "start": 86, "end": 91}]}
{"text": "tumours have intragenic WT1 mutations 90 of patients with the Denys Drash syndrome renal nephropathy gonadal anomaly predisposition to WT carry constitutional intragenic WT1 mutations WT1 mutations have also been reported in juvenile granulosa cell tumour non asbestos related mesothelioma [E1] desmoplastic small round cell tumour [/E1] and most recently acute myeloid leukemia", "mention_data": [{"mention": "desmoplastic small round cell tumour", "kb_id": "D058405", "start": 90, "end": 96}]}
{"text": "with the Denys Drash syndrome renal nephropathy gonadal anomaly predisposition to WT carry constitutional intragenic WT1 mutations WT1 mutations have also been reported in juvenile granulosa cell tumour non asbestos related mesothelioma desmoplastic small round cell tumour and most recently [E1] acute myeloid leukemia [/E1]", "mention_data": [{"mention": "acute myeloid leukemia", "kb_id": "D015470", "start": 98, "end": 102}]}
{"text": "Dual roles of ATM in the cellular response to radiation and in cell growth control The gene mutated in [E1] ataxia telangiectasia [/E1] AT patients denoted ATM encodes a putative protein or lipid kinase To elucidate the functions of ATM we disrupted the mouse ATM gene through homologous recombination in mice Consistent with cellular defects of AT patients the ATM / cells", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 19, "end": 22}]}
{"text": "Dual roles of ATM in the cellular response to radiation and in cell growth control The gene mutated in ataxia telangiectasia [E1] AT [/E1] patients denoted ATM encodes a putative protein or lipid kinase To elucidate the functions of ATM we disrupted the mouse ATM gene through homologous recombination in mice Consistent with cellular defects of AT patients the ATM / cells are", "mention_data": [{"mention": "AT", "kb_id": "D001260", "start": 21, "end": 23}]}
{"text": "control The gene mutated in ataxia telangiectasia AT patients denoted ATM encodes a putative protein or lipid kinase To elucidate the functions of ATM we disrupted the mouse ATM gene through homologous recombination in mice Consistent with cellular defects of [E1] AT [/E1] patients the ATM / cells are hypersensitive to gamma irradiation and defective in cell cycle arrest following radiation correlating with a defective up regulation of p53 In addition ATM / mouse thymocytes are more resistant to apoptosis induced by", "mention_data": [{"mention": "AT", "kb_id": "D001260", "start": 54, "end": 56}]}
{"text": "of p21CP1/WAF1 The ATM protein is therefore critical both for cellular responses to ionizing radiation and for normal cell cycle progression ATM / fibroblasts and thymocytes showed intermediately defective responses to irradiation but no growth defect suggesting that the increased [E1] cancer [/E1] risk of AT heterozygotes could be attributable to poor checkpoint function", "mention_data": [{"mention": "cancer", "kb_id": "D009369", "start": 168, "end": 170}]}
{"text": "ATM protein is therefore critical both for cellular responses to ionizing radiation and for normal cell cycle progression ATM / fibroblasts and thymocytes showed intermediately defective responses to irradiation but no growth defect suggesting that the increased cancer risk of [E1] AT [/E1] heterozygotes could be attributable to poor checkpoint function", "mention_data": [{"mention": "AT", "kb_id": "D001260", "start": 171, "end": 173}]}
{"text": "Identification and expression of eight novel mutations among non Jewish patients with [E1] Canavan disease [/E1] Canavan disease is inherited as an autosomal recessive trait that is caused by the deficiency of aspartoacylase ASPA The majority of patients with Canavan disease are from an Ashkenazi Jewish background Mutations in ASPA that lead to loss of", "mention_data": [{"mention": "Canavan disease", "kb_id": "D017825", "start": 12, "end": 15}]}
{"text": "Identification and expression of eight novel mutations among non Jewish patients with Canavan disease [E1] Canavan disease [/E1] is inherited as an autosomal recessive trait that is caused by the deficiency of aspartoacylase ASPA The majority of patients with Canavan disease are from an Ashkenazi Jewish background Mutations in ASPA that lead to loss of enzymatic activity", "mention_data": [{"mention": "Canavan disease", "kb_id": "D017825", "start": 14, "end": 17}]}
{"text": "Identification and expression of eight novel mutations among non Jewish patients with Canavan disease Canavan disease is inherited as an autosomal recessive trait that is caused by the [E1] deficiency of aspartoacylase [/E1] ASPA The majority of patients with Canavan disease are from an Ashkenazi Jewish background Mutations in ASPA that lead to loss of enzymatic activity have been identified and E285A and Y231X are the two predominant mutations that account for", "mention_data": [{"mention": "deficiency of aspartoacylase", "kb_id": "D017825", "start": 28, "end": 32}]}
{"text": "Identification and expression of eight novel mutations among non Jewish patients with Canavan disease Canavan disease is inherited as an autosomal recessive trait that is caused by the deficiency of aspartoacylase ASPA The majority of patients with [E1] Canavan disease [/E1] are from an Ashkenazi Jewish background Mutations in ASPA that lead to loss of enzymatic activity have been identified and E285A and Y231X are the two predominant mutations that account for 97 of the mutant chromosomes in Ashkenazi Jewish", "mention_data": [{"mention": "Canavan disease", "kb_id": "D017825", "start": 37, "end": 40}]}
{"text": "to loss of enzymatic activity have been identified and E285A and Y231X are the two predominant mutations that account for 97 of the mutant chromosomes in Ashkenazi Jewish patients The current study was aimed at finding the molecular basis of [E1] Canavan disease [/E1] in 25 independent patients of non Jewish background Eight novel and three previously characterized mutations accounted for 80 40/50 of mutant chromosomes The A305E missense mutation accounted for 48 24/50 of mutant chromosomes in patients of western European descent", "mention_data": [{"mention": "Canavan disease", "kb_id": "D017825", "start": 90, "end": 93}]}
{"text": "identified included 1 and 4 bp deletions 32 deltaT and 876 deltaAGAA respectively and I16T G27R D114E G123E C152Y and R168C missense mutations The homozygous 32 deltaT deletion was identified in the only known patient of African American origin with [E1] Canavan disease [/E1] The heterozygosity for 876 deltaAGAA mutation was identified in three independent patients from England Six single base changes leading to missense mutations were identified in patients from Turkey D114E R168C The Netherlands I16T Germany G27R Ireland C152Y and Canada", "mention_data": [{"mention": "Canavan disease", "kb_id": "D017825", "start": 188, "end": 191}]}
{"text": "I16T Germany G27R Ireland C152Y and Canada G123E A PCR based protocol is described that was used to introduce mutations in wild type cDNA In vitro expression of mutant cDNA clones demonstrated that all of these mutations led to a [E1] deficiency of ASPA [/E1] and should therefore result in Canavan disease", "mention_data": [{"mention": "deficiency of ASPA", "kb_id": "D017825", "start": 262, "end": 266}]}
{"text": "A PCR based protocol is described that was used to introduce mutations in wild type cDNA In vitro expression of mutant cDNA clones demonstrated that all of these mutations led to a deficiency of ASPA and should therefore result in [E1] Canavan disease [/E1]", "mention_data": [{"mention": "Canavan disease", "kb_id": "D017825", "start": 270, "end": 273}]}
{"text": "BRCA1 mutations in women attending clinics that evaluate the risk of [E1] breast cancer [/E1] BACKGROUND To define the incidence of BRCA1 mutations among patients seen in clinics that evaluate the risk of breast cancer we analyzed DNA samples from women seen in this setting and constructed probability tables to provide estimates of the", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 11, "end": 14}]}
{"text": "BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer BACKGROUND To define the incidence of BRCA1 mutations among patients seen in clinics that evaluate the risk of [E1] breast cancer [/E1] we analyzed DNA samples from women seen in this setting and constructed probability tables to provide estimates of the likelihood of finding a BRCA1 mutation in individual families METHODS Clinical information family histories and blood for DNA analysis were", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 31, "end": 34}]}
{"text": "from women seen in this setting and constructed probability tables to provide estimates of the likelihood of finding a BRCA1 mutation in individual families METHODS Clinical information family histories and blood for DNA analysis were obtained from 263 women with [E1] breast cancer [/E1] Conformation sensitive gel electrophoresis and DNA sequencing were used to identify BRCA1 mutations RESULTS BRCA1 mutations were identified in 16 percent of women with a family history of breast cancer Only 7 percent of women from families with a", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 77, "end": 80}]}
{"text": "blood for DNA analysis were obtained from 263 women with breast cancer Conformation sensitive gel electrophoresis and DNA sequencing were used to identify BRCA1 mutations RESULTS BRCA1 mutations were identified in 16 percent of women with a family history of [E1] breast cancer [/E1] Only 7 percent of women from families with a history of breast cancer but not ovarian cancer had BRCA1 mutations The rates were higher among women from families with a history of both breast and ovarian cancer Among family", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 107, "end": 110}]}
{"text": "sensitive gel electrophoresis and DNA sequencing were used to identify BRCA1 mutations RESULTS BRCA1 mutations were identified in 16 percent of women with a family history of breast cancer Only 7 percent of women from families with a history of [E1] breast cancer [/E1] but not ovarian cancer had BRCA1 mutations The rates were higher among women from families with a history of both breast and ovarian cancer Among family members an average age of less than 55 years at the diagnosis of", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 120, "end": 123}]}
{"text": "DNA sequencing were used to identify BRCA1 mutations RESULTS BRCA1 mutations were identified in 16 percent of women with a family history of breast cancer Only 7 percent of women from families with a history of breast cancer but not [E1] ovarian cancer [/E1] had BRCA1 mutations The rates were higher among women from families with a history of both breast and ovarian cancer Among family members an average age of less than 55 years at the diagnosis of breast cancer the presence", "mention_data": [{"mention": "ovarian cancer", "kb_id": "D010051", "start": 124, "end": 127}]}
{"text": "with a family history of breast cancer Only 7 percent of women from families with a history of breast cancer but not ovarian cancer had BRCA1 mutations The rates were higher among women from families with a history of both [E1] breast and ovarian cancer [/E1] Among family members an average age of less than 55 years at the diagnosis of breast cancer the presence of ovarian cancer the presence of breast and ovarian cancer in the same woman and Ashkenazi Jewish ancestry were all", "mention_data": [{"mention": "breast and ovarian cancer", "kb_id": "D001943|D010051", "start": 142, "end": 147}]}
{"text": "cancer but not ovarian cancer had BRCA1 mutations The rates were higher among women from families with a history of both breast and ovarian cancer Among family members an average age of less than 55 years at the diagnosis of [E1] breast cancer [/E1] the presence of ovarian cancer the presence of breast and ovarian cancer in the same woman and Ashkenazi Jewish ancestry were all associated with an increased risk of detecting a BRCA1 mutation No association was found between the presence", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 161, "end": 164}]}
{"text": "had BRCA1 mutations The rates were higher among women from families with a history of both breast and ovarian cancer Among family members an average age of less than 55 years at the diagnosis of breast cancer the presence of [E1] ovarian cancer [/E1] the presence of breast and ovarian cancer in the same woman and Ashkenazi Jewish ancestry were all associated with an increased risk of detecting a BRCA1 mutation No association was found between the presence of bilateral breast cancer or", "mention_data": [{"mention": "ovarian cancer", "kb_id": "D010051", "start": 166, "end": 169}]}
{"text": "were higher among women from families with a history of both breast and ovarian cancer Among family members an average age of less than 55 years at the diagnosis of breast cancer the presence of ovarian cancer the presence of [E1] breast and ovarian cancer [/E1] in the same woman and Ashkenazi Jewish ancestry were all associated with an increased risk of detecting a BRCA1 mutation No association was found between the presence of bilateral breast cancer or the number of breast cancers in a", "mention_data": [{"mention": "breast and ovarian cancer", "kb_id": "D001943|D010051", "start": 171, "end": 176}]}
{"text": "presence of ovarian cancer the presence of breast and ovarian cancer in the same woman and Ashkenazi Jewish ancestry were all associated with an increased risk of detecting a BRCA1 mutation No association was found between the presence of bilateral [E1] breast cancer [/E1] or the number of breast cancers in a family and the detection of a BRCA1 mutation or between the position of the mutation in the BRCA1 gene and the presence of ovarian cancer in a family CONCLUSIONS Among women", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 204, "end": 207}]}
{"text": "of breast and ovarian cancer in the same woman and Ashkenazi Jewish ancestry were all associated with an increased risk of detecting a BRCA1 mutation No association was found between the presence of bilateral breast cancer or the number of [E1] breast cancers [/E1] in a family and the detection of a BRCA1 mutation or between the position of the mutation in the BRCA1 gene and the presence of ovarian cancer in a family CONCLUSIONS Among women with breast cancer and a family", "mention_data": [{"mention": "breast cancers", "kb_id": "D001943", "start": 210, "end": 213}]}
{"text": "was found between the presence of bilateral breast cancer or the number of breast cancers in a family and the detection of a BRCA1 mutation or between the position of the mutation in the BRCA1 gene and the presence of [E1] ovarian cancer [/E1] in a family CONCLUSIONS Among women with breast cancer and a family history of the disease the percentage with BRCA1 coding region mutations is less than the 45 percent predicted by genetic linkage analysis These results suggest that even", "mention_data": [{"mention": "ovarian cancer", "kb_id": "D010051", "start": 237, "end": 240}]}
{"text": "or the number of breast cancers in a family and the detection of a BRCA1 mutation or between the position of the mutation in the BRCA1 gene and the presence of ovarian cancer in a family CONCLUSIONS Among women with [E1] breast cancer [/E1] and a family history of the disease the percentage with BRCA1 coding region mutations is less than the 45 percent predicted by genetic linkage analysis These results suggest that even in a referral clinic specializing in screening women from", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 246, "end": 249}]}
{"text": "The [E1] von Hippel Lindau tumor [/E1] suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity The von Hippel Lindau tumor suppressor gene VHL has a critical role in the pathogenesis of clear cell renal cell carcinoma RCC as VHL mutations", "mention_data": [{"mention": "von Hippel Lindau tumor", "kb_id": "D006623", "start": 1, "end": 6}]}
{"text": "The von Hippel Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity The [E1] von Hippel Lindau tumor [/E1] suppressor gene VHL has a critical role in the pathogenesis of clear cell renal cell carcinoma RCC as VHL mutations have been found in both von Hippel Lindau disease associated and sporadic RCCs Recent studies suggest that vascular endothelial", "mention_data": [{"mention": "von Hippel Lindau tumor", "kb_id": "D006623", "start": 20, "end": 25}]}
{"text": "The von Hippel Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity The von Hippel Lindau tumor suppressor gene VHL has a critical role in the pathogenesis of [E1] clear cell renal cell carcinoma [/E1] RCC as VHL mutations have been found in both von Hippel Lindau disease associated and sporadic RCCs Recent studies suggest that vascular endothelial growth factor VEGF mRNA is upregulated in RCC and von Hippel Lindau disease associated tumors We", "mention_data": [{"mention": "clear cell renal cell carcinoma", "kb_id": "C538445", "start": 35, "end": 41}]}
{"text": "The von Hippel Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity The von Hippel Lindau tumor suppressor gene VHL has a critical role in the pathogenesis of clear cell renal cell carcinoma [E1] RCC [/E1] as VHL mutations have been found in both von Hippel Lindau disease associated and sporadic RCCs Recent studies suggest that vascular endothelial growth factor VEGF mRNA is upregulated in RCC and von Hippel Lindau disease associated tumors We have", "mention_data": [{"mention": "RCC", "kb_id": "D002292", "start": 40, "end": 42}]}
{"text": "with Sp1 to repress vascular endothelial growth factor promoter activity The von Hippel Lindau tumor suppressor gene VHL has a critical role in the pathogenesis of clear cell renal cell carcinoma RCC as VHL mutations have been found in both [E1] von Hippel Lindau disease associated and sporadic RCCs [/E1] Recent studies suggest that vascular endothelial growth factor VEGF mRNA is upregulated in RCC and von Hippel Lindau disease associated tumors We have therefore assessed the effect of the VHL gene product on VEGF expression VEGF promoter luciferase constructs", "mention_data": [{"mention": "von Hippel Lindau disease associated and sporadic RCCs", "kb_id": "D006623", "start": 49, "end": 58}]}
{"text": "role in the pathogenesis of clear cell renal cell carcinoma RCC as VHL mutations have been found in both von Hippel Lindau disease associated and sporadic RCCs Recent studies suggest that vascular endothelial growth factor VEGF mRNA is upregulated in [E1] RCC and von Hippel Lindau disease associated tumors [/E1] We have therefore assessed the effect of the VHL gene product on VEGF expression VEGF promoter luciferase constructs were transiently cotransfected with a wild type VHL wt VHL vector in several cell lines including 293 embryonic kidney and RCC", "mention_data": [{"mention": "RCC and von Hippel Lindau disease associated tumors", "kb_id": "D006623", "start": 70, "end": 79}]}
{"text": "associated tumors We have therefore assessed the effect of the VHL gene product on VEGF expression VEGF promoter luciferase constructs were transiently cotransfected with a wild type VHL wt VHL vector in several cell lines including 293 embryonic kidney and [E1] RCC [/E1] cell lines wt VHL protein inhibited VEGF promoter activity in a dose dependent manner up to 5 to 10 fold Deletion analysis defined a 144 bp region of the VEGF promoter necessary for VHL repression This VHL responsive element", "mention_data": [{"mention": "RCC", "kb_id": "D002292", "start": 116, "end": 118}]}
{"text": "in coimmunoprecipitates that VHL and Sp1 were part of the same complex and by using a glutathione S transferase VHL fusion protein and purified Sp1 that VHL and Sp1 directly interact Furthermore endogenous VEGF mRNA levels were suppressed in permanent [E1] RCC [/E1] cell lines expressing wt VHL and nuclear run on studies indicated that VHL regulation of VEGF occurs at least partly at the transcriptional level These observations support a new mechanism for VHL mediated transcriptional repression via a direct inhibitory", "mention_data": [{"mention": "RCC", "kb_id": "D002292", "start": 230, "end": 232}]}
{"text": "occurs at least partly at the transcriptional level These observations support a new mechanism for VHL mediated transcriptional repression via a direct inhibitory action on Sp1 and suggest that loss of Sp1 inhibition may be important in the pathogenesis of [E1] von Hippel Lindau disease [/E1] and RCC", "mention_data": [{"mention": "von Hippel Lindau disease", "kb_id": "D006623", "start": 287, "end": 292}]}
{"text": "the transcriptional level These observations support a new mechanism for VHL mediated transcriptional repression via a direct inhibitory action on Sp1 and suggest that loss of Sp1 inhibition may be important in the pathogenesis of von Hippel Lindau disease and [E1] RCC [/E1]", "mention_data": [{"mention": "RCC", "kb_id": "D002292", "start": 292, "end": 294}]}
{"text": "Germline mutations in the RB1 gene in patients with [E1] hereditary retinoblastoma [/E1] We have analyzed the 27 exons and the promoter region of the RB1 gene in familial or sporadic bilateral retinoblastoma by using single strand conformation polymorphism analysis For improvement over previous studies a new set of primers has been", "mention_data": [{"mention": "hereditary retinoblastoma", "kb_id": "D012175", "start": 9, "end": 12}]}
{"text": "Germline mutations in the RB1 gene in patients with hereditary retinoblastoma We have analyzed the 27 exons and the promoter region of the RB1 gene in [E1] familial or sporadic bilateral retinoblastoma [/E1] by using single strand conformation polymorphism analysis For improvement over previous studies a new set of primers has been designed which allow for amplification of the coding and splicing sequences only The positioning of the polymerase chain reaction PCR", "mention_data": [{"mention": "familial or sporadic bilateral retinoblastoma", "kb_id": "D012175", "start": 26, "end": 32}]}
{"text": "Deletion of small nuclear ribonucleoprotein polypeptide N SNRPN in [E1] Prader Willi syndrome [/E1] detected by fluorescence in situ hybridization two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15q The small nuclear ribonucleoprotein polypeptide N SNRPN gene is regarded as one of the candidates for Prader Willi syndrome PWS", "mention_data": [{"mention": "Prader Willi syndrome", "kb_id": "D011218", "start": 9, "end": 13}]}
{"text": "SNRPN in Prader Willi syndrome detected by fluorescence in situ hybridization two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15q The small nuclear ribonucleoprotein polypeptide N SNRPN gene is regarded as one of the candidates for [E1] Prader Willi syndrome [/E1] PWS We describe two sibs with typical PWS presenting deletion of SNRPN detected by fluorescence in situ hybridization FISH Neither a cytogenetically detectable 15q12 deletion nor a deletion for the D15S11 D15S10 and GABRB3 cosmid probes were found in", "mention_data": [{"mention": "Prader Willi syndrome", "kb_id": "D011218", "start": 47, "end": 51}]}
{"text": "Willi syndrome detected by fluorescence in situ hybridization two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15q The small nuclear ribonucleoprotein polypeptide N SNRPN gene is regarded as one of the candidates for Prader Willi syndrome [E1] PWS [/E1] We describe two sibs with typical PWS presenting deletion of SNRPN detected by fluorescence in situ hybridization FISH Neither a cytogenetically detectable 15q12 deletion nor a deletion for the D15S11 D15S10 and GABRB3 cosmid probes were found in either", "mention_data": [{"mention": "PWS", "kb_id": "D011218", "start": 50, "end": 52}]}
{"text": "hybridization two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15q The small nuclear ribonucleoprotein polypeptide N SNRPN gene is regarded as one of the candidates for Prader Willi syndrome PWS We describe two sibs with typical [E1] PWS [/E1] presenting deletion of SNRPN detected by fluorescence in situ hybridization FISH Neither a cytogenetically detectable 15q12 deletion nor a deletion for the D15S11 D15S10 and GABRB3 cosmid probes were found in either patient This implies a smaller deletion limited", "mention_data": [{"mention": "PWS", "kb_id": "D011218", "start": 57, "end": 59}]}
{"text": "deletion of SNRPN detected by fluorescence in situ hybridization FISH Neither a cytogenetically detectable 15q12 deletion nor a deletion for the D15S11 D15S10 and GABRB3 cosmid probes were found in either patient This implies a smaller deletion limited to the [E1] PWS [/E1] critical region FISH with a SNRPN probe will permit analysis of PWS patients with limited deletions not detectable with other probes", "mention_data": [{"mention": "PWS", "kb_id": "D011218", "start": 99, "end": 101}]}
{"text": "cytogenetically detectable 15q12 deletion nor a deletion for the D15S11 D15S10 and GABRB3 cosmid probes were found in either patient This implies a smaller deletion limited to the PWS critical region FISH with a SNRPN probe will permit analysis of [E1] PWS [/E1] patients with limited deletions not detectable with other probes", "mention_data": [{"mention": "PWS", "kb_id": "D011218", "start": 111, "end": 113}]}
{"text": "The mouse homolog of the [E1] Wiskott Aldrich syndrome [/E1] protein WASP gene is highly conserved and maps near the scurfy sf mutation on the X chromosome The mouse WASP gene the homolog of the gene mutated in Wiskott Aldrich syndrome has been isolated and sequenced the predicted amino", "mention_data": [{"mention": "Wiskott Aldrich syndrome", "kb_id": "D014923", "start": 5, "end": 9}]}
{"text": "The mouse homolog of the Wiskott Aldrich syndrome protein WASP gene is highly conserved and maps near the scurfy sf mutation on the X chromosome The mouse WASP gene the homolog of the gene mutated in [E1] Wiskott Aldrich syndrome [/E1] has been isolated and sequenced the predicted amino acid sequence is 86 identical to the human WASP sequence A distinct feature of the mouse gene is an expanded polymorphic GGA trinucleotide repeat that codes for polyglycine and varies from", "mention_data": [{"mention": "Wiskott Aldrich syndrome", "kb_id": "D014923", "start": 36, "end": 40}]}
{"text": "in an interspecific M Musculus/M spretus backcross placed the Wasp locus near the centromere of the mouse X chromosome inseparable from Gata1 Tcfe3 and scurfy sf This localization makes Wasp a candidate for involvement in scurfy a T cell mediated [E1] fatal lymphoreticular disease [/E1] of mice that has previously been proposed as a mouse homolog of Wiskott Aldrich syndrome Northern analysis of sf tissue samples indicated the presence of WASP mRNA in liver and skin presumably as a consequence of lymphocytic infiltration but", "mention_data": [{"mention": "fatal lymphoreticular disease", "kb_id": "D008206", "start": 150, "end": 154}]}
{"text": "the mouse X chromosome inseparable from Gata1 Tcfe3 and scurfy sf This localization makes Wasp a candidate for involvement in scurfy a T cell mediated fatal lymphoreticular disease of mice that has previously been proposed as a mouse homolog of [E1] Wiskott Aldrich syndrome [/E1] Northern analysis of sf tissue samples indicated the presence of WASP mRNA in liver and skin presumably as a consequence of lymphocytic infiltration but non abnormalities in the amount or size of mRNA present", "mention_data": [{"mention": "Wiskott Aldrich syndrome", "kb_id": "D014923", "start": 165, "end": 169}]}
{"text": "An animal model for [E1] Norrie disease [/E1] ND gene targeting of the mouse ND gene In order to elucidate the cellular and molecular processes which are involved in Norrie disease ND we have used gene targeting technology to generate ND mutant mice The murine homologue of", "mention_data": [{"mention": "Norrie disease", "kb_id": "C537849", "start": 4, "end": 7}]}
{"text": "An animal model for Norrie disease [E1] ND [/E1] gene targeting of the mouse ND gene In order to elucidate the cellular and molecular processes which are involved in Norrie disease ND we have used gene targeting technology to generate ND mutant mice The murine homologue of the", "mention_data": [{"mention": "ND", "kb_id": "C537849", "start": 6, "end": 8}]}
{"text": "An animal model for Norrie disease ND gene targeting of the mouse [E1] ND [/E1] gene In order to elucidate the cellular and molecular processes which are involved in Norrie disease ND we have used gene targeting technology to generate ND mutant mice The murine homologue of the ND gene was cloned and shown", "mention_data": [{"mention": "ND", "kb_id": "C537849", "start": 12, "end": 14}]}
{"text": "An animal model for Norrie disease ND gene targeting of the mouse ND gene In order to elucidate the cellular and molecular processes which are involved in [E1] Norrie disease [/E1] ND we have used gene targeting technology to generate ND mutant mice The murine homologue of the ND gene was cloned and shown to encode a polypeptide that shares 94 of the amino acid sequence with its human counterpart", "mention_data": [{"mention": "Norrie disease", "kb_id": "C537849", "start": 27, "end": 30}]}
{"text": "An animal model for Norrie disease ND gene targeting of the mouse ND gene In order to elucidate the cellular and molecular processes which are involved in Norrie disease [E1] ND [/E1] we have used gene targeting technology to generate ND mutant mice The murine homologue of the ND gene was cloned and shown to encode a polypeptide that shares 94 of the amino acid sequence with its human counterpart RNA", "mention_data": [{"mention": "ND", "kb_id": "C537849", "start": 29, "end": 31}]}
{"text": "An animal model for Norrie disease ND gene targeting of the mouse ND gene In order to elucidate the cellular and molecular processes which are involved in Norrie disease ND we have used gene targeting technology to generate [E1] ND [/E1] mutant mice The murine homologue of the ND gene was cloned and shown to encode a polypeptide that shares 94 of the amino acid sequence with its human counterpart RNA in situ hybridization revealed expression in retina brain and", "mention_data": [{"mention": "ND", "kb_id": "C537849", "start": 38, "end": 40}]}
{"text": "ND gene targeting of the mouse ND gene In order to elucidate the cellular and molecular processes which are involved in Norrie disease ND we have used gene targeting technology to generate ND mutant mice The murine homologue of the [E1] ND [/E1] gene was cloned and shown to encode a polypeptide that shares 94 of the amino acid sequence with its human counterpart RNA in situ hybridization revealed expression in retina brain and the olfactory bulb and epithelium of 2 week", "mention_data": [{"mention": "ND", "kb_id": "C537849", "start": 46, "end": 48}]}
{"text": "of the amino acid sequence with its human counterpart RNA in situ hybridization revealed expression in retina brain and the olfactory bulb and epithelium of 2 week old mice Hemizygous mice carrying a replacement mutation in exon 2 of the [E1] ND [/E1] gene developed retrolental structures in the vitreous body and showed an overall disorganization of the retinal ganglion cell layer The outer plexiform layer disappears occasionally resulting in a juxtaposed inner and outer nuclear layer At the same regions the", "mention_data": [{"mention": "ND", "kb_id": "C537849", "start": 99, "end": 101}]}
{"text": "layer The outer plexiform layer disappears occasionally resulting in a juxtaposed inner and outer nuclear layer At the same regions the outer segments of the photoreceptor cell layer are no longer present These ocular findings are consistent with observations in [E1] ND [/E1] patients and the generated mouse line provides a faithful model for study of early pathogenic events in this severe X linked recessive neurological disorder", "mention_data": [{"mention": "ND", "kb_id": "C537849", "start": 158, "end": 160}]}
{"text": "the outer segments of the photoreceptor cell layer are no longer present These ocular findings are consistent with observations in ND patients and the generated mouse line provides a faithful model for study of early pathogenic events in this severe [E1] X linked recessive neurological disorder [/E1]", "mention_data": [{"mention": "X linked recessive neurological disorder", "kb_id": "D020271", "start": 178, "end": 184}]}
{"text": "Phenotypic characterization of individuals with 30 40 CAG repeats in the [E1] Huntington disease [/E1] HD gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36 39 repeats Abnormal CAG expansions in the IT 15 gene are associated with Huntington disease HD In the diagnostic setting it is necessary to", "mention_data": [{"mention": "Huntington disease", "kb_id": "D006816", "start": 11, "end": 14}]}
{"text": "Phenotypic characterization of individuals with 30 40 CAG repeats in the Huntington disease [E1] HD [/E1] gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36 39 repeats Abnormal CAG expansions in the IT 15 gene are associated with Huntington disease HD In the diagnostic setting it is necessary to define", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 13, "end": 15}]}
{"text": "Phenotypic characterization of individuals with 30 40 CAG repeats in the Huntington disease HD gene reveals [E1] HD [/E1] cases with 36 repeats and apparently normal elderly individuals with 36 39 repeats Abnormal CAG expansions in the IT 15 gene are associated with Huntington disease HD In the diagnostic setting it is necessary to define the limits of", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 16, "end": 18}]}
{"text": "characterization of individuals with 30 40 CAG repeats in the Huntington disease HD gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36 39 repeats Abnormal CAG expansions in the IT 15 gene are associated with [E1] Huntington disease [/E1] HD In the diagnostic setting it is necessary to define the limits of the CAG size ranges on normal and HD associated chromosomes Most large analyses that defined the limits of the normal and pathological size ranges employed PCR", "mention_data": [{"mention": "Huntington disease", "kb_id": "D006816", "start": 41, "end": 44}]}
{"text": "individuals with 30 40 CAG repeats in the Huntington disease HD gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36 39 repeats Abnormal CAG expansions in the IT 15 gene are associated with Huntington disease [E1] HD [/E1] In the diagnostic setting it is necessary to define the limits of the CAG size ranges on normal and HD associated chromosomes Most large analyses that defined the limits of the normal and pathological size ranges employed PCR assays", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 43, "end": 45}]}
{"text": "normal elderly individuals with 36 39 repeats Abnormal CAG expansions in the IT 15 gene are associated with Huntington disease HD In the diagnostic setting it is necessary to define the limits of the CAG size ranges on normal and [E1] HD [/E1] associated chromosomes Most large analyses that defined the limits of the normal and pathological size ranges employed PCR assays which included the CAG repeats and a CCG repeat tract that was thought to be invariant Many of these experiments", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 63, "end": 65}]}
{"text": "in Cambridge by using assays specific for the CAG repeats We have optimized methods for reliable sizing of CAG repeats and show cases that demonstrate the dangers of using PCR assays that include both the CAG and CCG polymorphisms Seven [E1] HD [/E1] patients had 36 repeats which confirms that this allele is associated with disease Individuals without apparent symptoms or signs of HD were found at 36 repeats aged 74 78 79 and 87 years 37 repeats aged 69 years 38", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 208, "end": 210}]}
{"text": "show cases that demonstrate the dangers of using PCR assays that include both the CAG and CCG polymorphisms Seven HD patients had 36 repeats which confirms that this allele is associated with disease Individuals without apparent symptoms or signs of [E1] HD [/E1] were found at 36 repeats aged 74 78 79 and 87 years 37 repeats aged 69 years 38 repeats aged 69 and 90 years and 39 repeats aged 67 90 and 95 years The detailed case histories of an", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 229, "end": 231}]}
{"text": "90 years and 39 repeats aged 67 90 and 95 years The detailed case histories of an exceptional case from this series will be presented a 95 year old man with 39 repeats who did not have classical features of [E1] HD [/E1] The apparently healthy survival into old age of some individuals with 36 39 repeats suggests that the HD mutation may not always be fully penetrant", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 292, "end": 294}]}
{"text": "case from this series will be presented a 95 year old man with 39 repeats who did not have classical features of HD The apparently healthy survival into old age of some individuals with 36 39 repeats suggests that the [E1] HD [/E1] mutation may not always be fully penetrant", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 310, "end": 312}]}
{"text": "[E1] HPRT APRT deficient [/E1] mice are not a model for lesch nyhan syndrome Complete hypoxanthine guanine phosphoribosyl transferase HPRT deficiency in humans results in the Lesch Nyhan syndrome which is characterized among other features by compulsive self injurious behavior HPRT deficient mice generated", "mention_data": [{"mention": "HPRT APRT deficient", "kb_id": "300322|102600", "start": 0, "end": 4}]}
{"text": "HPRT APRT deficient mice are not a model for [E1] lesch nyhan syndrome [/E1] Complete hypoxanthine guanine phosphoribosyl transferase HPRT deficiency in humans results in the Lesch Nyhan syndrome which is characterized among other features by compulsive self injurious behavior HPRT deficient mice generated using mouse embryonic stem cells exhibit none of the", "mention_data": [{"mention": "lesch nyhan syndrome", "kb_id": "D007926", "start": 9, "end": 13}]}
{"text": "HPRT APRT deficient mice are not a model for lesch nyhan syndrome [E1] Complete hypoxanthine guanine phosphoribosyl transferase HPRT deficiency [/E1] in humans results in the Lesch Nyhan syndrome which is characterized among other features by compulsive self injurious behavior HPRT deficient mice generated using mouse embryonic stem cells exhibit none of the behavioral symptoms associated with the Lesch Nyhan", "mention_data": [{"mention": "Complete hypoxanthine guanine phosphoribosyl transferase HPRT deficiency", "kb_id": "D007926", "start": 12, "end": 20}]}
{"text": "HPRT APRT deficient mice are not a model for lesch nyhan syndrome Complete hypoxanthine guanine phosphoribosyl transferase HPRT deficiency in humans results in the [E1] Lesch Nyhan syndrome [/E1] which is characterized among other features by compulsive self injurious behavior HPRT deficient mice generated using mouse embryonic stem cells exhibit none of the behavioral symptoms associated with the Lesch Nyhan syndrome Administration of drugs that inhibit adenine phosphoribosyltransferase", "mention_data": [{"mention": "Lesch Nyhan syndrome", "kb_id": "D007926", "start": 24, "end": 28}]}
{"text": "HPRT APRT deficient mice are not a model for lesch nyhan syndrome Complete hypoxanthine guanine phosphoribosyl transferase HPRT deficiency in humans results in the Lesch Nyhan syndrome which is characterized among other features by compulsive self injurious behavior [E1] HPRT deficient [/E1] mice generated using mouse embryonic stem cells exhibit none of the behavioral symptoms associated with the Lesch Nyhan syndrome Administration of drugs that inhibit adenine phosphoribosyltransferase APRT in HPRT deficient mice has produced the suggestion that deficiency of APRT", "mention_data": [{"mention": "HPRT deficient", "kb_id": "D007926", "start": 38, "end": 41}]}
{"text": "transferase HPRT deficiency in humans results in the Lesch Nyhan syndrome which is characterized among other features by compulsive self injurious behavior HPRT deficient mice generated using mouse embryonic stem cells exhibit none of the behavioral symptoms associated with the [E1] Lesch Nyhan syndrome [/E1] Administration of drugs that inhibit adenine phosphoribosyltransferase APRT in HPRT deficient mice has produced the suggestion that deficiency of APRT in combination with HPRT deficiency in mice may lead to self mutilation behavior [C L Wu and D W", "mention_data": [{"mention": "Lesch Nyhan syndrome", "kb_id": "D007926", "start": 56, "end": 60}]}
{"text": "is characterized among other features by compulsive self injurious behavior HPRT deficient mice generated using mouse embryonic stem cells exhibit none of the behavioral symptoms associated with the Lesch Nyhan syndrome Administration of drugs that inhibit adenine phosphoribosyltransferase APRT in [E1] HPRT deficient [/E1] mice has produced the suggestion that deficiency of APRT in combination with HPRT deficiency in mice may lead to self mutilation behavior [C L Wu and D W Melton 1993 Nature Genet 3 235 240] To test this proposition", "mention_data": [{"mention": "HPRT deficient", "kb_id": "D007926", "start": 68, "end": 71}]}
{"text": "injurious behavior HPRT deficient mice generated using mouse embryonic stem cells exhibit none of the behavioral symptoms associated with the Lesch Nyhan syndrome Administration of drugs that inhibit adenine phosphoribosyltransferase APRT in HPRT deficient mice has produced the suggestion that [E1] deficiency of APRT [/E1] in combination with HPRT deficiency in mice may lead to self mutilation behavior [C L Wu and D W Melton 1993 Nature Genet 3 235 240] To test this proposition we bred HPRT APRT deficient mice Although the doubly", "mention_data": [{"mention": "deficiency of APRT", "kb_id": "102600", "start": 76, "end": 80}]}
{"text": "using mouse embryonic stem cells exhibit none of the behavioral symptoms associated with the Lesch Nyhan syndrome Administration of drugs that inhibit adenine phosphoribosyltransferase APRT in HPRT deficient mice has produced the suggestion that deficiency of APRT in combination with [E1] HPRT deficiency [/E1] in mice may lead to self mutilation behavior [C L Wu and D W Melton 1993 Nature Genet 3 235 240] To test this proposition we bred HPRT APRT deficient mice Although the doubly deficient mice excrete adenine and", "mention_data": [{"mention": "HPRT deficiency", "kb_id": "D007926", "start": 82, "end": 85}]}
{"text": "has produced the suggestion that deficiency of APRT in combination with HPRT deficiency in mice may lead to self mutilation behavior [C L Wu and D W Melton 1993 Nature Genet 3 235 240] To test this proposition we bred [E1] HPRT APRT deficient [/E1] mice Although the doubly deficient mice excrete adenine and its highly insoluble derivative 2 8 dihydroxyadenine which are also associated with human APRT deficiency additional abnormalities or any self injurious behavior were not detected Thus APRT HPRT deficient mice", "mention_data": [{"mention": "HPRT APRT deficient", "kb_id": "300322|102600", "start": 111, "end": 115}]}
{"text": "D W Melton 1993 Nature Genet 3 235 240] To test this proposition we bred HPRT APRT deficient mice Although the doubly deficient mice excrete adenine and its highly insoluble derivative 2 8 dihydroxyadenine which are also associated with human [E1] APRT deficiency [/E1] additional abnormalities or any self injurious behavior were not detected Thus APRT HPRT deficient mice which are devoid of any purine salvage pathways show no novel phenotype and are not a model for the behavioral abnormalities associated with the", "mention_data": [{"mention": "APRT deficiency", "kb_id": "102600", "start": 136, "end": 139}]}
{"text": "we bred HPRT APRT deficient mice Although the doubly deficient mice excrete adenine and its highly insoluble derivative 2 8 dihydroxyadenine which are also associated with human APRT deficiency additional abnormalities or any self injurious behavior were not detected Thus [E1] APRT HPRT deficient [/E1] mice which are devoid of any purine salvage pathways show no novel phenotype and are not a model for the behavioral abnormalities associated with the Lesch Nyhan syndrome as previously suggested", "mention_data": [{"mention": "APRT HPRT deficient", "kb_id": "300322|102600", "start": 149, "end": 153}]}
{"text": "also associated with human APRT deficiency additional abnormalities or any self injurious behavior were not detected Thus APRT HPRT deficient mice which are devoid of any purine salvage pathways show no novel phenotype and are not a model for the [E1] behavioral abnormalities [/E1] associated with the Lesch Nyhan syndrome as previously suggested", "mention_data": [{"mention": "behavioral abnormalities", "kb_id": "D001523", "start": 172, "end": 175}]}
{"text": "deficiency additional abnormalities or any self injurious behavior were not detected Thus APRT HPRT deficient mice which are devoid of any purine salvage pathways show no novel phenotype and are not a model for the behavioral abnormalities associated with the [E1] Lesch Nyhan syndrome [/E1] as previously suggested", "mention_data": [{"mention": "Lesch Nyhan syndrome", "kb_id": "D007926", "start": 177, "end": 181}]}
{"text": "Mice lacking the [E1] myotonic dystrophy [/E1] protein kinase develop a late onset progressive myopathy Myotonic dystrophy DM is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3 untranslated region of a putative protein kinase DMPK To elucidate the role", "mention_data": [{"mention": "myotonic dystrophy", "kb_id": "D009223", "start": 3, "end": 6}]}
{"text": "Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive [E1] myopathy [/E1] Myotonic dystrophy DM is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3 untranslated region of a putative protein kinase DMPK To elucidate the role of DMPK in DM pathogenesis we have developed", "mention_data": [{"mention": "myopathy", "kb_id": "D009135", "start": 12, "end": 14}]}
{"text": "Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy [E1] Myotonic dystrophy [/E1] DM is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3 untranslated region of a putative protein kinase DMPK To elucidate the role of DMPK in DM pathogenesis we have developed Dmpk deficient", "mention_data": [{"mention": "Myotonic dystrophy", "kb_id": "D009223", "start": 13, "end": 16}]}
{"text": "Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy Myotonic dystrophy [E1] DM [/E1] is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3 untranslated region of a putative protein kinase DMPK To elucidate the role of DMPK in DM pathogenesis we have developed Dmpk deficient Dmpk", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 15, "end": 17}]}
{"text": "Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy Myotonic dystrophy DM is an [E1] autosomal dominant disorder [/E1] resulting from the expansion of a CTG repeat in the 3 untranslated region of a putative protein kinase DMPK To elucidate the role of DMPK in DM pathogenesis we have developed Dmpk deficient Dmpk / mice Dmpk / mice", "mention_data": [{"mention": "autosomal dominant disorder", "kb_id": "D030342", "start": 18, "end": 22}]}
{"text": "develop a late onset progressive myopathy Myotonic dystrophy DM is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3 untranslated region of a putative protein kinase DMPK To elucidate the role of DMPK in [E1] DM [/E1] pathogenesis we have developed Dmpk deficient Dmpk / mice Dmpk / mice develop a late onset progressive skeletal myopathy that shares some pathological features with DM Muscles from mature mice show variation in fibre size increased fibre degeneration and", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 47, "end": 49}]}
{"text": "myopathy Myotonic dystrophy DM is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3 untranslated region of a putative protein kinase DMPK To elucidate the role of DMPK in DM pathogenesis we have developed [E1] Dmpk deficient [/E1] Dmpk / mice Dmpk / mice develop a late onset progressive skeletal myopathy that shares some pathological features with DM Muscles from mature mice show variation in fibre size increased fibre degeneration and fibrosis Adult Dmpk / mice show", "mention_data": [{"mention": "Dmpk deficient", "kb_id": "160900", "start": 52, "end": 55}]}
{"text": "expansion of a CTG repeat in the 3 untranslated region of a putative protein kinase DMPK To elucidate the role of DMPK in DM pathogenesis we have developed Dmpk deficient Dmpk / mice Dmpk / mice develop a late onset [E1] progressive skeletal myopathy [/E1] that shares some pathological features with DM Muscles from mature mice show variation in fibre size increased fibre degeneration and fibrosis Adult Dmpk / mice show ultrastructural changes in muscle and a 50 decrease in force generation compared to", "mention_data": [{"mention": "progressive skeletal myopathy", "kb_id": "D009135", "start": 64, "end": 68}]}
{"text": "region of a putative protein kinase DMPK To elucidate the role of DMPK in DM pathogenesis we have developed Dmpk deficient Dmpk / mice Dmpk / mice develop a late onset progressive skeletal myopathy that shares some pathological features with [E1] DM [/E1] Muscles from mature mice show variation in fibre size increased fibre degeneration and fibrosis Adult Dmpk / mice show ultrastructural changes in muscle and a 50 decrease in force generation compared to young mice Our results indicate that DMPK", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 73, "end": 75}]}
{"text": "of DMPK in DM pathogenesis we have developed Dmpk deficient Dmpk / mice Dmpk / mice develop a late onset progressive skeletal myopathy that shares some pathological features with DM Muscles from mature mice show variation in fibre size increased [E1] fibre degeneration [/E1] and fibrosis Adult Dmpk / mice show ultrastructural changes in muscle and a 50 decrease in force generation compared to young mice Our results indicate that DMPK may be necessary for the maintenance of skeletal muscle structure and function", "mention_data": [{"mention": "fibre degeneration", "kb_id": "D020966", "start": 84, "end": 87}]}
{"text": "DM pathogenesis we have developed Dmpk deficient Dmpk / mice Dmpk / mice develop a late onset progressive skeletal myopathy that shares some pathological features with DM Muscles from mature mice show variation in fibre size increased fibre degeneration and [E1] fibrosis [/E1] Adult Dmpk / mice show ultrastructural changes in muscle and a 50 decrease in force generation compared to young mice Our results indicate that DMPK may be necessary for the maintenance of skeletal muscle structure and function and suggest", "mention_data": [{"mention": "fibrosis", "kb_id": "D005355", "start": 87, "end": 89}]}
{"text": "muscle and a 50 decrease in force generation compared to young mice Our results indicate that DMPK may be necessary for the maintenance of skeletal muscle structure and function and suggest that a decrease in DMPK levels may contribute to [E1] DM [/E1] pathology", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 136, "end": 138}]}
{"text": "Rapid detection of regionally clustered germ line BRCA1 mutations by multiplex heteroduplex analysis UKCCCR Familial [E1] Ovarian Cancer [/E1] Study Group Germ line mutations of the BRCA1 gene are responsible for a substantial proportion of families with multiple cases of early onset breast and/or ovarian cancer Since the isolation of BRCA1 last year 65 distinct mutations scattered throughout", "mention_data": [{"mention": "Ovarian Cancer", "kb_id": "D010051", "start": 15, "end": 18}]}
{"text": "Rapid detection of regionally clustered germ line BRCA1 mutations by multiplex heteroduplex analysis UKCCCR Familial Ovarian Cancer Study Group Germ line mutations of the BRCA1 gene are responsible for a substantial proportion of families with multiple cases of early onset [E1] breast and/or ovarian cancer [/E1] Since the isolation of BRCA1 last year 65 distinct mutations scattered throughout the coding region have been detected making analysis of the gene time consuming and technically challenging We have developed a multiplex heteroduplex analysis that is designed to", "mention_data": [{"mention": "breast and/or ovarian cancer", "kb_id": "604370", "start": 40, "end": 45}]}
{"text": "technically challenging We have developed a multiplex heteroduplex analysis that is designed to analyze one quarter of the coding sequence in a single step screening procedure and that will detect approximately 50 of all BRCA1 mutations so far reported in [E1] breast/ovarian cancer [/E1] families We have used this technique to analyze BRCA1 in 162 families with a history of breast and/or ovarian cancer and identified 12 distinct mutations in 35 families", "mention_data": [{"mention": "breast/ovarian cancer", "kb_id": "604370", "start": 110, "end": 113}]}
{"text": "coding sequence in a single step screening procedure and that will detect approximately 50 of all BRCA1 mutations so far reported in breast/ovarian cancer families We have used this technique to analyze BRCA1 in 162 families with a history of [E1] breast and/or ovarian cancer [/E1] and identified 12 distinct mutations in 35 families", "mention_data": [{"mention": "breast and/or ovarian cancer", "kb_id": "604370", "start": 128, "end": 133}]}
{"text": "LPP the preferred fusion partner gene of HMGIC in [E1] lipomas [/E1] is a novel member of the LIM protein gene family A major cytogenetic subgroup of lipomas is characterized by recurrent chromosome aberrations mainly translocations that involve chromosome segment 12q13 q15 Multiple chromosomes have been found as the translocation partners", "mention_data": [{"mention": "lipomas", "kb_id": "D008067", "start": 9, "end": 11}]}
{"text": "LPP the preferred fusion partner gene of HMGIC in lipomas is a novel member of the LIM protein gene family A major cytogenetic subgroup of [E1] lipomas [/E1] is characterized by recurrent chromosome aberrations mainly translocations that involve chromosome segment 12q13 q15 Multiple chromosomes have been found as the translocation partners of chromosome 12 but 3q27 q28 is preferentially involved In previous studies it has been shown", "mention_data": [{"mention": "lipomas", "kb_id": "D008067", "start": 25, "end": 27}]}
{"text": "that the high mobility group HMG protein gene HMGIC at 12q15 is consistently rearranged as a consequence of these translocations Here we report the identification and characterization of the chromosome 3 derived translocation partner gene which we have designated LPP [E1] lipoma [/E1] preferred partner gene Using 3 RACE analysis of HMGIC fusion transcripts in lipoma cell line Li 501/SV40 ectopic genetic sequences were obtained which by CASH chromosome assignment using somatic cell hybrids and FISH fluorescence in situ hybridization analysis were", "mention_data": [{"mention": "lipoma", "kb_id": "D008067", "start": 105, "end": 107}]}
{"text": "rearranged as a consequence of these translocations Here we report the identification and characterization of the chromosome 3 derived translocation partner gene which we have designated LPP lipoma preferred partner gene Using 3 RACE analysis of HMGIC fusion transcripts in [E1] lipoma [/E1] cell line Li 501/SV40 ectopic genetic sequences were obtained which by CASH chromosome assignment using somatic cell hybrids and FISH fluorescence in situ hybridization analysis were found to originate from chromosome segment 3q27 q28 In Northern blot analysis an", "mention_data": [{"mention": "lipoma", "kb_id": "D008067", "start": 118, "end": 120}]}
{"text": "carboxy terminal region The LPP encoded protein should be classified as a novel member of the group 3 proteins of the LIM protein gene family Using reverse transcriptase combined with polymerase chain reactions in the analysis of a number of [E1] lipoma [/E1] cell lines and primary lipomas it appeared that LPP is frequently rearranged also in cases without a cytogenetically detectable involvement of 3q27 q28 Two alternative HMGIC/LPP hybrid transcripts have been detected the difference between them is mainly the presence", "mention_data": [{"mention": "lipoma", "kb_id": "D008067", "start": 287, "end": 289}]}
{"text": "LPP encoded protein should be classified as a novel member of the group 3 proteins of the LIM protein gene family Using reverse transcriptase combined with polymerase chain reactions in the analysis of a number of lipoma cell lines and [E1] primary lipomas [/E1] it appeared that LPP is frequently rearranged also in cases without a cytogenetically detectable involvement of 3q27 q28 Two alternative HMGIC/LPP hybrid transcripts have been detected the difference between them is mainly the presence of either two or three", "mention_data": [{"mention": "primary lipomas", "kb_id": "D008067", "start": 291, "end": 294}]}
{"text": "Exon intron structure of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit CHRNA4 The human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene CHRNA4 is located in the candidate region for three different phenotypes [E1] benign familial neonatal convulsions [/E1] autosomal dominant nocturnal frontal lobe epilepsy and low voltage EEG Recently a missense mutation in transmembrane domain 2 of CHRNA4 was found to be associated with autosomal dominant nocturnal frontal lobe epilepsy in one extended pedigree We have determined", "mention_data": [{"mention": "benign familial neonatal convulsions", "kb_id": "D020936", "start": 35, "end": 40}]}
{"text": "Exon intron structure of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit CHRNA4 The human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene CHRNA4 is located in the candidate region for three different phenotypes benign familial neonatal convulsions [E1] autosomal dominant nocturnal frontal lobe epilepsy [/E1] and low voltage EEG Recently a missense mutation in transmembrane domain 2 of CHRNA4 was found to be associated with autosomal dominant nocturnal frontal lobe epilepsy in one extended pedigree We have determined the genomic organization of CHRNA4 which", "mention_data": [{"mention": "autosomal dominant nocturnal frontal lobe epilepsy", "kb_id": "D017034", "start": 39, "end": 46}]}
{"text": "is located in the candidate region for three different phenotypes benign familial neonatal convulsions autosomal dominant nocturnal frontal lobe epilepsy and low voltage EEG Recently a missense mutation in transmembrane domain 2 of CHRNA4 was found to be associated with [E1] autosomal dominant nocturnal frontal lobe epilepsy [/E1] in one extended pedigree We have determined the genomic organization of CHRNA4 which consists of six exons distributed over approximately 17 kb of genomic DNA The nucleotide sequence obtained from the genomic regions adjacent to the exon boundaries enabled", "mention_data": [{"mention": "autosomal dominant nocturnal frontal lobe epilepsy", "kb_id": "D017034", "start": 65, "end": 72}]}
{"text": "us to develop a set of primer pairs for PCR amplification of the complete coding region The sequence analysis provides the basis for a comprehensive mutation screening of CHRNA4 in the above mentioned phenotypes and possibly in other types of [E1] idiopathic epilepsies [/E1]", "mention_data": [{"mention": "idiopathic epilepsies", "kb_id": "D004827", "start": 150, "end": 153}]}
{"text": "A novel homeodomain encoding gene is associated with a large CpG island interrupted by the [E1] myotonic dystrophy [/E1] unstable CTG n repeat Myotonic dystrophy DM is associated with a CTG n trinucleotide repeat expansion in the 3 untranslated region of a protein kinase encoding gene DMPK which maps to chromosome 19q13 3 Characterisation of the expression of", "mention_data": [{"mention": "myotonic dystrophy", "kb_id": "D009223", "start": 15, "end": 18}]}
{"text": "A novel homeodomain encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable CTG n repeat [E1] Myotonic dystrophy [/E1] DM is associated with a CTG n trinucleotide repeat expansion in the 3 untranslated region of a protein kinase encoding gene DMPK which maps to chromosome 19q13 3 Characterisation of the expression of this gene in patient tissues has", "mention_data": [{"mention": "Myotonic dystrophy", "kb_id": "D009223", "start": 21, "end": 24}]}
{"text": "A novel homeodomain encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable CTG n repeat Myotonic dystrophy [E1] DM [/E1] is associated with a CTG n trinucleotide repeat expansion in the 3 untranslated region of a protein kinase encoding gene DMPK which maps to chromosome 19q13 3 Characterisation of the expression of this gene in patient tissues has thus", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 23, "end": 25}]}
{"text": "Characterisation of the expression of this gene in patient tissues has thus far generated conflicting data on alterations in the steady state levels of DMPK mRNA and on the final DMPK protein levels in the presence of the expansion The [E1] DM [/E1] region of chromosome 19 is gene rich and it is possible that the repeat expansion may lead to dysfunction of a number of transcription units in the vicinity perhaps as a consequence of chromatin disruption We have searched for", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 91, "end": 93}]}
{"text": "genomic sequences downstream centromeric of the repeat in human and mouse identified regions of significant homology These correspond to exons of a gene predicted to encode a homeodomain protein RT PCR analysis shows that this gene which we have called [E1] DM [/E1] locus associated homeodomain protein DMAHP is expressed in a number of human tissues including skeletal muscle heart and brain", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 206, "end": 208}]}
{"text": "Missense mutations in the Fas gene resulting in [E1] autoimmune lymphoproliferative syndrome [/E1] a molecular and immunological analysis Programmed cell death or apoptosis is a physiological process essential to the normal development and homeostatic maintenance of the immune system The Fas/Apo 1 receptor plays a crucial role in the regulation of apoptosis", "mention_data": [{"mention": "autoimmune lymphoproliferative syndrome", "kb_id": "D056735", "start": 8, "end": 12}]}
{"text": "physiological process essential to the normal development and homeostatic maintenance of the immune system The Fas/Apo 1 receptor plays a crucial role in the regulation of apoptosis as demonstrated by lymphoproliferation in MRL lpr/lpr mice and by the recently described [E1] autoimmune lymphoproliferative syndrome [/E1] ALPS in humans both of which are due to mutations in the Fas gene We describe a novel family with ALPS in which three affected siblings carry two distinct missense mutations on both the Fas gene alleles and show", "mention_data": [{"mention": "autoimmune lymphoproliferative syndrome", "kb_id": "D056735", "start": 63, "end": 67}]}
{"text": "to the normal development and homeostatic maintenance of the immune system The Fas/Apo 1 receptor plays a crucial role in the regulation of apoptosis as demonstrated by lymphoproliferation in MRL lpr/lpr mice and by the recently described autoimmune lymphoproliferative syndrome [E1] ALPS [/E1] in humans both of which are due to mutations in the Fas gene We describe a novel family with ALPS in which three affected siblings carry two distinct missense mutations on both the Fas gene alleles and show lack", "mention_data": [{"mention": "ALPS", "kb_id": "D056735", "start": 66, "end": 68}]}
{"text": "the regulation of apoptosis as demonstrated by lymphoproliferation in MRL lpr/lpr mice and by the recently described autoimmune lymphoproliferative syndrome ALPS in humans both of which are due to mutations in the Fas gene We describe a novel family with [E1] ALPS [/E1] in which three affected siblings carry two distinct missense mutations on both the Fas gene alleles and show lack of Fas induced apoptosis The children share common clinical features including splenomegaly and lymphadenopathy but only one developed severe autoimmune", "mention_data": [{"mention": "ALPS", "kb_id": "D056735", "start": 86, "end": 88}]}
{"text": "the Fas gene We describe a novel family with ALPS in which three affected siblings carry two distinct missense mutations on both the Fas gene alleles and show lack of Fas induced apoptosis The children share common clinical features including [E1] splenomegaly [/E1] and lymphadenopathy but only one developed severe autoimmune manifestations In all three siblings we demonstrated the presence of anergic CD3 CD4 CD8 double negative [DN] T cells moreover a chronic lymphocyte activation was found as demonstrated by the presence", "mention_data": [{"mention": "splenomegaly", "kb_id": "D013163", "start": 117, "end": 119}]}
{"text": "gene We describe a novel family with ALPS in which three affected siblings carry two distinct missense mutations on both the Fas gene alleles and show lack of Fas induced apoptosis The children share common clinical features including splenomegaly and [E1] lymphadenopathy [/E1] but only one developed severe autoimmune manifestations In all three siblings we demonstrated the presence of anergic CD3 CD4 CD8 double negative [DN] T cells moreover a chronic lymphocyte activation was found as demonstrated by the presence of high", "mention_data": [{"mention": "lymphadenopathy", "kb_id": "D008206", "start": 119, "end": 121}]}
{"text": "with ALPS in which three affected siblings carry two distinct missense mutations on both the Fas gene alleles and show lack of Fas induced apoptosis The children share common clinical features including splenomegaly and lymphadenopathy but only one developed severe [E1] autoimmune manifestations [/E1] In all three siblings we demonstrated the presence of anergic CD3 CD4 CD8 double negative [DN] T cells moreover a chronic lymphocyte activation was found as demonstrated by the presence of high levels of HLA DR expression on peripheral", "mention_data": [{"mention": "autoimmune manifestations", "kb_id": "D001327", "start": 125, "end": 128}]}
{"text": "Common BRCA1 variants and susceptibility to [E1] breast and ovarian cancer [/E1] in the general population Most multiple case families of young onset breast cancer and ovarian cancer are thought to be due to highly penetrant mutations in the predisposing genes BRCA1 and BRCA2 However these mutations are uncommon in the", "mention_data": [{"mention": "breast and ovarian cancer", "kb_id": "D001943|D010051", "start": 6, "end": 11}]}
{"text": "Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population Most multiple case families of young onset [E1] breast cancer [/E1] and ovarian cancer are thought to be due to highly penetrant mutations in the predisposing genes BRCA1 and BRCA2 However these mutations are uncommon in the population and they probably account for only a few percent of all breast", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 21, "end": 24}]}
{"text": "Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population Most multiple case families of young onset breast cancer and [E1] ovarian cancer [/E1] are thought to be due to highly penetrant mutations in the predisposing genes BRCA1 and BRCA2 However these mutations are uncommon in the population and they probably account for only a few percent of all breast cancer incidence A", "mention_data": [{"mention": "ovarian cancer", "kb_id": "D010051", "start": 24, "end": 27}]}
{"text": "breast cancer and ovarian cancer are thought to be due to highly penetrant mutations in the predisposing genes BRCA1 and BRCA2 However these mutations are uncommon in the population and they probably account for only a few percent of all [E1] breast cancer [/E1] incidence A much larger fraction of breast cancer might in principle be due to common variants which confer more modest individual risks There are several common polymorphisms in the BRCA1 gene which generate amino acid substitutions We have examined", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 61, "end": 64}]}
{"text": "be due to highly penetrant mutations in the predisposing genes BRCA1 and BRCA2 However these mutations are uncommon in the population and they probably account for only a few percent of all breast cancer incidence A much larger fraction of [E1] breast cancer [/E1] might in principle be due to common variants which confer more modest individual risks There are several common polymorphisms in the BRCA1 gene which generate amino acid substitutions We have examined the frequency of four of these polymorphisms Gln356Arg", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 69, "end": 72}]}
{"text": "variants which confer more modest individual risks There are several common polymorphisms in the BRCA1 gene which generate amino acid substitutions We have examined the frequency of four of these polymorphisms Gln356Arg Pro871Leu Glu1038Gly and Ser1613Gly in large series of [E1] breast and ovarian cancer [/E1] cases and matched controls Due to strong linkage disequilibrium these four sites generate only three haplotypes with a frequency 1 3 The most common haplotypes defined by the alleles Gln356Pro871Glu1038Ser1613 and Gln356Leu871Gly1038Gly1613 have frequencies of 0 57 and 0", "mention_data": [{"mention": "breast and ovarian cancer", "kb_id": "D001943|D010051", "start": 118, "end": 123}]}
{"text": "Gln356Pro871Glu1038Ser1613 and Gln356Leu871Gly1038Gly1613 have frequencies of 0 57 and 0 32 respectively and these frequencies do not differ significantly between patient and control groups Thus the most common polymorphisms of the BRCA1 gene do not make a significant contribution to [E1] breast or ovarian cancer [/E1] risk However our data suggest that the Arg356 allele may have a different genotype distribution in breast cancer patients from that in controls Arg356 homozygotes are more frequent in the control groups P 0 01 indicating that it may", "mention_data": [{"mention": "breast or ovarian cancer", "kb_id": "D001943|D010051", "start": 191, "end": 196}]}
{"text": "patient and control groups Thus the most common polymorphisms of the BRCA1 gene do not make a significant contribution to breast or ovarian cancer risk However our data suggest that the Arg356 allele may have a different genotype distribution in [E1] breast cancer [/E1] patients from that in controls Arg356 homozygotes are more frequent in the control groups P 0 01 indicating that it may be protective against breast cancer If this finding can be confirmed it may provide an insight into the", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 211, "end": 214}]}
{"text": "our data suggest that the Arg356 allele may have a different genotype distribution in breast cancer patients from that in controls Arg356 homozygotes are more frequent in the control groups P 0 01 indicating that it may be protective against [E1] breast cancer [/E1] If this finding can be confirmed it may provide an insight into the structural features of the BRCA1 protein that are important for its function", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 237, "end": 240}]}
{"text": "Mutation of the VHL gene is associated exclusively with the development of [E1] non papillary renal cell carcinomas [/E1] To define the possible role of the VHL gene in the development of sporadic renal cell carcinomas 91 different parenchymal tumours of the kidney have been investigated for mutation of the VHL gene by single strand conformation polymorphism SSCP", "mention_data": [{"mention": "non papillary renal cell carcinomas", "kb_id": "D002292", "start": 12, "end": 18}]}
{"text": "Mutation of the VHL gene is associated exclusively with the development of non papillary renal cell carcinomas To define the possible role of the [E1] VHL [/E1] gene in the development of sporadic renal cell carcinomas 91 different parenchymal tumours of the kidney have been investigated for mutation of the VHL gene by single strand conformation polymorphism SSCP and/or heteroduplex HD techniques Chromosome 3p deletion was", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 24, "end": 26}]}
{"text": "Mutation of the VHL gene is associated exclusively with the development of non papillary renal cell carcinomas To define the possible role of the VHL gene in the development of [E1] sporadic renal cell carcinomas [/E1] 91 different parenchymal tumours of the kidney have been investigated for mutation of the VHL gene by single strand conformation polymorphism SSCP and/or heteroduplex HD techniques Chromosome 3p deletion was detected in 98 per cent of non papillary renal", "mention_data": [{"mention": "sporadic renal cell carcinomas", "kb_id": "D002292", "start": 30, "end": 35}]}
{"text": "Mutation of the VHL gene is associated exclusively with the development of non papillary renal cell carcinomas To define the possible role of the VHL gene in the development of sporadic renal cell carcinomas 91 different [E1] parenchymal tumours of the kidney [/E1] have been investigated for mutation of the VHL gene by single strand conformation polymorphism SSCP and/or heteroduplex HD techniques Chromosome 3p deletion was detected in 98 per cent of non papillary renal cell carcinomas and in 25 per cent", "mention_data": [{"mention": "parenchymal tumours of the kidney", "kb_id": "D007674", "start": 36, "end": 42}]}
{"text": "with the development of non papillary renal cell carcinomas To define the possible role of the VHL gene in the development of sporadic renal cell carcinomas 91 different parenchymal tumours of the kidney have been investigated for mutation of the [E1] VHL [/E1] gene by single strand conformation polymorphism SSCP and/or heteroduplex HD techniques Chromosome 3p deletion was detected in 98 per cent of non papillary renal cell carcinomas and in 25 per cent of chromophobe renal cell carcinomas In 22 of", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 48, "end": 50}]}
{"text": "sporadic renal cell carcinomas 91 different parenchymal tumours of the kidney have been investigated for mutation of the VHL gene by single strand conformation polymorphism SSCP and/or heteroduplex HD techniques Chromosome 3p deletion was detected in 98 per cent of [E1] non papillary renal cell carcinomas [/E1] and in 25 per cent of chromophobe renal cell carcinomas In 22 of the 43 non papillary renal cell carcinomas abnormally migrating DNA bands were detected by SSCP and/or HD analysis No mobility shift was seen in any of", "mention_data": [{"mention": "non papillary renal cell carcinomas", "kb_id": "D002292", "start": 70, "end": 76}]}
{"text": "been investigated for mutation of the VHL gene by single strand conformation polymorphism SSCP and/or heteroduplex HD techniques Chromosome 3p deletion was detected in 98 per cent of non papillary renal cell carcinomas and in 25 per cent of chromophobe [E1] renal cell carcinomas [/E1] In 22 of the 43 non papillary renal cell carcinomas abnormally migrating DNA bands were detected by SSCP and/or HD analysis No mobility shift was seen in any of the 23 chromophobe renal cell carcinomas In addition 15 papillary", "mention_data": [{"mention": "renal cell carcinomas", "kb_id": "D002292", "start": 82, "end": 86}]}
{"text": "by single strand conformation polymorphism SSCP and/or heteroduplex HD techniques Chromosome 3p deletion was detected in 98 per cent of non papillary renal cell carcinomas and in 25 per cent of chromophobe renal cell carcinomas In 22 of the 43 [E1] non papillary renal cell carcinomas [/E1] abnormally migrating DNA bands were detected by SSCP and/or HD analysis No mobility shift was seen in any of the 23 chromophobe renal cell carcinomas In addition 15 papillary renal cell tumours and ten renal oncocytomas which are characterized", "mention_data": [{"mention": "non papillary renal cell carcinomas", "kb_id": "D002292", "start": 90, "end": 96}]}
{"text": "25 per cent of chromophobe renal cell carcinomas In 22 of the 43 non papillary renal cell carcinomas abnormally migrating DNA bands were detected by SSCP and/or HD analysis No mobility shift was seen in any of the 23 chromophobe [E1] renal cell carcinomas [/E1] In addition 15 papillary renal cell tumours and ten renal oncocytomas which are characterized by genetic changes other than loss of chromosome 3p sequences were analysed for mutation of the VHL gene None of these tumours showed abnormal migration", "mention_data": [{"mention": "renal cell carcinomas", "kb_id": "D002292", "start": 117, "end": 121}]}
{"text": "cell carcinomas In 22 of the 43 non papillary renal cell carcinomas abnormally migrating DNA bands were detected by SSCP and/or HD analysis No mobility shift was seen in any of the 23 chromophobe renal cell carcinomas In addition 15 [E1] papillary renal cell tumours [/E1] and ten renal oncocytomas which are characterized by genetic changes other than loss of chromosome 3p sequences were analysed for mutation of the VHL gene None of these tumours showed abnormal migration patterns The results indicate that mutation of", "mention_data": [{"mention": "papillary renal cell tumours", "kb_id": "D002292", "start": 123, "end": 128}]}
{"text": "43 non papillary renal cell carcinomas abnormally migrating DNA bands were detected by SSCP and/or HD analysis No mobility shift was seen in any of the 23 chromophobe renal cell carcinomas In addition 15 papillary renal cell tumours and ten [E1] renal oncocytomas [/E1] which are characterized by genetic changes other than loss of chromosome 3p sequences were analysed for mutation of the VHL gene None of these tumours showed abnormal migration patterns The results indicate that mutation of the VHL gene is", "mention_data": [{"mention": "renal oncocytomas", "kb_id": "C537750", "start": 129, "end": 132}]}
{"text": "seen in any of the 23 chromophobe renal cell carcinomas In addition 15 papillary renal cell tumours and ten renal oncocytomas which are characterized by genetic changes other than loss of chromosome 3p sequences were analysed for mutation of the [E1] VHL [/E1] gene None of these tumours showed abnormal migration patterns The results indicate that mutation of the VHL gene is associated exclusively with the development of non papillary renal cell carcinoma", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 150, "end": 152}]}
{"text": "23 chromophobe renal cell carcinomas In addition 15 papillary renal cell tumours and ten renal oncocytomas which are characterized by genetic changes other than loss of chromosome 3p sequences were analysed for mutation of the VHL gene None of these [E1] tumours [/E1] showed abnormal migration patterns The results indicate that mutation of the VHL gene is associated exclusively with the development of non papillary renal cell carcinoma", "mention_data": [{"mention": "tumours", "kb_id": "D009369", "start": 155, "end": 157}]}
{"text": "and ten renal oncocytomas which are characterized by genetic changes other than loss of chromosome 3p sequences were analysed for mutation of the VHL gene None of these tumours showed abnormal migration patterns The results indicate that mutation of the [E1] VHL [/E1] gene is associated exclusively with the development of non papillary renal cell carcinoma", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 167, "end": 169}]}
{"text": "changes other than loss of chromosome 3p sequences were analysed for mutation of the VHL gene None of these tumours showed abnormal migration patterns The results indicate that mutation of the VHL gene is associated exclusively with the development of [E1] non papillary renal cell carcinoma [/E1]", "mention_data": [{"mention": "non papillary renal cell carcinoma", "kb_id": "D002292", "start": 176, "end": 182}]}
{"text": "Comparative genome mapping of the [E1] ataxia telangiectasia [/E1] region in mouse rat and Syrian hamster Chromosomal locations of the Atm ataxia telangiectasia AT mutated and Acat1 mitochondrial acetoacetyl CoA thiolase genes in mouse rat and Syrian hamster were determined by direct R banding FISH Both genes were", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 5, "end": 8}]}
{"text": "Comparative genome mapping of the ataxia telangiectasia region in mouse rat and Syrian hamster Chromosomal locations of the Atm [E1] ataxia telangiectasia [/E1] AT mutated and Acat1 mitochondrial acetoacetyl CoA thiolase genes in mouse rat and Syrian hamster were determined by direct R banding FISH Both genes were colocalized to the C D band of mouse chromosome 9 the proximal end of", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 19, "end": 22}]}
{"text": "Comparative genome mapping of the ataxia telangiectasia region in mouse rat and Syrian hamster Chromosomal locations of the Atm ataxia telangiectasia [E1] AT [/E1] mutated and Acat1 mitochondrial acetoacetyl CoA thiolase genes in mouse rat and Syrian hamster were determined by direct R banding FISH Both genes were colocalized to the C D band of mouse chromosome 9 the proximal end of q24", "mention_data": [{"mention": "AT", "kb_id": "D001260", "start": 21, "end": 23}]}
{"text": "chromosome 9 the proximal end of q24 1 of rat chromosome 8 and qa4 qa5 of Syrian hamster chromosome 12 The regions in the mouse and rat were homologous to human chromosome 11q Fine genetic linkage mapping of the mouse [E1] AT [/E1] region was performed using the interspecific backcross mice Atm Acat1 and Npat which is a new gene isolated from the AT region and 12 flanking microsatellite DNA markers were examined No recombinations were found among the Atm Npat Acat1", "mention_data": [{"mention": "AT", "kb_id": "D001260", "start": 94, "end": 96}]}
{"text": "[E1] Tumor [/E1] suppression and apoptosis of human prostate carcinoma mediated by a genetic locus within human chromosome 10pter q11 Prostate cancer is the second leading cause of male cancer deaths in the United States Yet despite a large international effort little", "mention_data": [{"mention": "Tumor", "kb_id": "D009369", "start": 0, "end": 2}]}
{"text": "Tumor suppression and apoptosis of human [E1] prostate carcinoma [/E1] mediated by a genetic locus within human chromosome 10pter q11 Prostate cancer is the second leading cause of male cancer deaths in the United States Yet despite a large international effort little is known about the molecular mechanisms that", "mention_data": [{"mention": "prostate carcinoma", "kb_id": "D011471", "start": 6, "end": 9}]}
{"text": "Tumor suppression and apoptosis of human prostate carcinoma mediated by a genetic locus within human chromosome 10pter q11 [E1] Prostate cancer [/E1] is the second leading cause of male cancer deaths in the United States Yet despite a large international effort little is known about the molecular mechanisms that underlie this devastating disease Prostate secretory epithelial cells and androgen dependent prostate", "mention_data": [{"mention": "Prostate cancer", "kb_id": "D011471", "start": 18, "end": 21}]}
{"text": "Tumor suppression and apoptosis of human prostate carcinoma mediated by a genetic locus within human chromosome 10pter q11 Prostate cancer is the second leading cause of male [E1] cancer [/E1] deaths in the United States Yet despite a large international effort little is known about the molecular mechanisms that underlie this devastating disease Prostate secretory epithelial cells and androgen dependent prostate carcinomas undergo apoptosis in response to androgen deprivation", "mention_data": [{"mention": "cancer", "kb_id": "D009369", "start": 27, "end": 29}]}
{"text": "Prostate cancer is the second leading cause of male cancer deaths in the United States Yet despite a large international effort little is known about the molecular mechanisms that underlie this devastating disease Prostate secretory epithelial cells and androgen dependent [E1] prostate carcinomas [/E1] undergo apoptosis in response to androgen deprivation and furthermore most prostate carcinomas become androgen independent and refractory to further therapeutic manipulations during disease progression Definition of the genetic events that trigger apoptosis in the prostate could provide important insights", "mention_data": [{"mention": "prostate carcinomas", "kb_id": "D011471", "start": 58, "end": 61}]}
{"text": "the United States Yet despite a large international effort little is known about the molecular mechanisms that underlie this devastating disease Prostate secretory epithelial cells and androgen dependent prostate carcinomas undergo apoptosis in response to androgen deprivation and furthermore most [E1] prostate carcinomas [/E1] become androgen independent and refractory to further therapeutic manipulations during disease progression Definition of the genetic events that trigger apoptosis in the prostate could provide important insights into critical pathways in normal development as well as elucidate the perturbations", "mention_data": [{"mention": "prostate carcinomas", "kb_id": "D011471", "start": 70, "end": 73}]}
{"text": "as well as elucidate the perturbations of those key pathways in neoplastic transformation We report the functional definition of a novel genetic locus within human chromosome 10pter q11 that mediates both in vivo tumor suppression and in vitro apoptosis of [E1] prostatic adenocarcinoma [/E1] cells A defined fragment of human chromosome 10 was transferred via microcell fusion into a prostate adenocarcinoma cell line Microcell hybrids containing only the region 10pter q11 were suppressed for tumorigenicity following injection of microcell hybrids into nude mice", "mention_data": [{"mention": "prostatic adenocarcinoma", "kb_id": "D011471", "start": 145, "end": 148}]}
{"text": "definition of a novel genetic locus within human chromosome 10pter q11 that mediates both in vivo tumor suppression and in vitro apoptosis of prostatic adenocarcinoma cells A defined fragment of human chromosome 10 was transferred via microcell fusion into a [E1] prostate adenocarcinoma [/E1] cell line Microcell hybrids containing only the region 10pter q11 were suppressed for tumorigenicity following injection of microcell hybrids into nude mice Furthermore the complemented hybrids undergo programmed cell death in vitro via a mechanism that does not require", "mention_data": [{"mention": "prostate adenocarcinoma", "kb_id": "D011471", "start": 162, "end": 165}]}
{"text": "the complemented hybrids undergo programmed cell death in vitro via a mechanism that does not require nuclear localization of p53 These data functionally define a novel genetic locus designated PAC1 for prostate adenocarcinoma 1 involved in tumor suppression of human [E1] prostate carcinoma [/E1] and furthermore strongly suggest that the cell death pathway can be functionally restored in prostatic adenocarcinoma", "mention_data": [{"mention": "prostate carcinoma", "kb_id": "D011471", "start": 227, "end": 230}]}
{"text": "nuclear localization of p53 These data functionally define a novel genetic locus designated PAC1 for prostate adenocarcinoma 1 involved in tumor suppression of human prostate carcinoma and furthermore strongly suggest that the cell death pathway can be functionally restored in [E1] prostatic adenocarcinoma [/E1]", "mention_data": [{"mention": "prostatic adenocarcinoma", "kb_id": "D011471", "start": 243, "end": 246}]}
{"text": "Phenotypic and genotypic overlap between [E1] atelosteogenesis type 2 [/E1] and diastrophic dysplasia Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises in order of increasing severity diastrophic dysplasia DTD atelosteogenesis type 2 AO2 and achondrogenesis type 1B ACG1B", "mention_data": [{"mention": "atelosteogenesis type 2", "kb_id": "C535395", "start": 5, "end": 9}]}
{"text": "Phenotypic and genotypic overlap between atelosteogenesis type 2 and [E1] diastrophic dysplasia [/E1] Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises in order of increasing severity diastrophic dysplasia DTD atelosteogenesis type 2 AO2 and achondrogenesis type 1B ACG1B To learn more", "mention_data": [{"mention": "diastrophic dysplasia", "kb_id": "C536170", "start": 9, "end": 12}]}
{"text": "Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia Mutations in the [E1] diastrophic dysplasia [/E1] sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises in order of increasing severity diastrophic dysplasia DTD atelosteogenesis type 2 AO2 and achondrogenesis type 1B ACG1B To learn more about the molecular basis of", "mention_data": [{"mention": "diastrophic dysplasia", "kb_id": "C536170", "start": 14, "end": 17}]}
{"text": "Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of [E1] chondrodysplasias [/E1] that comprises in order of increasing severity diastrophic dysplasia DTD atelosteogenesis type 2 AO2 and achondrogenesis type 1B ACG1B To learn more about the molecular basis of DTDST chondrodysplasias and about genotype phenotype correlations we studied fibroblast cultures of", "mention_data": [{"mention": "chondrodysplasias", "kb_id": "D010009", "start": 27, "end": 29}]}
{"text": "Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises in order of increasing severity [E1] diastrophic dysplasia [/E1] DTD atelosteogenesis type 2 AO2 and achondrogenesis type 1B ACG1B To learn more about the molecular basis of DTDST chondrodysplasias and about genotype phenotype correlations we studied fibroblast cultures of three new patients one with AO 2 one with", "mention_data": [{"mention": "diastrophic dysplasia", "kb_id": "C536170", "start": 35, "end": 38}]}
{"text": "Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises in order of increasing severity diastrophic dysplasia [E1] DTD [/E1] atelosteogenesis type 2 AO2 and achondrogenesis type 1B ACG1B To learn more about the molecular basis of DTDST chondrodysplasias and about genotype phenotype correlations we studied fibroblast cultures of three new patients one with AO 2 one with DTD", "mention_data": [{"mention": "DTD", "kb_id": "C536170", "start": 37, "end": 39}]}
{"text": "Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises in order of increasing severity diastrophic dysplasia DTD [E1] atelosteogenesis type 2 [/E1] AO2 and achondrogenesis type 1B ACG1B To learn more about the molecular basis of DTDST chondrodysplasias and about genotype phenotype correlations we studied fibroblast cultures of three new patients one with AO 2 one with DTD and one with", "mention_data": [{"mention": "atelosteogenesis type 2", "kb_id": "C535395", "start": 38, "end": 42}]}
{"text": "and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises in order of increasing severity diastrophic dysplasia DTD atelosteogenesis type 2 [E1] AO2 [/E1] and achondrogenesis type 1B ACG1B To learn more about the molecular basis of DTDST chondrodysplasias and about genotype phenotype correlations we studied fibroblast cultures of three new patients one with AO 2 one with DTD and one with an", "mention_data": [{"mention": "AO2", "kb_id": "C535395", "start": 41, "end": 43}]}
{"text": "overlap between atelosteogenesis type 2 and diastrophic dysplasia Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises in order of increasing severity diastrophic dysplasia DTD atelosteogenesis type 2 AO2 and [E1] achondrogenesis type 1B [/E1] ACG1B To learn more about the molecular basis of DTDST chondrodysplasias and about genotype phenotype correlations we studied fibroblast cultures of three new patients one with AO 2 one with DTD and one with an intermediate phenotype AO2/DTD Reduced", "mention_data": [{"mention": "achondrogenesis type 1B", "kb_id": "C536016", "start": 43, "end": 47}]}
{"text": "type 2 and diastrophic dysplasia Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises in order of increasing severity diastrophic dysplasia DTD atelosteogenesis type 2 AO2 and achondrogenesis type 1B [E1] ACG1B [/E1] To learn more about the molecular basis of DTDST chondrodysplasias and about genotype phenotype correlations we studied fibroblast cultures of three new patients one with AO 2 one with DTD and one with an intermediate phenotype AO2/DTD Reduced incorporation", "mention_data": [{"mention": "ACG1B", "kb_id": "C536016", "start": 46, "end": 48}]}
{"text": "dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises in order of increasing severity diastrophic dysplasia DTD atelosteogenesis type 2 AO2 and achondrogenesis type 1B ACG1B To learn more about the molecular basis of [E1] DTDST chondrodysplasias [/E1] and about genotype phenotype correlations we studied fibroblast cultures of three new patients one with AO 2 one with DTD and one with an intermediate phenotype AO2/DTD Reduced incorporation of inorganic sulfate into macromolecules was found in all three", "mention_data": [{"mention": "DTDST chondrodysplasias", "kb_id": "222600", "start": 55, "end": 58}]}
{"text": "of increasing severity diastrophic dysplasia DTD atelosteogenesis type 2 AO2 and achondrogenesis type 1B ACG1B To learn more about the molecular basis of DTDST chondrodysplasias and about genotype phenotype correlations we studied fibroblast cultures of three new patients one with [E1] AO 2 [/E1] one with DTD and one with an intermediate phenotype AO2/DTD Reduced incorporation of inorganic sulfate into macromolecules was found in all three Each of the three patients was found to be heterozygous for a c862t transition predicting a R279W", "mention_data": [{"mention": "AO 2", "kb_id": "C535395", "start": 72, "end": 75}]}
{"text": "dysplasia DTD atelosteogenesis type 2 AO2 and achondrogenesis type 1B ACG1B To learn more about the molecular basis of DTDST chondrodysplasias and about genotype phenotype correlations we studied fibroblast cultures of three new patients one with AO 2 one with [E1] DTD [/E1] and one with an intermediate phenotype AO2/DTD Reduced incorporation of inorganic sulfate into macromolecules was found in all three Each of the three patients was found to be heterozygous for a c862t transition predicting a R279W substitution in the", "mention_data": [{"mention": "DTD", "kb_id": "C536170", "start": 76, "end": 78}]}
{"text": "achondrogenesis type 1B ACG1B To learn more about the molecular basis of DTDST chondrodysplasias and about genotype phenotype correlations we studied fibroblast cultures of three new patients one with AO 2 one with DTD and one with an intermediate phenotype [E1] AO2 [/E1] /DTD Reduced incorporation of inorganic sulfate into macromolecules was found in all three Each of the three patients was found to be heterozygous for a c862t transition predicting a R279W substitution in the third extracellular loop of DTDST In", "mention_data": [{"mention": "AO2", "kb_id": "C535395", "start": 83, "end": 85}]}
{"text": "type 1B ACG1B To learn more about the molecular basis of DTDST chondrodysplasias and about genotype phenotype correlations we studied fibroblast cultures of three new patients one with AO 2 one with DTD and one with an intermediate phenotype AO2/ [E1] DTD [/E1] Reduced incorporation of inorganic sulfate into macromolecules was found in all three Each of the three patients was found to be heterozygous for a c862t transition predicting a R279W substitution in the third extracellular loop of DTDST In two", "mention_data": [{"mention": "DTD", "kb_id": "C536170", "start": 84, "end": 86}]}
{"text": "Reduced incorporation of inorganic sulfate into macromolecules was found in all three Each of the three patients was found to be heterozygous for a c862t transition predicting a R279W substitution in the third extracellular loop of DTDST In two patients [E1] DTD [/E1] and AO2/DTD no other structural mutation was found but polymerase chain reaction amplification and single strand conformation polymorphism analysis of fibroblast cDNA showed reduced mRNA levels of the wild type DTDST allele these two patients may be compound heterozygotes", "mention_data": [{"mention": "DTD", "kb_id": "C536170", "start": 124, "end": 126}]}
{"text": "of inorganic sulfate into macromolecules was found in all three Each of the three patients was found to be heterozygous for a c862t transition predicting a R279W substitution in the third extracellular loop of DTDST In two patients DTD and [E1] AO2 [/E1] /DTD no other structural mutation was found but polymerase chain reaction amplification and single strand conformation polymorphism analysis of fibroblast cDNA showed reduced mRNA levels of the wild type DTDST allele these two patients may be compound heterozygotes for", "mention_data": [{"mention": "AO2", "kb_id": "C535395", "start": 126, "end": 128}]}
{"text": "inorganic sulfate into macromolecules was found in all three Each of the three patients was found to be heterozygous for a c862t transition predicting a R279W substitution in the third extracellular loop of DTDST In two patients DTD and AO2/ [E1] DTD [/E1] no other structural mutation was found but polymerase chain reaction amplification and single strand conformation polymorphism analysis of fibroblast cDNA showed reduced mRNA levels of the wild type DTDST allele these two patients may be compound heterozygotes for the", "mention_data": [{"mention": "DTD", "kb_id": "C536170", "start": 127, "end": 129}]}
{"text": "fibroblast cDNA showed reduced mRNA levels of the wild type DTDST allele these two patients may be compound heterozygotes for the Finnish mutation as yet uncharacterized at the DNA level which causes reduced expression of DTDST The third patient with [E1] AO2 [/E1] had the R279W mutation compounded with a novel mutation the deletion of cytosine 418 delta c418 predicting a frameshift with premature termination Also the delta c418 allele was underrepresented in the cDNA in accordance with previous observations that premature", "mention_data": [{"mention": "AO2", "kb_id": "C535395", "start": 185, "end": 187}]}
{"text": "frameshift with premature termination Also the delta c418 allele was underrepresented in the cDNA in accordance with previous observations that premature stop codons reduce mRNA levels The presence of the DTDST R279W mutation in a total of 11 patients with [E1] AO2 [/E1] or DTD emphasizes the overlap between these conditions This mutation has not been found so far in 8 analyzed ACG1B patients suggesting that it allows some residual activity of the sulfate transporter", "mention_data": [{"mention": "AO2", "kb_id": "C535395", "start": 244, "end": 246}]}
{"text": "premature termination Also the delta c418 allele was underrepresented in the cDNA in accordance with previous observations that premature stop codons reduce mRNA levels The presence of the DTDST R279W mutation in a total of 11 patients with AO2 or [E1] DTD [/E1] emphasizes the overlap between these conditions This mutation has not been found so far in 8 analyzed ACG1B patients suggesting that it allows some residual activity of the sulfate transporter", "mention_data": [{"mention": "DTD", "kb_id": "C536170", "start": 246, "end": 248}]}
{"text": "premature stop codons reduce mRNA levels The presence of the DTDST R279W mutation in a total of 11 patients with AO2 or DTD emphasizes the overlap between these conditions This mutation has not been found so far in 8 analyzed [E1] ACG1B [/E1] patients suggesting that it allows some residual activity of the sulfate transporter", "mention_data": [{"mention": "ACG1B", "kb_id": "C536016", "start": 264, "end": 266}]}
{"text": "Cloning of the homogentisate 1 2 dioxygenase gene the key enzyme of [E1] alkaptonuria [/E1] in mouse We determined 48 amino acid residues from five peptides from the homogeneous monomer of homogentisate 1 2 dioxygenase HGO E C 1 13 11 15 of mouse liver After digestion with trypsin peptides were separated by reversed", "mention_data": [{"mention": "alkaptonuria", "kb_id": "D000474", "start": 12, "end": 14}]}
{"text": "shown by RT PCR on different cDNAs FISH experiments with the whole murine cDNA as probe clearly revealed signals at the human chromosomal band 3q13 3 q21 This corresponds well to the previous assignment of the locus for the human [E1] alkaptonuria [/E1] gene AKU to the same chromosomal region by multipoint linkage analysis We therefore conclude that the HGO cDNA encodes the gene responsible for alkaptonuria", "mention_data": [{"mention": "alkaptonuria", "kb_id": "D000474", "start": 256, "end": 258}]}
{"text": "3q13 3 q21 This corresponds well to the previous assignment of the locus for the human alkaptonuria gene AKU to the same chromosomal region by multipoint linkage analysis We therefore conclude that the HGO cDNA encodes the gene responsible for [E1] alkaptonuria [/E1]", "mention_data": [{"mention": "alkaptonuria", "kb_id": "D000474", "start": 280, "end": 282}]}
{"text": "Abnormal [E1] myotonic dystrophy [/E1] protein kinase levels produce only mild myopathy in mice Myotonic dystrophy DM is commonly associated with CTG repeat expansions within the gene for DM protein kinase DMPK The effect of altered expression levels of DMPK which is ubiquitously expressed", "mention_data": [{"mention": "myotonic dystrophy", "kb_id": "D009223", "start": 1, "end": 4}]}
{"text": "Abnormal myotonic dystrophy protein kinase levels produce only mild [E1] myopathy [/E1] in mice Myotonic dystrophy DM is commonly associated with CTG repeat expansions within the gene for DM protein kinase DMPK The effect of altered expression levels of DMPK which is ubiquitously expressed in all muscle cell lineages during development", "mention_data": [{"mention": "myopathy", "kb_id": "D009135", "start": 9, "end": 11}]}
{"text": "Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice [E1] Myotonic dystrophy [/E1] DM is commonly associated with CTG repeat expansions within the gene for DM protein kinase DMPK The effect of altered expression levels of DMPK which is ubiquitously expressed in all muscle cell lineages during development was examined by disrupting", "mention_data": [{"mention": "Myotonic dystrophy", "kb_id": "D009223", "start": 12, "end": 15}]}
{"text": "Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice Myotonic dystrophy [E1] DM [/E1] is commonly associated with CTG repeat expansions within the gene for DM protein kinase DMPK The effect of altered expression levels of DMPK which is ubiquitously expressed in all muscle cell lineages during development was examined by disrupting the", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 14, "end": 16}]}
{"text": "the endogenous Dmpk gene and overexpressing a normal human DMPK transgene in mice Nullizygous / mice showed only inconsistent and minor size changes in head and neck muscle fibres at older age animals with the highest DMPK transgene expression showed [E1] hypertrophic cardiomyopathy [/E1] and enhanced neonatal mortality However both models lack other frequent DM symptoms including the fibre type dependent atrophy myotonia cataract and male infertility These results strengthen the contention that simple loss or gain of expression of DMPK is not", "mention_data": [{"mention": "hypertrophic cardiomyopathy", "kb_id": "D002312", "start": 93, "end": 96}]}
{"text": "mice Nullizygous / mice showed only inconsistent and minor size changes in head and neck muscle fibres at older age animals with the highest DMPK transgene expression showed hypertrophic cardiomyopathy and enhanced neonatal mortality However both models lack other frequent [E1] DM [/E1] symptoms including the fibre type dependent atrophy myotonia cataract and male infertility These results strengthen the contention that simple loss or gain of expression of DMPK is not the only crucial requirement for development of the disease", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 105, "end": 107}]}
{"text": "and minor size changes in head and neck muscle fibres at older age animals with the highest DMPK transgene expression showed hypertrophic cardiomyopathy and enhanced neonatal mortality However both models lack other frequent DM symptoms including the fibre type dependent [E1] atrophy [/E1] myotonia cataract and male infertility These results strengthen the contention that simple loss or gain of expression of DMPK is not the only crucial requirement for development of the disease", "mention_data": [{"mention": "atrophy", "kb_id": "D001284", "start": 112, "end": 114}]}
{"text": "minor size changes in head and neck muscle fibres at older age animals with the highest DMPK transgene expression showed hypertrophic cardiomyopathy and enhanced neonatal mortality However both models lack other frequent DM symptoms including the fibre type dependent atrophy [E1] myotonia [/E1] cataract and male infertility These results strengthen the contention that simple loss or gain of expression of DMPK is not the only crucial requirement for development of the disease", "mention_data": [{"mention": "myotonia", "kb_id": "D009222", "start": 113, "end": 115}]}
{"text": "size changes in head and neck muscle fibres at older age animals with the highest DMPK transgene expression showed hypertrophic cardiomyopathy and enhanced neonatal mortality However both models lack other frequent DM symptoms including the fibre type dependent atrophy myotonia [E1] cataract [/E1] and male infertility These results strengthen the contention that simple loss or gain of expression of DMPK is not the only crucial requirement for development of the disease", "mention_data": [{"mention": "cataract", "kb_id": "D002386", "start": 114, "end": 116}]}
{"text": "in head and neck muscle fibres at older age animals with the highest DMPK transgene expression showed hypertrophic cardiomyopathy and enhanced neonatal mortality However both models lack other frequent DM symptoms including the fibre type dependent atrophy myotonia cataract and [E1] male infertility [/E1] These results strengthen the contention that simple loss or gain of expression of DMPK is not the only crucial requirement for development of the disease", "mention_data": [{"mention": "male infertility", "kb_id": "D007248", "start": 116, "end": 119}]}
{"text": "Molecular bases of [E1] combined subtotal deficiencies of C6 and C7 [/E1] their effects in combination with other C6 and C7 deficiencies Combined subtotal deficiency of C6 and C7 in which both proteins are expressed at very low levels has been observed in homozygous form in two families A defect at", "mention_data": [{"mention": "combined subtotal deficiencies of C6 and C7", "kb_id": "612446|610102", "start": 3, "end": 11}]}
{"text": "Molecular bases of combined subtotal deficiencies of C6 and C7 their effects in combination with other [E1] C6 and C7 deficiencies [/E1] Combined subtotal deficiency of C6 and C7 in which both proteins are expressed at very low levels has been observed in homozygous form in two families A defect at the 5 splice donor site of intron 15 of the", "mention_data": [{"mention": "C6 and C7 deficiencies", "kb_id": "612446|610102", "start": 16, "end": 21}]}
{"text": "Molecular bases of combined subtotal deficiencies of C6 and C7 their effects in combination with other C6 and C7 deficiencies [E1] Combined subtotal deficiency of C6 and C7 [/E1] in which both proteins are expressed at very low levels has been observed in homozygous form in two families A defect at the 5 splice donor site of intron 15 of the C6 gene explains the low molecular weight", "mention_data": [{"mention": "Combined subtotal deficiency of C6 and C7", "kb_id": "612446|610102", "start": 20, "end": 28}]}
{"text": "These defects are associated with a characteristic set of polymorphic DNA markers in the C6/C7 region forming a distinct haplotype The haplotype has been found in combination with a number of other haplotypes containing defective genes that lead either to [E1] C6 or C7 deficiency [/E1] but with different consequences Where it is combined with a C6 deficient gene the serum C7 levels can be surprisingly high possibly because there is no C6 generating C56 to consume the C7 In contrast where the C7 genes", "mention_data": [{"mention": "C6 or C7 deficiency", "kb_id": "612446|610102", "start": 157, "end": 162}]}
{"text": "C6/C7 region forming a distinct haplotype The haplotype has been found in combination with a number of other haplotypes containing defective genes that lead either to C6 or C7 deficiency but with different consequences Where it is combined with a [E1] C6 deficient [/E1] gene the serum C7 levels can be surprisingly high possibly because there is no C6 generating C56 to consume the C7 In contrast where the C7 genes are both defective but still partially functional there may be a profound", "mention_data": [{"mention": "C6 deficient", "kb_id": "612446", "start": 171, "end": 174}]}
{"text": "Constitutively methylated CpG dinucleotides as mutation hot spots in the [E1] retinoblastoma [/E1] gene RB1 A wide spectrum of mutations ranging from point mutations to large deletions have been described in the retinoblastoma gene RB1 Mutations have been found throughout the gene however these genetic alterations do not appear to be homogeneously", "mention_data": [{"mention": "retinoblastoma", "kb_id": "D012175", "start": 10, "end": 12}]}
{"text": "Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene RB1 A wide spectrum of mutations ranging from point mutations to large deletions have been described in the [E1] retinoblastoma [/E1] gene RB1 Mutations have been found throughout the gene however these genetic alterations do not appear to be homogeneously distributed In particular a significant proportion of disease causing mutations results in the premature termination of protein synthesis and the", "mention_data": [{"mention": "retinoblastoma", "kb_id": "D012175", "start": 30, "end": 32}]}
{"text": "The TSG101 [E1] tumor [/E1] susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer Recent work has identified a mouse gene tsg101 whose inactivation in fibroblasts results in cellular transformation and the ability to produce metastatic tumors", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 2, "end": 4}]}
{"text": "The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human [E1] breast cancer [/E1] Recent work has identified a mouse gene tsg101 whose inactivation in fibroblasts results in cellular transformation and the ability to produce metastatic tumors in nude mice Here we report that the human homolog TSG101 which we isolated and mapped", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 17, "end": 20}]}
{"text": "The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer Recent work has identified a mouse gene tsg101 whose inactivation in fibroblasts results in cellular transformation and the ability to produce [E1] metastatic tumors [/E1] in nude mice Here we report that the human homolog TSG101 which we isolated and mapped to chromosome 11 bands 15 1 15 1 15 2 a region proposed to contain tumor suppressor gene s is mutated at high", "mention_data": [{"mention": "metastatic tumors", "kb_id": "D009362", "start": 40, "end": 43}]}
{"text": "cellular transformation and the ability to produce metastatic tumors in nude mice Here we report that the human homolog TSG101 which we isolated and mapped to chromosome 11 bands 15 1 15 1 15 2 a region proposed to contain [E1] tumor [/E1] suppressor gene s is mutated at high frequency in human breast cancer In 7 of 15 uncultured primary human breast carcinomas intragenic deletions were shown in TSG101 genomic DNA and transcripts by gel and sequence analysis and mutations affecting", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 73, "end": 75}]}
{"text": "mice Here we report that the human homolog TSG101 which we isolated and mapped to chromosome 11 bands 15 1 15 1 15 2 a region proposed to contain tumor suppressor gene s is mutated at high frequency in human [E1] breast cancer [/E1] In 7 of 15 uncultured primary human breast carcinomas intragenic deletions were shown in TSG101 genomic DNA and transcripts by gel and sequence analysis and mutations affecting two TSG101 alleles were identified in four of these cancers No TSG101", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 84, "end": 87}]}
{"text": "which we isolated and mapped to chromosome 11 bands 15 1 15 1 15 2 a region proposed to contain tumor suppressor gene s is mutated at high frequency in human breast cancer In 7 of 15 uncultured primary human [E1] breast carcinomas [/E1] intragenic deletions were shown in TSG101 genomic DNA and transcripts by gel and sequence analysis and mutations affecting two TSG101 alleles were identified in four of these cancers No TSG101 defects were found in matched normal breast tissue from", "mention_data": [{"mention": "breast carcinomas", "kb_id": "D001943", "start": 93, "end": 96}]}
{"text": "in human breast cancer In 7 of 15 uncultured primary human breast carcinomas intragenic deletions were shown in TSG101 genomic DNA and transcripts by gel and sequence analysis and mutations affecting two TSG101 alleles were identified in four of these [E1] cancers [/E1] No TSG101 defects were found in matched normal breast tissue from the breast cancer patients These findings strongly implicate TSG101 mutations in human breast cancer", "mention_data": [{"mention": "cancers", "kb_id": "D009369", "start": 122, "end": 124}]}
{"text": "intragenic deletions were shown in TSG101 genomic DNA and transcripts by gel and sequence analysis and mutations affecting two TSG101 alleles were identified in four of these cancers No TSG101 defects were found in matched normal breast tissue from the [E1] breast cancer [/E1] patients These findings strongly implicate TSG101 mutations in human breast cancer", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 135, "end": 138}]}
{"text": "gel and sequence analysis and mutations affecting two TSG101 alleles were identified in four of these cancers No TSG101 defects were found in matched normal breast tissue from the breast cancer patients These findings strongly implicate TSG101 mutations in human [E1] breast cancer [/E1]", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 146, "end": 149}]}
{"text": "The [E1] Emery Dreifuss muscular dystrophy [/E1] protein emerin is a nuclear membrane protein A large fragment of emerin cDNA was prepared by PCR and expressed as a recombinant protein in Escherichia coli Using this as immunogen we prepared a panel of 12 monoclonal antibodies which", "mention_data": [{"mention": "Emery Dreifuss muscular dystrophy", "kb_id": "D020389", "start": 1, "end": 6}]}
{"text": "recognised a 34 kDa protein in all tissues tested though minor emerin related bands were also detected in some tissues Immunofluorescence microscopy showed that emerin is located at the nuclear rim in all tissues examined A muscle biopsy from an [E1] Emery Dreifuss muscular dystrophy [/E1] EMDM patient showed complete absence of emerin by both Western blotting and immunohistochemistry suggesting a simple diagnostic antibody test for EDMD families Biochemical fractionation of brain and liver tissues showed that emerin was present in nuclei purified by centrifugation", "mention_data": [{"mention": "Emery Dreifuss muscular dystrophy", "kb_id": "D020389", "start": 110, "end": 115}]}
{"text": "protein in all tissues tested though minor emerin related bands were also detected in some tissues Immunofluorescence microscopy showed that emerin is located at the nuclear rim in all tissues examined A muscle biopsy from an Emery Dreifuss muscular dystrophy [E1] EMDM [/E1] patient showed complete absence of emerin by both Western blotting and immunohistochemistry suggesting a simple diagnostic antibody test for EDMD families Biochemical fractionation of brain and liver tissues showed that emerin was present in nuclei purified by centrifugation through", "mention_data": [{"mention": "EMDM", "kb_id": "D020389", "start": 114, "end": 116}]}
{"text": "emerin is located at the nuclear rim in all tissues examined A muscle biopsy from an Emery Dreifuss muscular dystrophy EMDM patient showed complete absence of emerin by both Western blotting and immunohistochemistry suggesting a simple diagnostic antibody test for [E1] EDMD [/E1] families Biochemical fractionation of brain and liver tissues showed that emerin was present in nuclei purified by centrifugation through 65 sucrose and was absent from soluble fractions post 100 000 g From these results together with sequence and structural", "mention_data": [{"mention": "EDMD", "kb_id": "D020389", "start": 134, "end": 136}]}
{"text": "Influence of PAX6 gene dosage on development overexpression causes severe [E1] eye abnormalities [/E1] Aniridia in man and Small eye in mice are semidominant developmental disorders caused by mutations within the paired box gene PAX6 Whereas heterozygotes suffer from iris hypoplasia homozygous mice lack eyes and nasal cavities and exhibit brain abnormalities To", "mention_data": [{"mention": "eye abnormalities", "kb_id": "D005124", "start": 10, "end": 13}]}
{"text": "Influence of PAX6 gene dosage on development overexpression causes severe eye abnormalities [E1] Aniridia [/E1] in man and Small eye in mice are semidominant developmental disorders caused by mutations within the paired box gene PAX6 Whereas heterozygotes suffer from iris hypoplasia homozygous mice lack eyes and nasal cavities and exhibit brain abnormalities To investigate", "mention_data": [{"mention": "Aniridia", "kb_id": "D015783", "start": 12, "end": 14}]}
{"text": "Influence of PAX6 gene dosage on development overexpression causes severe eye abnormalities Aniridia in man and Small eye in mice are [E1] semidominant developmental disorders [/E1] caused by mutations within the paired box gene PAX6 Whereas heterozygotes suffer from iris hypoplasia homozygous mice lack eyes and nasal cavities and exhibit brain abnormalities To investigate the role of gene dosage in more detail we have generated", "mention_data": [{"mention": "semidominant developmental disorders", "kb_id": "D002658", "start": 21, "end": 25}]}
{"text": "Influence of PAX6 gene dosage on development overexpression causes severe eye abnormalities Aniridia in man and Small eye in mice are semidominant developmental disorders caused by mutations within the paired box gene PAX6 Whereas heterozygotes suffer from [E1] iris hypoplasia [/E1] homozygous mice lack eyes and nasal cavities and exhibit brain abnormalities To investigate the role of gene dosage in more detail we have generated yeast artificial chromosome transgenic mice carrying the human PAX6 locus When crossed onto the Small", "mention_data": [{"mention": "iris hypoplasia", "kb_id": "D007499", "start": 37, "end": 40}]}
{"text": "causes severe eye abnormalities Aniridia in man and Small eye in mice are semidominant developmental disorders caused by mutations within the paired box gene PAX6 Whereas heterozygotes suffer from iris hypoplasia homozygous mice lack eyes and nasal cavities and exhibit [E1] brain abnormalities [/E1] To investigate the role of gene dosage in more detail we have generated yeast artificial chromosome transgenic mice carrying the human PAX6 locus When crossed onto the Small eye background the transgene rescues the mutant phenotype Strikingly mice carrying", "mention_data": [{"mention": "brain abnormalities", "kb_id": "D001927", "start": 48, "end": 51}]}
{"text": "more detail we have generated yeast artificial chromosome transgenic mice carrying the human PAX6 locus When crossed onto the Small eye background the transgene rescues the mutant phenotype Strikingly mice carrying multiple copies on a wild type background show specific [E1] developmental abnormalities of the eye [/E1] but not of other tissues expressing the gene Thus at least five different eye phenotypes are associated with changes in PAX6 expression We provide evidence that not only reduced but also increased levels of transcriptional regulators can cause developmental", "mention_data": [{"mention": "developmental abnormalities of the eye", "kb_id": "D005124", "start": 98, "end": 104}]}
{"text": "the eye but not of other tissues expressing the gene Thus at least five different eye phenotypes are associated with changes in PAX6 expression We provide evidence that not only reduced but also increased levels of transcriptional regulators can cause [E1] developmental defects [/E1]", "mention_data": [{"mention": "developmental defects", "kb_id": "D002658", "start": 141, "end": 144}]}
{"text": "Founding BRCA1 mutations in [E1] hereditary breast and ovarian cancer [/E1] in southern Sweden Nine different germ line mutations in the BRCA1 breast and ovarian cancer susceptibility gene were identified in 15 of 47 kindreds from southern Sweden by use of SSCP and heteroduplex analysis of all exons and flanking", "mention_data": [{"mention": "hereditary breast and ovarian cancer", "kb_id": "D061325", "start": 4, "end": 10}]}
{"text": "Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden Nine different germ line mutations in the BRCA1 [E1] breast and ovarian cancer [/E1] susceptibility gene were identified in 15 of 47 kindreds from southern Sweden by use of SSCP and heteroduplex analysis of all exons and flanking intron region and by a protein truncation test for exon 11 followed by direct sequencing", "mention_data": [{"mention": "breast and ovarian cancer", "kb_id": "D061325", "start": 20, "end": 25}]}
{"text": "in three families the 3166 insertion TGAGA in three families and the nucleotide 1201 deletion 11 in two families Analysis of the intragenic polymorphism D17S855 supports common origins of the mutations Eleven of the 15 kindreds manifesting BRCA1 mutations were [E1] breast ovarian cancer [/E1] families several of them with a predominant ovarian cancer phenotype The set of 32 families in which no BRCA1 alterations were detected included 1 breast ovarian cancer kindred manifesting clear linkage to the BRCA1 region and loss of the", "mention_data": [{"mention": "breast ovarian cancer", "kb_id": "D061325", "start": 170, "end": 174}]}
{"text": "and the nucleotide 1201 deletion 11 in two families Analysis of the intragenic polymorphism D17S855 supports common origins of the mutations Eleven of the 15 kindreds manifesting BRCA1 mutations were breast ovarian cancer families several of them with a predominant [E1] ovarian cancer [/E1] phenotype The set of 32 families in which no BRCA1 alterations were detected included 1 breast ovarian cancer kindred manifesting clear linkage to the BRCA1 region and loss of the wild type chromosome in associated tumors Other tumor types", "mention_data": [{"mention": "ovarian cancer", "kb_id": "D010051", "start": 180, "end": 183}]}
{"text": "origins of the mutations Eleven of the 15 kindreds manifesting BRCA1 mutations were breast ovarian cancer families several of them with a predominant ovarian cancer phenotype The set of 32 families in which no BRCA1 alterations were detected included 1 [E1] breast ovarian cancer [/E1] kindred manifesting clear linkage to the BRCA1 region and loss of the wild type chromosome in associated tumors Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic pancreas skin and lung cancer a malignant melanoma an oligodendroglioma and", "mention_data": [{"mention": "breast ovarian cancer", "kb_id": "D061325", "start": 197, "end": 201}]}
{"text": "with a predominant ovarian cancer phenotype The set of 32 families in which no BRCA1 alterations were detected included 1 breast ovarian cancer kindred manifesting clear linkage to the BRCA1 region and loss of the wild type chromosome in associated [E1] tumors [/E1] Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic pancreas skin and lung cancer a malignant melanoma an oligodendroglioma and a carcinosarcoma In all 12 of 16 kindreds manifesting BRCA1 mutation or linkage contained ovarian cancer as compared", "mention_data": [{"mention": "tumors", "kb_id": "D009369", "start": 217, "end": 219}]}
{"text": "predominant ovarian cancer phenotype The set of 32 families in which no BRCA1 alterations were detected included 1 breast ovarian cancer kindred manifesting clear linkage to the BRCA1 region and loss of the wild type chromosome in associated tumors Other [E1] tumor [/E1] types found in BRCA1 mutation/haplotype carriers included prostatic pancreas skin and lung cancer a malignant melanoma an oligodendroglioma and a carcinosarcoma In all 12 of 16 kindreds manifesting BRCA1 mutation or linkage contained ovarian cancer as compared with only", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 219, "end": 221}]}
{"text": "families in which no BRCA1 alterations were detected included 1 breast ovarian cancer kindred manifesting clear linkage to the BRCA1 region and loss of the wild type chromosome in associated tumors Other tumor types found in BRCA1 mutation/haplotype carriers included [E1] prostatic pancreas skin and lung cancer [/E1] a malignant melanoma an oligodendroglioma and a carcinosarcoma In all 12 of 16 kindreds manifesting BRCA1 mutation or linkage contained ovarian cancer as compared with only 6 of the remaining 31 families P 001 The present study confirms the", "mention_data": [{"mention": "prostatic pancreas skin and lung cancer", "kb_id": "D011471|D010190|D012878|D008175", "start": 227, "end": 234}]}
{"text": "detected included 1 breast ovarian cancer kindred manifesting clear linkage to the BRCA1 region and loss of the wild type chromosome in associated tumors Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic pancreas skin and lung cancer a [E1] malignant melanoma [/E1] an oligodendroglioma and a carcinosarcoma In all 12 of 16 kindreds manifesting BRCA1 mutation or linkage contained ovarian cancer as compared with only 6 of the remaining 31 families P 001 The present study confirms the involvement of BRCA1", "mention_data": [{"mention": "malignant melanoma", "kb_id": "D008545", "start": 234, "end": 237}]}
{"text": "breast ovarian cancer kindred manifesting clear linkage to the BRCA1 region and loss of the wild type chromosome in associated tumors Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic pancreas skin and lung cancer a malignant melanoma an [E1] oligodendroglioma [/E1] and a carcinosarcoma In all 12 of 16 kindreds manifesting BRCA1 mutation or linkage contained ovarian cancer as compared with only 6 of the remaining 31 families P 001 The present study confirms the involvement of BRCA1 in disease", "mention_data": [{"mention": "oligodendroglioma", "kb_id": "D009837", "start": 237, "end": 239}]}
{"text": "kindred manifesting clear linkage to the BRCA1 region and loss of the wild type chromosome in associated tumors Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic pancreas skin and lung cancer a malignant melanoma an oligodendroglioma and a [E1] carcinosarcoma [/E1] In all 12 of 16 kindreds manifesting BRCA1 mutation or linkage contained ovarian cancer as compared with only 6 of the remaining 31 families P 001 The present study confirms the involvement of BRCA1 in disease predisposition for a", "mention_data": [{"mention": "carcinosarcoma", "kb_id": "D002296", "start": 240, "end": 242}]}
{"text": "type chromosome in associated tumors Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic pancreas skin and lung cancer a malignant melanoma an oligodendroglioma and a carcinosarcoma In all 12 of 16 kindreds manifesting BRCA1 mutation or linkage contained [E1] ovarian cancer [/E1] as compared with only 6 of the remaining 31 families P 001 The present study confirms the involvement of BRCA1 in disease predisposition for a subset of hereditary breast cancer families often characterized by ovarian cancers", "mention_data": [{"mention": "ovarian cancer", "kb_id": "D010051", "start": 253, "end": 256}]}
{"text": "all 12 of 16 kindreds manifesting BRCA1 mutation or linkage contained ovarian cancer as compared with only 6 of the remaining 31 families P 001 The present study confirms the involvement of BRCA1 in disease predisposition for a subset of [E1] hereditary breast cancer [/E1] families often characterized by ovarian cancers", "mention_data": [{"mention": "hereditary breast cancer", "kb_id": "D001943", "start": 282, "end": 286}]}
{"text": "mutation or linkage contained ovarian cancer as compared with only 6 of the remaining 31 families P 001 The present study confirms the involvement of BRCA1 in disease predisposition for a subset of hereditary breast cancer families often characterized by [E1] ovarian cancers [/E1]", "mention_data": [{"mention": "ovarian cancers", "kb_id": "D010051", "start": 289, "end": 292}]}
{"text": "The DCC protein and prognosis in [E1] colorectal cancer [/E1] BACKGROUND Allelic loss of chromosome 18q predicts a poor outcome in patients with stage II colorectal cancer Although the specific gene inactivated by this allelic loss has not been elucidated the DCC deleted in colorectal cancer gene is a", "mention_data": [{"mention": "colorectal cancer", "kb_id": "D015179", "start": 6, "end": 9}]}
{"text": "The DCC protein and prognosis in colorectal cancer BACKGROUND Allelic loss of chromosome 18q predicts a poor outcome in patients with [E1] stage II colorectal cancer [/E1] Although the specific gene inactivated by this allelic loss has not been elucidated the DCC deleted in colorectal cancer gene is a candidate We investigated whether the expression of the DCC protein in tumor cells is a prognostic marker", "mention_data": [{"mention": "stage II colorectal cancer", "kb_id": "D015179", "start": 21, "end": 26}]}
{"text": "protein and prognosis in colorectal cancer BACKGROUND Allelic loss of chromosome 18q predicts a poor outcome in patients with stage II colorectal cancer Although the specific gene inactivated by this allelic loss has not been elucidated the DCC deleted in [E1] colorectal cancer [/E1] gene is a candidate We investigated whether the expression of the DCC protein in tumor cells is a prognostic marker in colorectal carcinoma METHODS The expression of DCC was evaluated immunohistochemically in 132 paraffin embedded samples from patients with", "mention_data": [{"mention": "colorectal cancer", "kb_id": "D015179", "start": 42, "end": 45}]}
{"text": "in patients with stage II colorectal cancer Although the specific gene inactivated by this allelic loss has not been elucidated the DCC deleted in colorectal cancer gene is a candidate We investigated whether the expression of the DCC protein in [E1] tumor [/E1] cells is a prognostic marker in colorectal carcinoma METHODS The expression of DCC was evaluated immunohistochemically in 132 paraffin embedded samples from patients with curatively resected stage II and III colorectal carcinomas The Cox proportional hazards model was used", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 58, "end": 60}]}
{"text": "Although the specific gene inactivated by this allelic loss has not been elucidated the DCC deleted in colorectal cancer gene is a candidate We investigated whether the expression of the DCC protein in tumor cells is a prognostic marker in [E1] colorectal carcinoma [/E1] METHODS The expression of DCC was evaluated immunohistochemically in 132 paraffin embedded samples from patients with curatively resected stage II and III colorectal carcinomas The Cox proportional hazards model was used to adjust for covariates including age sex tumor", "mention_data": [{"mention": "colorectal carcinoma", "kb_id": "D015179", "start": 65, "end": 68}]}
{"text": "is a candidate We investigated whether the expression of the DCC protein in tumor cells is a prognostic marker in colorectal carcinoma METHODS The expression of DCC was evaluated immunohistochemically in 132 paraffin embedded samples from patients with curatively resected [E1] stage II and III colorectal carcinomas [/E1] The Cox proportional hazards model was used to adjust for covariates including age sex tumor site degree of tumor differentiation and use of adjuvant therapy RESULTS The expression of DCC was a strong positive predictive factor for survival in", "mention_data": [{"mention": "stage II and III colorectal carcinomas", "kb_id": "D015179", "start": 85, "end": 92}]}
{"text": "colorectal carcinoma METHODS The expression of DCC was evaluated immunohistochemically in 132 paraffin embedded samples from patients with curatively resected stage II and III colorectal carcinomas The Cox proportional hazards model was used to adjust for covariates including age sex [E1] tumor [/E1] site degree of tumor differentiation and use of adjuvant therapy RESULTS The expression of DCC was a strong positive predictive factor for survival in both stage II and stage III colorectal carcinomas In patients with stage II disease whose", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 105, "end": 107}]}
{"text": "expression of DCC was evaluated immunohistochemically in 132 paraffin embedded samples from patients with curatively resected stage II and III colorectal carcinomas The Cox proportional hazards model was used to adjust for covariates including age sex tumor site degree of [E1] tumor [/E1] differentiation and use of adjuvant therapy RESULTS The expression of DCC was a strong positive predictive factor for survival in both stage II and stage III colorectal carcinomas In patients with stage II disease whose tumors expressed DCC the", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 109, "end": 111}]}
{"text": "The Cox proportional hazards model was used to adjust for covariates including age sex tumor site degree of tumor differentiation and use of adjuvant therapy RESULTS The expression of DCC was a strong positive predictive factor for survival in both [E1] stage II and stage III colorectal carcinomas [/E1] In patients with stage II disease whose tumors expressed DCC the five year survival rate was 94 3 percent whereas in patients with DCC negative tumors the survival rate was 61 6 percent P 0 001 In patients with", "mention_data": [{"mention": "stage II and stage III colorectal carcinomas", "kb_id": "D015179", "start": 131, "end": 139}]}
{"text": "tumor site degree of tumor differentiation and use of adjuvant therapy RESULTS The expression of DCC was a strong positive predictive factor for survival in both stage II and stage III colorectal carcinomas In patients with stage II disease whose [E1] tumors [/E1] expressed DCC the five year survival rate was 94 3 percent whereas in patients with DCC negative tumors the survival rate was 61 6 percent P 0 001 In patients with stage III disease the respective survival rates were", "mention_data": [{"mention": "tumors", "kb_id": "D009369", "start": 145, "end": 147}]}
{"text": "was a strong positive predictive factor for survival in both stage II and stage III colorectal carcinomas In patients with stage II disease whose tumors expressed DCC the five year survival rate was 94 3 percent whereas in patients with [E1] DCC negative tumors [/E1] the survival rate was 61 6 percent P 0 001 In patients with stage III disease the respective survival rates were 59 3 percent and 33 2 percent P 0 03 CONCLUSIONS DCC is a prognostic marker in patients", "mention_data": [{"mention": "DCC negative tumors", "kb_id": "D009369", "start": 161, "end": 165}]}
{"text": "carcinomas In patients with stage II disease whose tumors expressed DCC the five year survival rate was 94 3 percent whereas in patients with DCC negative tumors the survival rate was 61 6 percent P 0 001 In patients with [E1] stage III disease [/E1] the respective survival rates were 59 3 percent and 33 2 percent P 0 03 CONCLUSIONS DCC is a prognostic marker in patients with stage II or stage III colorectal cancer In stage II colorectal carcinomas the absence of", "mention_data": [{"mention": "stage III disease", "kb_id": "D009369", "start": 177, "end": 181}]}
{"text": "the survival rate was 61 6 percent P 0 001 In patients with stage III disease the respective survival rates were 59 3 percent and 33 2 percent P 0 03 CONCLUSIONS DCC is a prognostic marker in patients with [E1] stage II or stage III colorectal cancer [/E1] In stage II colorectal carcinomas the absence of DCC identifies a subgroup of patients with lesions that behave like stage III cancers These findings may thus have therapeutic implications in this group of patients", "mention_data": [{"mention": "stage II or stage III colorectal cancer", "kb_id": "D015179", "start": 204, "end": 212}]}
{"text": "0 001 In patients with stage III disease the respective survival rates were 59 3 percent and 33 2 percent P 0 03 CONCLUSIONS DCC is a prognostic marker in patients with stage II or stage III colorectal cancer In [E1] stage II colorectal carcinomas [/E1] the absence of DCC identifies a subgroup of patients with lesions that behave like stage III cancers These findings may thus have therapeutic implications in this group of patients", "mention_data": [{"mention": "stage II colorectal carcinomas", "kb_id": "D015179", "start": 212, "end": 217}]}
{"text": "2 percent P 0 03 CONCLUSIONS DCC is a prognostic marker in patients with stage II or stage III colorectal cancer In stage II colorectal carcinomas the absence of DCC identifies a subgroup of patients with lesions that behave like [E1] stage III cancers [/E1] These findings may thus have therapeutic implications in this group of patients", "mention_data": [{"mention": "stage III cancers", "kb_id": "D009369", "start": 230, "end": 234}]}
{"text": "Gene therapy for [E1] phenylketonuria [/E1] Classical phenylketonuria PKU is an autosomal recessive disorder caused by a deficiency of hepatic phenylalanine hydroxylase PAH Limitations of the current dietary treatment for PKU have led to the development of potential treatments based on somatic gene transfer Three", "mention_data": [{"mention": "phenylketonuria", "kb_id": "D010661", "start": 3, "end": 5}]}
{"text": "Gene therapy for phenylketonuria Classical [E1] phenylketonuria [/E1] PKU is an autosomal recessive disorder caused by a deficiency of hepatic phenylalanine hydroxylase PAH Limitations of the current dietary treatment for PKU have led to the development of potential treatments based on somatic gene transfer Three different vector", "mention_data": [{"mention": "phenylketonuria", "kb_id": "D010661", "start": 5, "end": 7}]}
{"text": "Gene therapy for phenylketonuria Classical phenylketonuria [E1] PKU [/E1] is an autosomal recessive disorder caused by a deficiency of hepatic phenylalanine hydroxylase PAH Limitations of the current dietary treatment for PKU have led to the development of potential treatments based on somatic gene transfer Three different vector systems", "mention_data": [{"mention": "PKU", "kb_id": "D010661", "start": 6, "end": 8}]}
{"text": "Gene therapy for phenylketonuria Classical phenylketonuria PKU is an [E1] autosomal recessive disorder [/E1] caused by a deficiency of hepatic phenylalanine hydroxylase PAH Limitations of the current dietary treatment for PKU have led to the development of potential treatments based on somatic gene transfer Three different vector systems have been examined Vectors derived", "mention_data": [{"mention": "autosomal recessive disorder", "kb_id": "D030342", "start": 9, "end": 13}]}
{"text": "Gene therapy for phenylketonuria Classical phenylketonuria PKU is an autosomal recessive disorder caused by a [E1] deficiency of hepatic phenylalanine hydroxylase [/E1] PAH Limitations of the current dietary treatment for PKU have led to the development of potential treatments based on somatic gene transfer Three different vector systems have been examined Vectors derived from a recombinant retrovirus or a DNA/protein complex", "mention_data": [{"mention": "deficiency of hepatic phenylalanine hydroxylase", "kb_id": "261600", "start": 15, "end": 21}]}
{"text": "Gene therapy for phenylketonuria Classical phenylketonuria PKU is an autosomal recessive disorder caused by a deficiency of hepatic phenylalanine hydroxylase PAH Limitations of the current dietary treatment for [E1] PKU [/E1] have led to the development of potential treatments based on somatic gene transfer Three different vector systems have been examined Vectors derived from a recombinant retrovirus or a DNA/protein complex can efficiently transduce the PAH cDNA into PAH deficient", "mention_data": [{"mention": "PKU", "kb_id": "D010661", "start": 28, "end": 30}]}
{"text": "treatment for PKU have led to the development of potential treatments based on somatic gene transfer Three different vector systems have been examined Vectors derived from a recombinant retrovirus or a DNA/protein complex can efficiently transduce the PAH cDNA into [E1] PAH deficient [/E1] hepatocytes in vitro but the application of these vector systems is presently limited by their low transduction efficiency in vivo In contrast a vector derived from a recombinant adenovirus can restore 10 80 of normal hepatic PAH activity into", "mention_data": [{"mention": "PAH deficient", "kb_id": "261600", "start": 66, "end": 69}]}
{"text": "deficient hepatocytes in vitro but the application of these vector systems is presently limited by their low transduction efficiency in vivo In contrast a vector derived from a recombinant adenovirus can restore 10 80 of normal hepatic PAH activity into [E1] PAH deficient [/E1] mice which completely normalizes serum phenylalanine levels This treatment is transient and cannot be effectively re administered due to the presence of neutralizing antibodies directed against the recombinant adenoviral vector However these findings suggest that PKU can be completely", "mention_data": [{"mention": "PAH deficient", "kb_id": "261600", "start": 107, "end": 110}]}
{"text": "PAH activity into PAH deficient mice which completely normalizes serum phenylalanine levels This treatment is transient and cannot be effectively re administered due to the presence of neutralizing antibodies directed against the recombinant adenoviral vector However these findings suggest that [E1] PKU [/E1] can be completely corrected by somatic gene therapy and provide some direction for the future development of adenoviral vectors", "mention_data": [{"mention": "PKU", "kb_id": "D010661", "start": 144, "end": 146}]}
{"text": "Identification of a RING protein that can interact in vivo with the BRCA1 gene product The [E1] hereditary breast and ovarian cancer [/E1] gene BRCA1 encodes a large polypeptide that contains the cysteine rich RING motif a zinc binding domain found in a variety of regulatory proteins Here we describe a novel protein that interacts in vivo with the N terminal region", "mention_data": [{"mention": "hereditary breast and ovarian cancer", "kb_id": "D061325", "start": 16, "end": 22}]}
{"text": "RING motif three tandem ankyrin repeats and a C terminal sequence with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCA1 The BARD1/BRCA1 interaction is disrupted by BRCA1 missense mutations that segregate with [E1] breast cancer [/E1] susceptibility indicating that BARD1 may be involved in mediating tumour suppression by BRCA1", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 113, "end": 116}]}
{"text": "with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCA1 The BARD1/BRCA1 interaction is disrupted by BRCA1 missense mutations that segregate with breast cancer susceptibility indicating that BARD1 may be involved in mediating [E1] tumour [/E1] suppression by BRCA1", "mention_data": [{"mention": "tumour", "kb_id": "D009369", "start": 124, "end": 126}]}
{"text": "[E1] Wiskott Aldrich syndrome [/E1] no strict genotype phenotype correlations but clustering of missense mutations in the amino terminal part of the WASP gene product The Wiskott Aldrich syndrome protein WASP gene was found to be mutated in patients presenting with WAS and in", "mention_data": [{"mention": "Wiskott Aldrich syndrome", "kb_id": "D014923", "start": 0, "end": 4}]}
{"text": "Wiskott Aldrich syndrome no strict genotype phenotype correlations but clustering of missense mutations in the amino terminal part of the WASP gene product The [E1] Wiskott Aldrich syndrome [/E1] protein WASP gene was found to be mutated in patients presenting with WAS and in patients showing X linked thrombocytopenia Mutation analysis in 19 families of German Swiss and Turkish descent by single strand conformation polymorphism and sequencing resulted", "mention_data": [{"mention": "Wiskott Aldrich syndrome", "kb_id": "D014923", "start": 24, "end": 28}]}
{"text": "Wiskott Aldrich syndrome no strict genotype phenotype correlations but clustering of missense mutations in the amino terminal part of the WASP gene product The Wiskott Aldrich syndrome protein WASP gene was found to be mutated in patients presenting with [E1] WAS [/E1] and in patients showing X linked thrombocytopenia Mutation analysis in 19 families of German Swiss and Turkish descent by single strand conformation polymorphism and sequencing resulted in the detection of seven novel and 10 known mutations A striking clustering", "mention_data": [{"mention": "WAS", "kb_id": "D014923", "start": 39, "end": 41}]}
{"text": "strict genotype phenotype correlations but clustering of missense mutations in the amino terminal part of the WASP gene product The Wiskott Aldrich syndrome protein WASP gene was found to be mutated in patients presenting with WAS and in patients showing [E1] X linked thrombocytopenia [/E1] Mutation analysis in 19 families of German Swiss and Turkish descent by single strand conformation polymorphism and sequencing resulted in the detection of seven novel and 10 known mutations A striking clustering of missense mutations in the first four", "mention_data": [{"mention": "X linked thrombocytopenia", "kb_id": "313900", "start": 44, "end": 48}]}
{"text": "in the amino terminal stretch of the WASP gene product this region contained a mutational hot spot at codon 86 No genotype phenotype correlation emerged after a comparison of the identified mutations with the resulting clinical picture for a classical [E1] WAS [/E1] phenotype A substitution at codon 86 resulted in an extremely variable expression of the disease in a large Swiss family An extended homology search revealed a distant relationship of this stretch to the vasodilator stimulated phosphoprotein VASP which is", "mention_data": [{"mention": "WAS", "kb_id": "D014923", "start": 145, "end": 147}]}
{"text": "Autosomal dominant primary [E1] hyperparathyroidism and jaw tumor syndrome [/E1] associated with renal hamartomas and cystic kidney disease linkage to 1q21 q32 and loss of the wild type allele in renal hamartomas Hereditary hyperparathyroidism jaw tumor syndrome HPT JT is an autosomal dominant disease OMIM 145001 that has recently", "mention_data": [{"mention": "hyperparathyroidism and jaw tumor syndrome", "kb_id": "145001", "start": 3, "end": 9}]}
{"text": "Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with [E1] renal hamartomas [/E1] and cystic kidney disease linkage to 1q21 q32 and loss of the wild type allele in renal hamartomas Hereditary hyperparathyroidism jaw tumor syndrome HPT JT is an autosomal dominant disease OMIM 145001 that has recently been mapped to chromosomal", "mention_data": [{"mention": "renal hamartomas", "kb_id": "D007674|D006222", "start": 10, "end": 13}]}
{"text": "Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and [E1] cystic kidney disease [/E1] linkage to 1q21 q32 and loss of the wild type allele in renal hamartomas Hereditary hyperparathyroidism jaw tumor syndrome HPT JT is an autosomal dominant disease OMIM 145001 that has recently been mapped to chromosomal region 1q21 q32 HRPT2", "mention_data": [{"mention": "cystic kidney disease", "kb_id": "D052177", "start": 13, "end": 17}]}
{"text": "Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease linkage to 1q21 q32 and loss of the wild type allele in [E1] renal hamartomas [/E1] Hereditary hyperparathyroidism jaw tumor syndrome HPT JT is an autosomal dominant disease OMIM 145001 that has recently been mapped to chromosomal region 1q21 q32 HRPT2 Here we report two families with HPT JT syndrome in which adult renal hamartomas", "mention_data": [{"mention": "renal hamartomas", "kb_id": "D007674|D006222", "start": 28, "end": 31}]}
{"text": "Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease linkage to 1q21 q32 and loss of the wild type allele in renal hamartomas [E1] Hereditary hyperparathyroidism jaw tumor syndrome [/E1] HPT JT is an autosomal dominant disease OMIM 145001 that has recently been mapped to chromosomal region 1q21 q32 HRPT2 Here we report two families with HPT JT syndrome in which adult renal hamartomas or cystic kidney disease were", "mention_data": [{"mention": "Hereditary hyperparathyroidism jaw tumor syndrome", "kb_id": "145001", "start": 30, "end": 36}]}
{"text": "Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease linkage to 1q21 q32 and loss of the wild type allele in renal hamartomas Hereditary hyperparathyroidism jaw tumor syndrome [E1] HPT JT [/E1] is an autosomal dominant disease OMIM 145001 that has recently been mapped to chromosomal region 1q21 q32 HRPT2 Here we report two families with HPT JT syndrome in which adult renal hamartomas or cystic kidney disease were prominent associated", "mention_data": [{"mention": "HPT JT", "kb_id": "145001", "start": 35, "end": 38}]}
{"text": "Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease linkage to 1q21 q32 and loss of the wild type allele in renal hamartomas Hereditary hyperparathyroidism jaw tumor syndrome HPT JT is an [E1] autosomal dominant disease [/E1] OMIM 145001 that has recently been mapped to chromosomal region 1q21 q32 HRPT2 Here we report two families with HPT JT syndrome in which adult renal hamartomas or cystic kidney disease were prominent associated features possibly representing a new", "mention_data": [{"mention": "autosomal dominant disease", "kb_id": "D030342", "start": 39, "end": 43}]}
{"text": "loss of the wild type allele in renal hamartomas Hereditary hyperparathyroidism jaw tumor syndrome HPT JT is an autosomal dominant disease OMIM 145001 that has recently been mapped to chromosomal region 1q21 q32 HRPT2 Here we report two families with [E1] HPT JT syndrome [/E1] in which adult renal hamartomas or cystic kidney disease were prominent associated features possibly representing a new phenotypic variant of the HPT JT syndrome In the first family renal lesions were present in five out of six affected individuals", "mention_data": [{"mention": "HPT JT syndrome", "kb_id": "145001", "start": 61, "end": 65}]}
{"text": "allele in renal hamartomas Hereditary hyperparathyroidism jaw tumor syndrome HPT JT is an autosomal dominant disease OMIM 145001 that has recently been mapped to chromosomal region 1q21 q32 HRPT2 Here we report two families with HPT JT syndrome in which [E1] adult renal hamartomas [/E1] or cystic kidney disease were prominent associated features possibly representing a new phenotypic variant of the HPT JT syndrome In the first family renal lesions were present in five out of six affected individuals whereas HPT and JT were", "mention_data": [{"mention": "adult renal hamartomas", "kb_id": "C536399", "start": 66, "end": 70}]}
{"text": "Hereditary hyperparathyroidism jaw tumor syndrome HPT JT is an autosomal dominant disease OMIM 145001 that has recently been mapped to chromosomal region 1q21 q32 HRPT2 Here we report two families with HPT JT syndrome in which adult renal hamartomas or [E1] cystic kidney disease [/E1] were prominent associated features possibly representing a new phenotypic variant of the HPT JT syndrome In the first family renal lesions were present in five out of six affected individuals whereas HPT and JT were seen in four and", "mention_data": [{"mention": "cystic kidney disease", "kb_id": "D052177", "start": 70, "end": 74}]}
{"text": "has recently been mapped to chromosomal region 1q21 q32 HRPT2 Here we report two families with HPT JT syndrome in which adult renal hamartomas or cystic kidney disease were prominent associated features possibly representing a new phenotypic variant of the [E1] HPT JT syndrome [/E1] In the first family renal lesions were present in five out of six affected individuals whereas HPT and JT were seen in four and two cases respectively In the second family JT was found in three of the five", "mention_data": [{"mention": "HPT JT syndrome", "kb_id": "145001", "start": 85, "end": 89}]}
{"text": "1q21 q32 HRPT2 Here we report two families with HPT JT syndrome in which adult renal hamartomas or cystic kidney disease were prominent associated features possibly representing a new phenotypic variant of the HPT JT syndrome In the first family [E1] renal lesions [/E1] were present in five out of six affected individuals whereas HPT and JT were seen in four and two cases respectively In the second family JT was found in three of the five affected individuals and two affected members", "mention_data": [{"mention": "renal lesions", "kb_id": "D007680", "start": 92, "end": 95}]}
{"text": "in which adult renal hamartomas or cystic kidney disease were prominent associated features possibly representing a new phenotypic variant of the HPT JT syndrome In the first family renal lesions were present in five out of six affected individuals whereas [E1] HPT [/E1] and JT were seen in four and two cases respectively In the second family JT was found in three of the five affected individuals and two affected members also exhibited polycystic kidney disease The possibility of the latter cosegregating", "mention_data": [{"mention": "HPT", "kb_id": "D006961", "start": 104, "end": 106}]}
{"text": "adult renal hamartomas or cystic kidney disease were prominent associated features possibly representing a new phenotypic variant of the HPT JT syndrome In the first family renal lesions were present in five out of six affected individuals whereas HPT and [E1] JT [/E1] were seen in four and two cases respectively In the second family JT was found in three of the five affected individuals and two affected members also exhibited polycystic kidney disease The possibility of the latter cosegregating as a", "mention_data": [{"mention": "JT", "kb_id": "D007573", "start": 106, "end": 108}]}
{"text": "a new phenotypic variant of the HPT JT syndrome In the first family renal lesions were present in five out of six affected individuals whereas HPT and JT were seen in four and two cases respectively In the second family [E1] JT [/E1] was found in three of the five affected individuals and two affected members also exhibited polycystic kidney disease The possibility of the latter cosegregating as a separate autosomal dominant gene can not be ruled out A sex dependent penetrance", "mention_data": [{"mention": "JT", "kb_id": "D007573", "start": 119, "end": 121}]}
{"text": "present in five out of six affected individuals whereas HPT and JT were seen in four and two cases respectively In the second family JT was found in three of the five affected individuals and two affected members also exhibited [E1] polycystic kidney disease [/E1] The possibility of the latter cosegregating as a separate autosomal dominant gene can not be ruled out A sex dependent penetrance of primary HPT resulting in predominantly male affected cases was evident in the two families Twenty microsatellite markers", "mention_data": [{"mention": "polycystic kidney disease", "kb_id": "D007690", "start": 135, "end": 139}]}
{"text": "was found in three of the five affected individuals and two affected members also exhibited polycystic kidney disease The possibility of the latter cosegregating as a separate autosomal dominant gene can not be ruled out A sex dependent penetrance of [E1] primary HPT [/E1] resulting in predominantly male affected cases was evident in the two families Twenty microsatellite markers in the HRPT2 region were typed in addition to markers in the multiple endocrine neoplasia MEN types 1 and 2 regions at 11q13 and", "mention_data": [{"mention": "primary HPT", "kb_id": "D049950", "start": 160, "end": 163}]}
{"text": "gene can not be ruled out A sex dependent penetrance of primary HPT resulting in predominantly male affected cases was evident in the two families Twenty microsatellite markers in the HRPT2 region were typed in addition to markers in the [E1] multiple endocrine neoplasia MEN types 1 and 2 [/E1] regions at 11q13 and 10q11 The disease in these two kindreds was linked to five markers in the 1q21 q32 region logarithm of odds scores 3 2 4 2 4 2 whereas linkage to the MEN1 and MEN2 regions", "mention_data": [{"mention": "multiple endocrine neoplasia MEN types 1 and 2", "kb_id": "D009377", "start": 189, "end": 198}]}
{"text": "MEN types 1 and 2 regions at 11q13 and 10q11 The disease in these two kindreds was linked to five markers in the 1q21 q32 region logarithm of odds scores 3 2 4 2 4 2 whereas linkage to the [E1] MEN1 [/E1] and MEN2 regions was excluded Meiotic recombinations detected in affected individuals placed the locus telomeric of D1S215 thus narrowing the HRPT2 region from 60 to approximately 34 centimorgans Loss of heterozygosity was studied in seven renal hamartomas from two", "mention_data": [{"mention": "MEN1", "kb_id": "131100", "start": 232, "end": 234}]}
{"text": "1 and 2 regions at 11q13 and 10q11 The disease in these two kindreds was linked to five markers in the 1q21 q32 region logarithm of odds scores 3 2 4 2 4 2 whereas linkage to the MEN1 and [E1] MEN2 [/E1] regions was excluded Meiotic recombinations detected in affected individuals placed the locus telomeric of D1S215 thus narrowing the HRPT2 region from 60 to approximately 34 centimorgans Loss of heterozygosity was studied in seven renal hamartomas from two affected individuals", "mention_data": [{"mention": "MEN2", "kb_id": "D018813", "start": 234, "end": 236}]}
{"text": "whereas linkage to the MEN1 and MEN2 regions was excluded Meiotic recombinations detected in affected individuals placed the locus telomeric of D1S215 thus narrowing the HRPT2 region from 60 to approximately 34 centimorgans Loss of heterozygosity was studied in seven [E1] renal hamartomas [/E1] from two affected individuals in the first family as well as in a jaw tumor and a parathyroid tumor from the second family All renal hamartomas showed loss of heterozygosity at the 1q21 q32 region The losses invariably involved", "mention_data": [{"mention": "renal hamartomas", "kb_id": "D007674|D006222", "start": 268, "end": 271}]}
{"text": "individuals placed the locus telomeric of D1S215 thus narrowing the HRPT2 region from 60 to approximately 34 centimorgans Loss of heterozygosity was studied in seven renal hamartomas from two affected individuals in the first family as well as in a [E1] jaw tumor [/E1] and a parathyroid tumor from the second family All renal hamartomas showed loss of heterozygosity at the 1q21 q32 region The losses invariably involved the wild type allele derived from the unaffected parent suggesting the inactivation of a tumor", "mention_data": [{"mention": "jaw tumor", "kb_id": "D007573", "start": 283, "end": 286}]}
{"text": "telomeric of D1S215 thus narrowing the HRPT2 region from 60 to approximately 34 centimorgans Loss of heterozygosity was studied in seven renal hamartomas from two affected individuals in the first family as well as in a jaw tumor and a [E1] parathyroid tumor [/E1] from the second family All renal hamartomas showed loss of heterozygosity at the 1q21 q32 region The losses invariably involved the wild type allele derived from the unaffected parent suggesting the inactivation of a tumor suppressor gene in this", "mention_data": [{"mention": "parathyroid tumor", "kb_id": "D010282", "start": 287, "end": 290}]}
{"text": "region from 60 to approximately 34 centimorgans Loss of heterozygosity was studied in seven renal hamartomas from two affected individuals in the first family as well as in a jaw tumor and a parathyroid tumor from the second family All [E1] renal hamartomas [/E1] showed loss of heterozygosity at the 1q21 q32 region The losses invariably involved the wild type allele derived from the unaffected parent suggesting the inactivation of a tumor suppressor gene in this region", "mention_data": [{"mention": "renal hamartomas", "kb_id": "D007674|D006222", "start": 294, "end": 297}]}
{"text": "jaw tumor and a parathyroid tumor from the second family All renal hamartomas showed loss of heterozygosity at the 1q21 q32 region The losses invariably involved the wild type allele derived from the unaffected parent suggesting the inactivation of a [E1] tumor [/E1] suppressor gene in this region", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 323, "end": 325}]}
{"text": "and function of dimeric enzymes involves the impact of naturally occurring mutations on subunit assembly and heterodimer activity This question is of particular interest for the human enzyme galactose l phosphate uridylyl transferase GALT impairment of which results in the [E1] inherited metabolic disorder [/E1] galactosemia because many if not most patients studied to date are compound heterozygotes rather than true molecular homozygotes Furthermore the broad range of phenotypic severity observed in these patients raises the possibility that allelic combination not just allelic constitution", "mention_data": [{"mention": "inherited metabolic disorder", "kb_id": "D008659", "start": 59, "end": 63}]}
{"text": "dimeric enzymes involves the impact of naturally occurring mutations on subunit assembly and heterodimer activity This question is of particular interest for the human enzyme galactose l phosphate uridylyl transferase GALT impairment of which results in the inherited metabolic disorder [E1] galactosemia [/E1] because many if not most patients studied to date are compound heterozygotes rather than true molecular homozygotes Furthermore the broad range of phenotypic severity observed in these patients raises the possibility that allelic combination not just allelic constitution may", "mention_data": [{"mention": "galactosemia", "kb_id": "D005693", "start": 62, "end": 64}]}
{"text": "found that both homodimers and heterodimers do form involving each of the mutant subunits tested and that both heterodimer pools retain substantial enzymatic activity These results are significant not only in terms of their implications for furthering our understanding of [E1] galactosemia [/E1] and GALT holoenzyme structure function relationships but also because the system described may serve as a model for similar studies of other complexes composed of multiple subunits", "mention_data": [{"mention": "galactosemia", "kb_id": "D005693", "start": 230, "end": 232}]}
{"text": "BRCA1 R841W a strong candidate for a common mutation with moderate phenotype BRCA1 mutations cause increased risk for [E1] breast and ovarian cancer [/E1] frequently of early onset Many different mutations occur in BRCA1 including several examples of recurrent mutations each of which accounts for a significant number of families with heritable cancer predisposition These common mutations have an etiological role in many", "mention_data": [{"mention": "breast and ovarian cancer", "kb_id": "D001943|D010051", "start": 18, "end": 23}]}
{"text": "moderate phenotype BRCA1 mutations cause increased risk for breast and ovarian cancer frequently of early onset Many different mutations occur in BRCA1 including several examples of recurrent mutations each of which accounts for a significant number of families with heritable [E1] cancer [/E1] predisposition These common mutations have an etiological role in many breast and ovarian cancer cases and provide the opportunity to examine genotype phenotype correlations and genotype environment interactions in individuals with the identical BRCA1 lesion We report a novel", "mention_data": [{"mention": "cancer", "kb_id": "D009369", "start": 50, "end": 52}]}
{"text": "cancer frequently of early onset Many different mutations occur in BRCA1 including several examples of recurrent mutations each of which accounts for a significant number of families with heritable cancer predisposition These common mutations have an etiological role in many [E1] breast and ovarian cancer [/E1] cases and provide the opportunity to examine genotype phenotype correlations and genotype environment interactions in individuals with the identical BRCA1 lesion We report a novel missense change in BRCA1 2640 C T R841W found in 3 cases from a", "mention_data": [{"mention": "breast and ovarian cancer", "kb_id": "D001943|D010051", "start": 61, "end": 66}]}
{"text": "the opportunity to examine genotype phenotype correlations and genotype environment interactions in individuals with the identical BRCA1 lesion We report a novel missense change in BRCA1 2640 C T R841W found in 3 cases from a subject group of 305 [E1] breast and 79 ovarian cancer [/E1] cases from Orange County CA These are consecutive population based cases not selected for age or family history In all three cases there is a strong family history of breast ovarian or other cancers possibly related to a BRCA1", "mention_data": [{"mention": "breast and 79 ovarian cancer", "kb_id": "D001943|D010051", "start": 108, "end": 114}]}
{"text": "from a subject group of 305 breast and 79 ovarian cancer cases from Orange County CA These are consecutive population based cases not selected for age or family history In all three cases there is a strong family history of [E1] breast ovarian or other cancers [/E1] possibly related to a BRCA1 defect and family members showed a high concordance of cancer incidence with the presence of R841W The age of cancer onset was not always distinct from typical sporadic cases Testing of a sample of", "mention_data": [{"mention": "breast ovarian or other cancers", "kb_id": "D001943|D010051|D009369", "start": 142, "end": 148}]}
{"text": "population based cases not selected for age or family history In all three cases there is a strong family history of breast ovarian or other cancers possibly related to a BRCA1 defect and family members showed a high concordance of [E1] cancer [/E1] incidence with the presence of R841W The age of cancer onset was not always distinct from typical sporadic cases Testing of a sample of 413 unrelated individuals to examine the hypothesis that R841W might be a rare polymorphism detected", "mention_data": [{"mention": "cancer", "kb_id": "D009369", "start": 161, "end": 163}]}
{"text": "In all three cases there is a strong family history of breast ovarian or other cancers possibly related to a BRCA1 defect and family members showed a high concordance of cancer incidence with the presence of R841W The age of [E1] cancer [/E1] onset was not always distinct from typical sporadic cases Testing of a sample of 413 unrelated individuals to examine the hypothesis that R841W might be a rare polymorphism detected one additional instance in a woman with breast cancer diagnosed", "mention_data": [{"mention": "cancer", "kb_id": "D009369", "start": 171, "end": 173}]}
{"text": "The age of cancer onset was not always distinct from typical sporadic cases Testing of a sample of 413 unrelated individuals to examine the hypothesis that R841W might be a rare polymorphism detected one additional instance in a woman with [E1] breast cancer [/E1] diagnosed at age 77 years and cancer in one parent R841W is likely to be an etiologically significant lesion with involvement in close to 1 95 confidence interval of 0 1 7 of all breast and ovarian cancers in", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 208, "end": 211}]}
{"text": "distinct from typical sporadic cases Testing of a sample of 413 unrelated individuals to examine the hypothesis that R841W might be a rare polymorphism detected one additional instance in a woman with breast cancer diagnosed at age 77 years and [E1] cancer [/E1] in one parent R841W is likely to be an etiologically significant lesion with involvement in close to 1 95 confidence interval of 0 1 7 of all breast and ovarian cancers in this population", "mention_data": [{"mention": "cancer", "kb_id": "D009369", "start": 216, "end": 218}]}
{"text": "in a woman with breast cancer diagnosed at age 77 years and cancer in one parent R841W is likely to be an etiologically significant lesion with involvement in close to 1 95 confidence interval of 0 1 7 of all [E1] breast and ovarian cancers [/E1] in this population", "mention_data": [{"mention": "breast and ovarian cancers", "kb_id": "D001943|D010051", "start": 244, "end": 249}]}
{"text": "mutations In the four polymorphic variants that have two point mutations one of the mutations is always 376 A G 126 Asn Asp which on its own gives rise to the nondeficient polymorphic variant G6PD A In a study of [E1] G6PD deficient [/E1] patients who presented with clinical favism in Spain we have found a new polymorphic variant that we have called G6PD Malaga whose only abnormality is a 542 A T 181 Asp Val mutation This is the same mutation as", "mention_data": [{"mention": "G6PD deficient", "kb_id": "D005955", "start": 70, "end": 73}]}
{"text": "have two point mutations one of the mutations is always 376 A G 126 Asn Asp which on its own gives rise to the nondeficient polymorphic variant G6PD A In a study of G6PD deficient patients who presented with clinical [E1] favism [/E1] in Spain we have found a new polymorphic variant that we have called G6PD Malaga whose only abnormality is a 542 A T 181 Asp Val mutation This is the same mutation as previously found in association with the", "mention_data": [{"mention": "favism", "kb_id": "D005236", "start": 77, "end": 79}]}
{"text": "Malaga whose only abnormality is a 542 A T 181 Asp Val mutation This is the same mutation as previously found in association with the mutation of G6PD A in the double mutant G6PD Santamaria G6PD Malaga is associated with [E1] enzyme deficiency [/E1] class III and the enzymic properties of G6PD Malaga and G6PD Santamaria are quite similar indicating that in this case the effects of the two mutations are additive rather than synergistic G6PD Santamaria might have been produced by recombination", "mention_data": [{"mention": "enzyme deficiency", "kb_id": "D008661", "start": 132, "end": 135}]}
{"text": "FISH studies in a patient with [E1] sporadic aniridia [/E1] and t 7 11 q31 2 p13 A 2 year old female presenting with bilateral sporadic aniridia was found to have an apparently balanced reciprocal translocation with a chromosome 11 breakpoint within band p13 Fluorescence in situ hybridisation FISH", "mention_data": [{"mention": "sporadic aniridia", "kb_id": "D015783", "start": 6, "end": 9}]}
{"text": "FISH studies in a patient with sporadic aniridia and t 7 11 q31 2 p13 A 2 year old female presenting with [E1] bilateral sporadic aniridia [/E1] was found to have an apparently balanced reciprocal translocation with a chromosome 11 breakpoint within band p13 Fluorescence in situ hybridisation FISH studies with distal 11p13 specific cosmids showed that the chromosome 11 breakpoint lay between the aniridia PAX6", "mention_data": [{"mention": "bilateral sporadic aniridia", "kb_id": "D015783", "start": 22, "end": 26}]}
{"text": "bilateral sporadic aniridia was found to have an apparently balanced reciprocal translocation with a chromosome 11 breakpoint within band p13 Fluorescence in situ hybridisation FISH studies with distal 11p13 specific cosmids showed that the chromosome 11 breakpoint lay between the [E1] aniridia [/E1] PAX6 locus and a region approximately 100 kb distal to PAX6 defined by the cosmid FO2121 Although this patient did not have a detectable deletion within PAX6 her aniridia may have resulted from a disruption of the distal chromatin", "mention_data": [{"mention": "aniridia", "kb_id": "D015783", "start": 62, "end": 64}]}
{"text": "specific cosmids showed that the chromosome 11 breakpoint lay between the aniridia PAX6 locus and a region approximately 100 kb distal to PAX6 defined by the cosmid FO2121 Although this patient did not have a detectable deletion within PAX6 her [E1] aniridia [/E1] may have resulted from a disruption of the distal chromatin domain containing either enhancers or regulators for PAX6 This case may therefore be another example of aniridia caused by a position effect as recently described in two familial aniridia", "mention_data": [{"mention": "aniridia", "kb_id": "D015783", "start": 91, "end": 93}]}
{"text": "FO2121 Although this patient did not have a detectable deletion within PAX6 her aniridia may have resulted from a disruption of the distal chromatin domain containing either enhancers or regulators for PAX6 This case may therefore be another example of [E1] aniridia [/E1] caused by a position effect as recently described in two familial aniridia patients in which the phenotype cosegregated with chromosome abnormalities with 11p13 breakpoints", "mention_data": [{"mention": "aniridia", "kb_id": "D015783", "start": 118, "end": 120}]}
{"text": "PAX6 her aniridia may have resulted from a disruption of the distal chromatin domain containing either enhancers or regulators for PAX6 This case may therefore be another example of aniridia caused by a position effect as recently described in two [E1] familial aniridia [/E1] patients in which the phenotype cosegregated with chromosome abnormalities with 11p13 breakpoints", "mention_data": [{"mention": "familial aniridia", "kb_id": "D015783", "start": 129, "end": 132}]}
{"text": "of the distal chromatin domain containing either enhancers or regulators for PAX6 This case may therefore be another example of aniridia caused by a position effect as recently described in two familial aniridia patients in which the phenotype cosegregated with [E1] chromosome abnormalities [/E1] with 11p13 breakpoints", "mention_data": [{"mention": "chromosome abnormalities", "kb_id": "D002869", "start": 138, "end": 141}]}
{"text": "[E1] Ovarian cancer [/E1] risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat VNTR locus Women who carry a mutation in the BRCA1 gene on chromosome 17q21 have an 80 risk of breast cancer and a 40 risk", "mention_data": [{"mention": "Ovarian cancer", "kb_id": "D010051", "start": 0, "end": 3}]}
{"text": "Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat VNTR locus Women who carry a mutation in the BRCA1 gene on chromosome 17q21 have an 80 risk of [E1] breast cancer [/E1] and a 40 risk of ovarian cancer by the age of 70 ref 1 The variable penetrance of BRCA1 suggests that other genetic and non genetic factors play a role in tumourigenesis in these individuals The HRAS1 variable number", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 35, "end": 38}]}
{"text": "risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat VNTR locus Women who carry a mutation in the BRCA1 gene on chromosome 17q21 have an 80 risk of breast cancer and a 40 risk of [E1] ovarian cancer [/E1] by the age of 70 ref 1 The variable penetrance of BRCA1 suggests that other genetic and non genetic factors play a role in tumourigenesis in these individuals The HRAS1 variable number of tandem repeats VNTR polymorphism located 1", "mention_data": [{"mention": "ovarian cancer", "kb_id": "D010051", "start": 42, "end": 45}]}
{"text": "and non genetic factors play a role in tumourigenesis in these individuals The HRAS1 variable number of tandem repeats VNTR polymorphism located 1 kilobase kb downstream of the HRAS1 proto oncogene chromosome 11p15 5 is one possible genetic modifier of [E1] cancer [/E1] penetrance Individuals who have rare alleles of the VNTR have an increased risk of certain types of cancers including breast cancer 2 4 To investigate whether the presence of rare HRAS1 alleles increases susceptibility to hereditary breast and ovarian", "mention_data": [{"mention": "cancer", "kb_id": "D009369", "start": 100, "end": 102}]}
{"text": "repeats VNTR polymorphism located 1 kilobase kb downstream of the HRAS1 proto oncogene chromosome 11p15 5 is one possible genetic modifier of cancer penetrance Individuals who have rare alleles of the VNTR have an increased risk of certain types of [E1] cancers [/E1] including breast cancer 2 4 To investigate whether the presence of rare HRAS1 alleles increases susceptibility to hereditary breast and ovarian cancer we have typed a panel of 307 female BRCA1 carriers at this locus using a PCR based", "mention_data": [{"mention": "cancers", "kb_id": "D009369", "start": 118, "end": 120}]}
{"text": "polymorphism located 1 kilobase kb downstream of the HRAS1 proto oncogene chromosome 11p15 5 is one possible genetic modifier of cancer penetrance Individuals who have rare alleles of the VNTR have an increased risk of certain types of cancers including [E1] breast cancer [/E1] 2 4 To investigate whether the presence of rare HRAS1 alleles increases susceptibility to hereditary breast and ovarian cancer we have typed a panel of 307 female BRCA1 carriers at this locus using a PCR based technique The risk", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 120, "end": 123}]}
{"text": "possible genetic modifier of cancer penetrance Individuals who have rare alleles of the VNTR have an increased risk of certain types of cancers including breast cancer 2 4 To investigate whether the presence of rare HRAS1 alleles increases susceptibility to [E1] hereditary breast and ovarian cancer [/E1] we have typed a panel of 307 female BRCA1 carriers at this locus using a PCR based technique The risk for ovarian cancer was 2 11 times greater for BRCA1 carriers harbouring one or two rare HRAS1 alleles compared", "mention_data": [{"mention": "hereditary breast and ovarian cancer", "kb_id": "D061325", "start": 136, "end": 142}]}
{"text": "2 4 To investigate whether the presence of rare HRAS1 alleles increases susceptibility to hereditary breast and ovarian cancer we have typed a panel of 307 female BRCA1 carriers at this locus using a PCR based technique The risk for [E1] ovarian cancer [/E1] was 2 11 times greater for BRCA1 carriers harbouring one or two rare HRAS1 alleles compared to carriers with only common alleles P 0 015 The magnitude of the relative risk associated with a rare HRAS1 allele was not", "mention_data": [{"mention": "ovarian cancer", "kb_id": "D010051", "start": 162, "end": 165}]}
{"text": "one or two rare HRAS1 alleles compared to carriers with only common alleles P 0 015 The magnitude of the relative risk associated with a rare HRAS1 allele was not altered by adjusting for the other known risk factors for [E1] hereditary ovarian cancer [/E1] 5 Susceptibility to breast cancer did not appear to be affected by the presence of rare HRAS1 alleles This study is the first to show the effect of a modifying gene on the penetrance of an inherited cancer syndrome", "mention_data": [{"mention": "hereditary ovarian cancer", "kb_id": "D061325", "start": 213, "end": 217}]}
{"text": "compared to carriers with only common alleles P 0 015 The magnitude of the relative risk associated with a rare HRAS1 allele was not altered by adjusting for the other known risk factors for hereditary ovarian cancer 5 Susceptibility to [E1] breast cancer [/E1] did not appear to be affected by the presence of rare HRAS1 alleles This study is the first to show the effect of a modifying gene on the penetrance of an inherited cancer syndrome", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 219, "end": 222}]}
{"text": "for hereditary ovarian cancer 5 Susceptibility to breast cancer did not appear to be affected by the presence of rare HRAS1 alleles This study is the first to show the effect of a modifying gene on the penetrance of an [E1] inherited cancer syndrome [/E1]", "mention_data": [{"mention": "inherited cancer syndrome", "kb_id": "D009386", "start": 252, "end": 256}]}
{"text": "A previously undescribed mutation within the tetramerisation domain of TP53 in a family with [E1] Li Fraumeni syndrome [/E1] We report details of a family with classic Li Fraumeni syndrome in which there is a mutation in codon 344 of the tumour suppressor gene TP53 Codon 344 is a key residue within the tetramerisation domain and the amino", "mention_data": [{"mention": "Li Fraumeni syndrome", "kb_id": "D016864", "start": 14, "end": 18}]}
{"text": "A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li Fraumeni syndrome We report details of a family with classic [E1] Li Fraumeni syndrome [/E1] in which there is a mutation in codon 344 of the tumour suppressor gene TP53 Codon 344 is a key residue within the tetramerisation domain and the amino acid substitution of a proline for a leucine is predicted to", "mention_data": [{"mention": "Li Fraumeni syndrome", "kb_id": "D016864", "start": 25, "end": 29}]}
{"text": "A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li Fraumeni syndrome We report details of a family with classic Li Fraumeni syndrome in which there is a mutation in codon 344 of the [E1] tumour [/E1] suppressor gene TP53 Codon 344 is a key residue within the tetramerisation domain and the amino acid substitution of a proline for a leucine is predicted to have profound implications for tetramerisation and potentially DNA binding This is the", "mention_data": [{"mention": "tumour", "kb_id": "D009369", "start": 39, "end": 41}]}
{"text": "within the tetramerisation domain and the amino acid substitution of a proline for a leucine is predicted to have profound implications for tetramerisation and potentially DNA binding This is the first report of a mutation at this residue in either [E1] sporadic tumours [/E1] or in the germline and the first report of a germline mutation within the tetramerisation domain The family does not appear to be remarkable in the spectrum of tumours and there is loss of the wild type allele in", "mention_data": [{"mention": "sporadic tumours", "kb_id": "D009369", "start": 89, "end": 92}]}
{"text": "first report of a mutation at this residue in either sporadic tumours or in the germline and the first report of a germline mutation within the tetramerisation domain The family does not appear to be remarkable in the spectrum of [E1] tumours [/E1] and there is loss of the wild type allele in a leiomyosarcoma from the proband A cell line has been established from the tumour of the proband and cytogenetic and molecular studies carried out providing an extensive analysis in", "mention_data": [{"mention": "tumours", "kb_id": "D009369", "start": 119, "end": 121}]}
{"text": "or in the germline and the first report of a germline mutation within the tetramerisation domain The family does not appear to be remarkable in the spectrum of tumours and there is loss of the wild type allele in a [E1] leiomyosarcoma [/E1] from the proband A cell line has been established from the tumour of the proband and cytogenetic and molecular studies carried out providing an extensive analysis in this family", "mention_data": [{"mention": "leiomyosarcoma", "kb_id": "D007890", "start": 131, "end": 133}]}
{"text": "within the tetramerisation domain The family does not appear to be remarkable in the spectrum of tumours and there is loss of the wild type allele in a leiomyosarcoma from the proband A cell line has been established from the [E1] tumour [/E1] of the proband and cytogenetic and molecular studies carried out providing an extensive analysis in this family", "mention_data": [{"mention": "tumour", "kb_id": "D009369", "start": 143, "end": 145}]}
{"text": "Trinucleotide repeat expansion at the [E1] myotonic dystrophy [/E1] locus reduces expression of DMAHP Myotonic dystrophy or dystrophia myotonica DM is an autosomal dominant multisystem disorder caused by the expansion of a CTG trinucleotide repeat in the 3 untranslated region of the DMPK protein kinase gene on chromosome", "mention_data": [{"mention": "myotonic dystrophy", "kb_id": "D009223", "start": 5, "end": 8}]}
{"text": "Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP [E1] Myotonic dystrophy [/E1] or dystrophia myotonica DM is an autosomal dominant multisystem disorder caused by the expansion of a CTG trinucleotide repeat in the 3 untranslated region of the DMPK protein kinase gene on chromosome 19q13 3 refs 1 3 Although the", "mention_data": [{"mention": "Myotonic dystrophy", "kb_id": "D009223", "start": 12, "end": 15}]}
{"text": "Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP Myotonic dystrophy or [E1] dystrophia myotonica [/E1] DM is an autosomal dominant multisystem disorder caused by the expansion of a CTG trinucleotide repeat in the 3 untranslated region of the DMPK protein kinase gene on chromosome 19q13 3 refs 1 3 Although the DM mutation was", "mention_data": [{"mention": "dystrophia myotonica", "kb_id": "D009223", "start": 15, "end": 18}]}
{"text": "Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP Myotonic dystrophy or dystrophia myotonica [E1] DM [/E1] is an autosomal dominant multisystem disorder caused by the expansion of a CTG trinucleotide repeat in the 3 untranslated region of the DMPK protein kinase gene on chromosome 19q13 3 refs 1 3 Although the DM mutation was identified", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 17, "end": 19}]}
{"text": "Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP Myotonic dystrophy or dystrophia myotonica DM is an [E1] autosomal dominant multisystem disorder [/E1] caused by the expansion of a CTG trinucleotide repeat in the 3 untranslated region of the DMPK protein kinase gene on chromosome 19q13 3 refs 1 3 Although the DM mutation was identified more than five years ago the", "mention_data": [{"mention": "autosomal dominant multisystem disorder", "kb_id": "D030342", "start": 20, "end": 25}]}
{"text": "dystrophy or dystrophia myotonica DM is an autosomal dominant multisystem disorder caused by the expansion of a CTG trinucleotide repeat in the 3 untranslated region of the DMPK protein kinase gene on chromosome 19q13 3 refs 1 3 Although the [E1] DM [/E1] mutation was identified more than five years ago the pathogenic mechanisms underlying this most prevalent form of hereditary adult neuromuscular disease remain elusive Previous work from our laboratory demonstrated that a DNase l hypersensitive site located adjacent to the", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 53, "end": 55}]}
{"text": "in the 3 untranslated region of the DMPK protein kinase gene on chromosome 19q13 3 refs 1 3 Although the DM mutation was identified more than five years ago the pathogenic mechanisms underlying this most prevalent form of hereditary adult [E1] neuromuscular disease [/E1] remain elusive Previous work from our laboratory demonstrated that a DNase l hypersensitive site located adjacent to the repeats on the wild type allele is eliminated by repeat expansion indicating that large CTG repeat arrays may be associated with", "mention_data": [{"mention": "neuromuscular disease", "kb_id": "D009468", "start": 73, "end": 76}]}
{"text": "may be associated with a local chromatin environment that represses gene expression Here we report that the hypersensitive site contains an enhancer element that regulates transcription of the adjacent DMAHP homeobox gene Analysis of DMAHP expression in the cells of [E1] DM [/E1] patients with loss of the hypersensitive site revealed a two to fourfold reduction in steady state DMAHP transcript levels relative to wild type controls Allele specific analysis of DMAHP expression showed that steady state transcript levels from the expanded", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 150, "end": 152}]}
{"text": "expression showed that steady state transcript levels from the expanded allele were greatly reduced in comparison to those from the wild type allele Together these results demonstrate that CTG repeat expansions can suppress local gene expression and implicate DMAHP in [E1] DM [/E1] pathogenesis", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 220, "end": 222}]}
{"text": "A mutation in [E1] autosomal dominant myotonia congenita [/E1] affects pore properties of the muscle chloride channel Autosomal dominant myotonia congenita is an inherited disorder of skeletal muscle caused by mutations in a voltage gated Cl channel gene CLCN1 7q35 Here we report that a mutation predicting the", "mention_data": [{"mention": "autosomal dominant myotonia congenita", "kb_id": "160800", "start": 3, "end": 8}]}
{"text": "A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel [E1] Autosomal dominant myotonia congenita [/E1] is an inherited disorder of skeletal muscle caused by mutations in a voltage gated Cl channel gene CLCN1 7q35 Here we report that a mutation predicting the substitution of Gly 230 by glutamic acid G230E between segments D3 and", "mention_data": [{"mention": "Autosomal dominant myotonia congenita", "kb_id": "160800", "start": 15, "end": 20}]}
{"text": "A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel Autosomal dominant myotonia congenita is an [E1] inherited disorder of skeletal muscle [/E1] caused by mutations in a voltage gated Cl channel gene CLCN1 7q35 Here we report that a mutation predicting the substitution of Gly 230 by glutamic acid G230E between segments D3 and D4 dramatically alters the pore properties of", "mention_data": [{"mention": "inherited disorder of skeletal muscle", "kb_id": "D009135|D030342", "start": 21, "end": 27}]}
{"text": "Mutation analysis of BRCA1 and BRCA2 in a [E1] male breast cancer [/E1] population A population based series of 54 male breast cancer cases from Southern California were analyzed for germ line mutations in the inherited breast/ovarian cancer genes BRCA1 and BRCA2 Nine 17 of the patients had a family history of", "mention_data": [{"mention": "male breast cancer", "kb_id": "D018567", "start": 8, "end": 12}]}
{"text": "Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population A population based series of 54 [E1] male breast cancer [/E1] cases from Southern California were analyzed for germ line mutations in the inherited breast/ovarian cancer genes BRCA1 and BRCA2 Nine 17 of the patients had a family history of breast and/or ovarian cancer in at least one first degree", "mention_data": [{"mention": "male breast cancer", "kb_id": "D018567", "start": 18, "end": 22}]}
{"text": "Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population A population based series of 54 male breast cancer cases from Southern California were analyzed for germ line mutations in the [E1] inherited breast/ovarian cancer [/E1] genes BRCA1 and BRCA2 Nine 17 of the patients had a family history of breast and/or ovarian cancer in at least one first degree relative A further seven 13 of the patients reported breast/ovarian cancer in at least one", "mention_data": [{"mention": "inherited breast/ovarian cancer", "kb_id": "D061325", "start": 33, "end": 37}]}
{"text": "cancer population A population based series of 54 male breast cancer cases from Southern California were analyzed for germ line mutations in the inherited breast/ovarian cancer genes BRCA1 and BRCA2 Nine 17 of the patients had a family history of [E1] breast and/or ovarian cancer [/E1] in at least one first degree relative A further seven 13 of the patients reported breast/ovarian cancer in at least one second degree relative and in no first degree relatives No germ line BRCA1 mutations were found Two male", "mention_data": [{"mention": "breast and/or ovarian cancer", "kb_id": "D061325", "start": 50, "end": 55}]}
{"text": "line mutations in the inherited breast/ovarian cancer genes BRCA1 and BRCA2 Nine 17 of the patients had a family history of breast and/or ovarian cancer in at least one first degree relative A further seven 13 of the patients reported [E1] breast/ovarian cancer [/E1] in at least one second degree relative and in no first degree relatives No germ line BRCA1 mutations were found Two male breast cancer patients 4 of the total were found to carry novel truncating mutations in the BRCA2", "mention_data": [{"mention": "breast/ovarian cancer", "kb_id": "D061325", "start": 69, "end": 72}]}
{"text": "ovarian cancer in at least one first degree relative A further seven 13 of the patients reported breast/ovarian cancer in at least one second degree relative and in no first degree relatives No germ line BRCA1 mutations were found Two [E1] male breast cancer [/E1] patients 4 of the total were found to carry novel truncating mutations in the BRCA2 gene Only one of the two male breast cancer patients carrying a BRCA2 mutation had a family history of cancer with one case of", "mention_data": [{"mention": "male breast cancer", "kb_id": "D018567", "start": 92, "end": 96}]}
{"text": "degree relative and in no first degree relatives No germ line BRCA1 mutations were found Two male breast cancer patients 4 of the total were found to carry novel truncating mutations in the BRCA2 gene Only one of the two [E1] male breast cancer [/E1] patients carrying a BRCA2 mutation had a family history of cancer with one case of ovarian cancer in a first degree relative The remaining eight cases 89 of male breast cancer with a family history of breast/ovarian cancer in", "mention_data": [{"mention": "male breast cancer", "kb_id": "D018567", "start": 116, "end": 120}]}
{"text": "were found Two male breast cancer patients 4 of the total were found to carry novel truncating mutations in the BRCA2 gene Only one of the two male breast cancer patients carrying a BRCA2 mutation had a family history of [E1] cancer [/E1] with one case of ovarian cancer in a first degree relative The remaining eight cases 89 of male breast cancer with a family history of breast/ovarian cancer in first degree relatives remain unaccounted for by mutations in either the", "mention_data": [{"mention": "cancer", "kb_id": "D009369", "start": 129, "end": 131}]}
{"text": "cancer patients 4 of the total were found to carry novel truncating mutations in the BRCA2 gene Only one of the two male breast cancer patients carrying a BRCA2 mutation had a family history of cancer with one case of [E1] ovarian cancer [/E1] in a first degree relative The remaining eight cases 89 of male breast cancer with a family history of breast/ovarian cancer in first degree relatives remain unaccounted for by mutations in either the BRCA1 gene or the BRCA2 gene", "mention_data": [{"mention": "ovarian cancer", "kb_id": "D010051", "start": 134, "end": 137}]}
{"text": "in the BRCA2 gene Only one of the two male breast cancer patients carrying a BRCA2 mutation had a family history of cancer with one case of ovarian cancer in a first degree relative The remaining eight cases 89 of [E1] male breast cancer [/E1] with a family history of breast/ovarian cancer in first degree relatives remain unaccounted for by mutations in either the BRCA1 gene or the BRCA2 gene", "mention_data": [{"mention": "male breast cancer", "kb_id": "D018567", "start": 147, "end": 151}]}
{"text": "two male breast cancer patients carrying a BRCA2 mutation had a family history of cancer with one case of ovarian cancer in a first degree relative The remaining eight cases 89 of male breast cancer with a family history of [E1] breast/ovarian cancer [/E1] in first degree relatives remain unaccounted for by mutations in either the BRCA1 gene or the BRCA2 gene", "mention_data": [{"mention": "breast/ovarian cancer", "kb_id": "D061325", "start": 155, "end": 158}]}
{"text": "Expression of the [E1] von Hippel Lindau disease tumour [/E1] suppressor gene during human embryogenesis The von Hippel Lindau VHL disease product is thought to down regulate transcription by antagonizing elongin enhanced transcriptional elongation Germline VHL gene mutations predispose to the development of retinal cerebellar and spinal haemangioblastomas renal", "mention_data": [{"mention": "von Hippel Lindau disease tumour", "kb_id": "D006623", "start": 3, "end": 9}]}
{"text": "Expression of the von Hippel Lindau disease tumour suppressor gene during human embryogenesis The [E1] von Hippel Lindau VHL disease [/E1] product is thought to down regulate transcription by antagonizing elongin enhanced transcriptional elongation Germline VHL gene mutations predispose to the development of retinal cerebellar and spinal haemangioblastomas renal cell carcinoma and phaeochromocytoma In addition somatic Inactivation of the VHL", "mention_data": [{"mention": "von Hippel Lindau VHL disease", "kb_id": "D006623", "start": 14, "end": 20}]}
{"text": "Expression of the von Hippel Lindau disease tumour suppressor gene during human embryogenesis The von Hippel Lindau VHL disease product is thought to down regulate transcription by antagonizing elongin enhanced transcriptional elongation Germline [E1] VHL [/E1] gene mutations predispose to the development of retinal cerebellar and spinal haemangioblastomas renal cell carcinoma and phaeochromocytoma In addition somatic Inactivation of the VHL gene is frequent in sporadic renal cell carcinoma and haemangioblastoma Regulation of transcript elongation is", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 33, "end": 35}]}
{"text": "of the von Hippel Lindau disease tumour suppressor gene during human embryogenesis The von Hippel Lindau VHL disease product is thought to down regulate transcription by antagonizing elongin enhanced transcriptional elongation Germline VHL gene mutations predispose to the development of [E1] retinal cerebellar and spinal haemangioblastomas [/E1] renal cell carcinoma and phaeochromocytoma In addition somatic Inactivation of the VHL gene is frequent in sporadic renal cell carcinoma and haemangioblastoma Regulation of transcript elongation is an important control mechanism for gene expression and the VHL gene might", "mention_data": [{"mention": "retinal cerebellar and spinal haemangioblastomas", "kb_id": "D012175|D018325", "start": 41, "end": 47}]}
{"text": "disease tumour suppressor gene during human embryogenesis The von Hippel Lindau VHL disease product is thought to down regulate transcription by antagonizing elongin enhanced transcriptional elongation Germline VHL gene mutations predispose to the development of retinal cerebellar and spinal haemangioblastomas [E1] renal cell carcinoma [/E1] and phaeochromocytoma In addition somatic Inactivation of the VHL gene is frequent in sporadic renal cell carcinoma and haemangioblastoma Regulation of transcript elongation is an important control mechanism for gene expression and the VHL gene might modify the expression", "mention_data": [{"mention": "renal cell carcinoma", "kb_id": "D002292", "start": 46, "end": 50}]}
{"text": "during human embryogenesis The von Hippel Lindau VHL disease product is thought to down regulate transcription by antagonizing elongin enhanced transcriptional elongation Germline VHL gene mutations predispose to the development of retinal cerebellar and spinal haemangioblastomas renal cell carcinoma and [E1] phaeochromocytoma [/E1] In addition somatic Inactivation of the VHL gene is frequent in sporadic renal cell carcinoma and haemangioblastoma Regulation of transcript elongation is an important control mechanism for gene expression and the VHL gene might modify the expression of proto", "mention_data": [{"mention": "phaeochromocytoma", "kb_id": "D010673", "start": 50, "end": 52}]}
{"text": "VHL disease product is thought to down regulate transcription by antagonizing elongin enhanced transcriptional elongation Germline VHL gene mutations predispose to the development of retinal cerebellar and spinal haemangioblastomas renal cell carcinoma and phaeochromocytoma In addition somatic Inactivation of the [E1] VHL [/E1] gene is frequent in sporadic renal cell carcinoma and haemangioblastoma Regulation of transcript elongation is an important control mechanism for gene expression and the VHL gene might modify the expression of proto oncogenes and growth suppressor genes during embryogenesis", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 57, "end": 59}]}
{"text": "to down regulate transcription by antagonizing elongin enhanced transcriptional elongation Germline VHL gene mutations predispose to the development of retinal cerebellar and spinal haemangioblastomas renal cell carcinoma and phaeochromocytoma In addition somatic Inactivation of the VHL gene is frequent in [E1] sporadic renal cell carcinoma [/E1] and haemangioblastoma Regulation of transcript elongation is an important control mechanism for gene expression and the VHL gene might modify the expression of proto oncogenes and growth suppressor genes during embryogenesis We therefore investigated the expression of VHL mRNA", "mention_data": [{"mention": "sporadic renal cell carcinoma", "kb_id": "D002292", "start": 62, "end": 67}]}
{"text": "antagonizing elongin enhanced transcriptional elongation Germline VHL gene mutations predispose to the development of retinal cerebellar and spinal haemangioblastomas renal cell carcinoma and phaeochromocytoma In addition somatic Inactivation of the VHL gene is frequent in sporadic renal cell carcinoma and [E1] haemangioblastoma [/E1] Regulation of transcript elongation is an important control mechanism for gene expression and the VHL gene might modify the expression of proto oncogenes and growth suppressor genes during embryogenesis We therefore investigated the expression of VHL mRNA during human", "mention_data": [{"mention": "haemangioblastoma", "kb_id": "D018325", "start": 67, "end": 69}]}
{"text": "cerebellar and spinal haemangioblastomas renal cell carcinoma and phaeochromocytoma In addition somatic Inactivation of the VHL gene is frequent in sporadic renal cell carcinoma and haemangioblastoma Regulation of transcript elongation is an important control mechanism for gene expression and the [E1] VHL [/E1] gene might modify the expression of proto oncogenes and growth suppressor genes during embryogenesis We therefore investigated the expression of VHL mRNA during human embryogenesis by in situ hybridization studies at 4 6 and 10 weeks post conception Although", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 82, "end": 84}]}
{"text": "renal cell carcinoma and haemangioblastoma Regulation of transcript elongation is an important control mechanism for gene expression and the VHL gene might modify the expression of proto oncogenes and growth suppressor genes during embryogenesis We therefore investigated the expression of [E1] VHL [/E1] mRNA during human embryogenesis by in situ hybridization studies at 4 6 and 10 weeks post conception Although VHL mRNA was expressed in all three germ layers strong expression was noted in the central nervous system kidneys testis and", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 103, "end": 105}]}
{"text": "VHL gene might modify the expression of proto oncogenes and growth suppressor genes during embryogenesis We therefore investigated the expression of VHL mRNA during human embryogenesis by in situ hybridization studies at 4 6 and 10 weeks post conception Although [E1] VHL [/E1] mRNA was expressed in all three germ layers strong expression was noted in the central nervous system kidneys testis and lung Within the kidney VHL mRNA was differentially expressed within renal tubules suggesting that the VHL gene product may", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 122, "end": 124}]}
{"text": "embryogenesis by in situ hybridization studies at 4 6 and 10 weeks post conception Although VHL mRNA was expressed in all three germ layers strong expression was noted in the central nervous system kidneys testis and lung Within the kidney [E1] VHL [/E1] mRNA was differentially expressed within renal tubules suggesting that the VHL gene product may have a specific role in kidney development Two alternatively spliced VHL mRNAs characterized by inclusion isoform I or exclusion isoform II of exon 2 are", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 147, "end": 149}]}
{"text": "weeks post conception Although VHL mRNA was expressed in all three germ layers strong expression was noted in the central nervous system kidneys testis and lung Within the kidney VHL mRNA was differentially expressed within renal tubules suggesting that the [E1] VHL [/E1] gene product may have a specific role in kidney development Two alternatively spliced VHL mRNAs characterized by inclusion isoform I or exclusion isoform II of exon 2 are transcribed in adult tissues To investigate if the two isoforms are", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 158, "end": 160}]}
{"text": "expression was noted in the central nervous system kidneys testis and lung Within the kidney VHL mRNA was differentially expressed within renal tubules suggesting that the VHL gene product may have a specific role in kidney development Two alternatively spliced [E1] VHL [/E1] mRNAs characterized by inclusion isoform I or exclusion isoform II of exon 2 are transcribed in adult tissues To investigate if the two isoforms are differentially expressed during embryogenesis VHL mRNA was reverse transcribed from 13 fetal tissues 8", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 172, "end": 174}]}
{"text": "have a specific role in kidney development Two alternatively spliced VHL mRNAs characterized by inclusion isoform I or exclusion isoform II of exon 2 are transcribed in adult tissues To investigate if the two isoforms are differentially expressed during embryogenesis [E1] VHL [/E1] mRNA was reverse transcribed from 13 fetal tissues 8 10 weeks gestation The quantitative distribution of VHL mRNA within fetal tissues reflected that seen by in situ hybridization and the ratio of the two VHL isoforms was similar between", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 202, "end": 204}]}
{"text": "or exclusion isoform II of exon 2 are transcribed in adult tissues To investigate if the two isoforms are differentially expressed during embryogenesis VHL mRNA was reverse transcribed from 13 fetal tissues 8 10 weeks gestation The quantitative distribution of [E1] VHL [/E1] mRNA within fetal tissues reflected that seen by in situ hybridization and the ratio of the two VHL isoforms was similar between tissues Although the genes regulated by the VHL gene product have not yet been identified our findings", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 219, "end": 221}]}
{"text": "are differentially expressed during embryogenesis VHL mRNA was reverse transcribed from 13 fetal tissues 8 10 weeks gestation The quantitative distribution of VHL mRNA within fetal tissues reflected that seen by in situ hybridization and the ratio of the two [E1] VHL [/E1] isoforms was similar between tissues Although the genes regulated by the VHL gene product have not yet been identified our findings are compatible with the hypothesis that VHL mediated control of transcriptional elongation may have a role in normal", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 237, "end": 239}]}
{"text": "fetal tissues 8 10 weeks gestation The quantitative distribution of VHL mRNA within fetal tissues reflected that seen by in situ hybridization and the ratio of the two VHL isoforms was similar between tissues Although the genes regulated by the [E1] VHL [/E1] gene product have not yet been identified our findings are compatible with the hypothesis that VHL mediated control of transcriptional elongation may have a role in normal human development", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 249, "end": 251}]}
{"text": "that seen by in situ hybridization and the ratio of the two VHL isoforms was similar between tissues Although the genes regulated by the VHL gene product have not yet been identified our findings are compatible with the hypothesis that [E1] VHL [/E1] mediated control of transcriptional elongation may have a role in normal human development", "mention_data": [{"mention": "VHL", "kb_id": "D006623", "start": 265, "end": 267}]}
{"text": "Screening for ESR mutations in [E1] breast and ovarian cancer [/E1] patients In the present study leukocyte DNA from 143 patients with familial clustering of breast and/or ovarian cancer and tumour DNA from 96 breast carcinomas were screened for base mutations in the estrogen receptor gene ESR Three patients with", "mention_data": [{"mention": "breast and ovarian cancer", "kb_id": "D061325", "start": 5, "end": 10}]}
{"text": "Screening for ESR mutations in breast and ovarian cancer patients In the present study leukocyte DNA from 143 patients with familial clustering of [E1] breast and/or ovarian cancer [/E1] and tumour DNA from 96 breast carcinomas were screened for base mutations in the estrogen receptor gene ESR Three patients with a family history of cancer were carrying a Gly160Cys germline substitution This alteration was also detected in eight", "mention_data": [{"mention": "breast and/or ovarian cancer", "kb_id": "D061325", "start": 23, "end": 28}]}
{"text": "Screening for ESR mutations in breast and ovarian cancer patients In the present study leukocyte DNA from 143 patients with familial clustering of breast and/or ovarian cancer and [E1] tumour [/E1] DNA from 96 breast carcinomas were screened for base mutations in the estrogen receptor gene ESR Three patients with a family history of cancer were carrying a Gly160Cys germline substitution This alteration was also detected in eight four females", "mention_data": [{"mention": "tumour", "kb_id": "D009369", "start": 28, "end": 30}]}
{"text": "Screening for ESR mutations in breast and ovarian cancer patients In the present study leukocyte DNA from 143 patients with familial clustering of breast and/or ovarian cancer and tumour DNA from 96 [E1] breast carcinomas [/E1] were screened for base mutations in the estrogen receptor gene ESR Three patients with a family history of cancer were carrying a Gly160Cys germline substitution This alteration was also detected in eight four females and four males of 729", "mention_data": [{"mention": "breast carcinomas", "kb_id": "D001943", "start": 32, "end": 35}]}
{"text": "present study leukocyte DNA from 143 patients with familial clustering of breast and/or ovarian cancer and tumour DNA from 96 breast carcinomas were screened for base mutations in the estrogen receptor gene ESR Three patients with a family history of [E1] cancer [/E1] were carrying a Gly160Cys germline substitution This alteration was also detected in eight four females and four males of 729 controls 366 female 363 males indicating that the substitution probably represents a polymorphism However in the 229 female controls", "mention_data": [{"mention": "cancer", "kb_id": "D009369", "start": 52, "end": 54}]}
{"text": "germline substitution This alteration was also detected in eight four females and four males of 729 controls 366 female 363 males indicating that the substitution probably represents a polymorphism However in the 229 female controls in whom family history of [E1] cancer [/E1] was known one of two who had a sister with breast cancer was carrying the variant allele Hence a possible clinical significance of the glycine into cysteine cannot be completely ruled out and should be further investigated Somatic mutations", "mention_data": [{"mention": "cancer", "kb_id": "D009369", "start": 97, "end": 99}]}
{"text": "and four males of 729 controls 366 female 363 males indicating that the substitution probably represents a polymorphism However in the 229 female controls in whom family history of cancer was known one of two who had a sister with [E1] breast cancer [/E1] was carrying the variant allele Hence a possible clinical significance of the glycine into cysteine cannot be completely ruled out and should be further investigated Somatic mutations were not detected in any of the tumours studied and the present", "mention_data": [{"mention": "breast cancer", "kb_id": "D001943", "start": 108, "end": 111}]}
{"text": "had a sister with breast cancer was carrying the variant allele Hence a possible clinical significance of the glycine into cysteine cannot be completely ruled out and should be further investigated Somatic mutations were not detected in any of the [E1] tumours [/E1] studied and the present data do not provide support for somatic ESR base mutations as an important mechanism for hormonal therapy resistance in estrogen receptor positive breast carcinomas", "mention_data": [{"mention": "tumours", "kb_id": "D009369", "start": 144, "end": 146}]}
{"text": "ruled out and should be further investigated Somatic mutations were not detected in any of the tumours studied and the present data do not provide support for somatic ESR base mutations as an important mechanism for hormonal therapy resistance in [E1] estrogen receptor positive breast carcinomas [/E1]", "mention_data": [{"mention": "estrogen receptor positive breast carcinomas", "kb_id": "D001943", "start": 168, "end": 174}]}
{"text": "Increased [E1] coronary heart disease [/E1] in Japanese American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels Plasma high density lipoprotein HDL levels are strongly genetically determined and show a general inverse relationship with coronary heart disease CHD The", "mention_data": [{"mention": "coronary heart disease", "kb_id": "D003327", "start": 1, "end": 5}]}
{"text": "Increased coronary heart disease in Japanese American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels Plasma high density lipoprotein HDL levels are strongly genetically determined and show a general inverse relationship with [E1] coronary heart disease [/E1] CHD The cholesteryl ester transfer protein CETP mediates the transfer of cholesteryl esters from HDL to other lipoproteins and is a key participant in the reverse transport of cholesterol from the periphery to the liver A high prevalence of", "mention_data": [{"mention": "coronary heart disease", "kb_id": "D003327", "start": 38, "end": 42}]}
{"text": "coronary heart disease in Japanese American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels Plasma high density lipoprotein HDL levels are strongly genetically determined and show a general inverse relationship with coronary heart disease [E1] CHD [/E1] The cholesteryl ester transfer protein CETP mediates the transfer of cholesteryl esters from HDL to other lipoproteins and is a key participant in the reverse transport of cholesterol from the periphery to the liver A high prevalence of two", "mention_data": [{"mention": "CHD", "kb_id": "D003327", "start": 41, "end": 43}]}
{"text": "14G A 0 5 was found in 3 469 men of Japanese ancestry in the Honolulu Heart Program and mutations were associated with decreased CETP 35 and increased HDL chol levels 10 for D442G However the overall prevalence of definite [E1] CHD [/E1] was 21 in men with mutations and 16 in men without mutations The relative risk RR of CHD was 1 43 in men with mutations P 05 after adjustment for CHD risk factors the RR was 1 55 P", "mention_data": [{"mention": "CHD", "kb_id": "D003327", "start": 129, "end": 131}]}
{"text": "and mutations were associated with decreased CETP 35 and increased HDL chol levels 10 for D442G However the overall prevalence of definite CHD was 21 in men with mutations and 16 in men without mutations The relative risk RR of [E1] CHD [/E1] was 1 43 in men with mutations P 05 after adjustment for CHD risk factors the RR was 1 55 P 02 after additional adjustment for HDL levels the RR was 1 68 P 008 Similar RR values were", "mention_data": [{"mention": "CHD", "kb_id": "D003327", "start": 147, "end": 149}]}
{"text": "10 for D442G However the overall prevalence of definite CHD was 21 in men with mutations and 16 in men without mutations The relative risk RR of CHD was 1 43 in men with mutations P 05 after adjustment for [E1] CHD [/E1] risk factors the RR was 1 55 P 02 after additional adjustment for HDL levels the RR was 1 68 P 008 Similar RR values were obtained for the D442G mutation alone Increased CHD in men with mutations was", "mention_data": [{"mention": "CHD", "kb_id": "D003327", "start": 160, "end": 162}]}
{"text": "mutations P 05 after adjustment for CHD risk factors the RR was 1 55 P 02 after additional adjustment for HDL levels the RR was 1 68 P 008 Similar RR values were obtained for the D442G mutation alone Increased [E1] CHD [/E1] in men with mutations was primarily observed for HDL chol 41 60 mg/dl for HDL chol 60 mg/dl men with and without mutations had low CHD prevalence Thus genetic CETP deficiency appears to be an independent risk factor for", "mention_data": [{"mention": "CHD", "kb_id": "D003327", "start": 194, "end": 196}]}
{"text": "68 P 008 Similar RR values were obtained for the D442G mutation alone Increased CHD in men with mutations was primarily observed for HDL chol 41 60 mg/dl for HDL chol 60 mg/dl men with and without mutations had low [E1] CHD [/E1] prevalence Thus genetic CETP deficiency appears to be an independent risk factor for CHD primarily due to increased CHD prevalence in men with the D442G mutation and HDL cholesterol between 41 and 60 mg/dl The findings suggest that both", "mention_data": [{"mention": "CHD", "kb_id": "D003327", "start": 220, "end": 222}]}
{"text": "RR values were obtained for the D442G mutation alone Increased CHD in men with mutations was primarily observed for HDL chol 41 60 mg/dl for HDL chol 60 mg/dl men with and without mutations had low CHD prevalence Thus genetic [E1] CETP deficiency [/E1] appears to be an independent risk factor for CHD primarily due to increased CHD prevalence in men with the D442G mutation and HDL cholesterol between 41 and 60 mg/dl The findings suggest that both HDL concentration and the dynamics", "mention_data": [{"mention": "CETP deficiency", "kb_id": "143470", "start": 224, "end": 227}]}
{"text": "CHD in men with mutations was primarily observed for HDL chol 41 60 mg/dl for HDL chol 60 mg/dl men with and without mutations had low CHD prevalence Thus genetic CETP deficiency appears to be an independent risk factor for [E1] CHD [/E1] primarily due to increased CHD prevalence in men with the D442G mutation and HDL cholesterol between 41 and 60 mg/dl The findings suggest that both HDL concentration and the dynamics of cholesterol transport through HDL i e reverse cholesterol", "mention_data": [{"mention": "CHD", "kb_id": "D003327", "start": 234, "end": 236}]}
{"text": "was primarily observed for HDL chol 41 60 mg/dl for HDL chol 60 mg/dl men with and without mutations had low CHD prevalence Thus genetic CETP deficiency appears to be an independent risk factor for CHD primarily due to increased [E1] CHD [/E1] prevalence in men with the D442G mutation and HDL cholesterol between 41 and 60 mg/dl The findings suggest that both HDL concentration and the dynamics of cholesterol transport through HDL i e reverse cholesterol transport determine the anti atherogenicity", "mention_data": [{"mention": "CHD", "kb_id": "D003327", "start": 239, "end": 241}]}
{"text": "Analysis of meiotic segregation using single sperm typing meiotic drive at the [E1] myotonic dystrophy [/E1] locus Meiotic drive at the myotonic dystrophy DM locus has recently been suggested as being responsible for maintaining the frequency in the human population of DM chromosomes capable of expansion to the disease state In order to test this", "mention_data": [{"mention": "myotonic dystrophy", "kb_id": "D009223", "start": 12, "end": 15}]}
{"text": "Analysis of meiotic segregation using single sperm typing meiotic drive at the myotonic dystrophy locus Meiotic drive at the [E1] myotonic dystrophy [/E1] DM locus has recently been suggested as being responsible for maintaining the frequency in the human population of DM chromosomes capable of expansion to the disease state In order to test this hypothesis we have studied samples of single", "mention_data": [{"mention": "myotonic dystrophy", "kb_id": "D009223", "start": 19, "end": 22}]}
{"text": "Analysis of meiotic segregation using single sperm typing meiotic drive at the myotonic dystrophy locus Meiotic drive at the myotonic dystrophy [E1] DM [/E1] locus has recently been suggested as being responsible for maintaining the frequency in the human population of DM chromosomes capable of expansion to the disease state In order to test this hypothesis we have studied samples of single sperm", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 21, "end": 23}]}
{"text": "Analysis of meiotic segregation using single sperm typing meiotic drive at the myotonic dystrophy locus Meiotic drive at the myotonic dystrophy DM locus has recently been suggested as being responsible for maintaining the frequency in the human population of [E1] DM [/E1] chromosomes capable of expansion to the disease state In order to test this hypothesis we have studied samples of single sperm from three individuals heterozygous at the DM locus each with one allele larger and one allele smaller than", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 39, "end": 41}]}
{"text": "as being responsible for maintaining the frequency in the human population of DM chromosomes capable of expansion to the disease state In order to test this hypothesis we have studied samples of single sperm from three individuals heterozygous at the [E1] DM [/E1] locus each with one allele larger and one allele smaller than 19 CTG repeats To guard against the possible problem of differential PCR amplification rates based on the lengths of the alleles the sperm were also typed at another", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 67, "end": 69}]}
{"text": "repeats To guard against the possible problem of differential PCR amplification rates based on the lengths of the alleles the sperm were also typed at another closely linked marker whose allele size was unrelated to the allele size at the [E1] DM [/E1] locus Using statistical models specifically designed to study single sperm segregation data we find no evidence of meiotic segregation distortion The upper limit of the two sided 95 confidence interval for the estimate of the common segregation probability for", "mention_data": [{"mention": "DM", "kb_id": "D009223", "start": 121, "end": 123}]}
{"text": "segregation probability for the three donors is at or below 515 for all models considered and no statistically significant difference from 5 is detected in any of the models This suggests that any greater amount of segregation distortion at the [E1] myotonic dystrophy [/E1] locus must result from events following sperm ejaculation", "mention_data": [{"mention": "myotonic dystrophy", "kb_id": "D009223", "start": 198, "end": 201}]}
{"text": "Isolation of full length ATM cDNA and correction of the [E1] ataxia telangiectasia [/E1] cellular phenotype A gene mutated in the human genetic disorder ataxia telangiectasia A T ATM was recently identified by positional cloning ATM is a member of the phosphatidylinositol 3 kinase superfamily some of which are protein kinases and appear", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 10, "end": 13}]}
{"text": "Isolation of full length ATM cDNA and correction of the ataxia telangiectasia cellular phenotype A gene mutated in the human [E1] genetic disorder [/E1] ataxia telangiectasia A T ATM was recently identified by positional cloning ATM is a member of the phosphatidylinositol 3 kinase superfamily some of which are protein kinases and appear to have important roles in cell cycle control and radiation", "mention_data": [{"mention": "genetic disorder", "kb_id": "D030342", "start": 20, "end": 23}]}
{"text": "Isolation of full length ATM cDNA and correction of the ataxia telangiectasia cellular phenotype A gene mutated in the human genetic disorder [E1] ataxia telangiectasia [/E1] A T ATM was recently identified by positional cloning ATM is a member of the phosphatidylinositol 3 kinase superfamily some of which are protein kinases and appear to have important roles in cell cycle control and radiation signal transduction", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 22, "end": 25}]}
{"text": "Isolation of full length ATM cDNA and correction of the ataxia telangiectasia cellular phenotype A gene mutated in the human genetic disorder ataxia telangiectasia [E1] A T [/E1] ATM was recently identified by positional cloning ATM is a member of the phosphatidylinositol 3 kinase superfamily some of which are protein kinases and appear to have important roles in cell cycle control and radiation signal transduction We describe", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 24, "end": 27}]}
{"text": "important roles in cell cycle control and radiation signal transduction We describe herein to our knowledge for the first time the cloning of a full length cDNA for ATM and correction of multiple aspects of the radio sensitive phenotype of [E1] A T [/E1] cells by transfection with this cDNA Overexpression of ATM cDNA in A T cells enhanced the survival of these cells in response to radiation exposure decreased radiation induced chromosome aberrations reduced radio resistant DNA synthesis and partially corrected defective", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 93, "end": 96}]}
{"text": "to our knowledge for the first time the cloning of a full length cDNA for ATM and correction of multiple aspects of the radio sensitive phenotype of A T cells by transfection with this cDNA Overexpression of ATM cDNA in [E1] A T [/E1] cells enhanced the survival of these cells in response to radiation exposure decreased radiation induced chromosome aberrations reduced radio resistant DNA synthesis and partially corrected defective cell cycle checkpoints and induction of stress activated protein kinase This correction of", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 106, "end": 109}]}
{"text": "the survival of these cells in response to radiation exposure decreased radiation induced chromosome aberrations reduced radio resistant DNA synthesis and partially corrected defective cell cycle checkpoints and induction of stress activated protein kinase This correction of the defects in [E1] A T [/E1] cells provides further evidence of the multiplicity of effector functions of the ATM protein and suggests possible approaches to gene therapy", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 150, "end": 153}]}
{"text": "The spectrum of RB1 germ line mutations in [E1] hereditary retinoblastoma [/E1] We have searched for germ line RB1 mutations in 119 patients with hereditary retinoblastoma Previous investigations by Southern blot hybridization and PCR fragment length analysis had revealed mutations in 48 patients Here we report on the analysis of the", "mention_data": [{"mention": "hereditary retinoblastoma", "kb_id": "D012175", "start": 8, "end": 11}]}
{"text": "The spectrum of RB1 germ line mutations in hereditary retinoblastoma We have searched for germ line RB1 mutations in 119 patients with [E1] hereditary retinoblastoma [/E1] Previous investigations by Southern blot hybridization and PCR fragment length analysis had revealed mutations in 48 patients Here we report on the analysis of the remaining 71 patients By applying heteroduplex analysis nonisotopic SSCP and direct sequencing we detected", "mention_data": [{"mention": "hereditary retinoblastoma", "kb_id": "D012175", "start": 22, "end": 25}]}
{"text": "of 99 83 of 119 patients The spectrum comprises 15 large deletions 26 small length alterations and 42 base substitutions No correlation between the location of frameshift or nonsense mutations and phenotypic features including age at diagnosis the number of [E1] tumor [/E1] foci and manifestation of nonocular tumors was observed", "mention_data": [{"mention": "tumor", "kb_id": "D009369", "start": 206, "end": 208}]}
{"text": "patients The spectrum comprises 15 large deletions 26 small length alterations and 42 base substitutions No correlation between the location of frameshift or nonsense mutations and phenotypic features including age at diagnosis the number of tumor foci and manifestation of [E1] nonocular tumors [/E1] was observed", "mention_data": [{"mention": "nonocular tumors", "kb_id": "D009369", "start": 211, "end": 214}]}
{"text": "[E1] Wiskott Aldrich syndrome [/E1] protein a novel effector for the GTPase CDC42Hs is implicated in actin polymerization The Rho family of GTPases control diverse biological processes including cell morphology and mitogenesis We have identified WASP the protein that is defective in Wiskott Aldrich", "mention_data": [{"mention": "Wiskott Aldrich syndrome", "kb_id": "D014923", "start": 0, "end": 4}]}
{"text": "Wiskott Aldrich syndrome protein a novel effector for the GTPase CDC42Hs is implicated in actin polymerization The Rho family of GTPases control diverse biological processes including cell morphology and mitogenesis We have identified WASP the protein that is defective in [E1] Wiskott Aldrich syndrome [/E1] WAS as a novel effector for CDC42Hs but not for the other Rho family members Rac and Rho This interaction is dependent on the presence of the G protein binding domain Cellular expression of epitope tagged WASP produces clusters", "mention_data": [{"mention": "Wiskott Aldrich syndrome", "kb_id": "D014923", "start": 40, "end": 44}]}
{"text": "protein a novel effector for the GTPase CDC42Hs is implicated in actin polymerization The Rho family of GTPases control diverse biological processes including cell morphology and mitogenesis We have identified WASP the protein that is defective in Wiskott Aldrich syndrome [E1] WAS [/E1] as a novel effector for CDC42Hs but not for the other Rho family members Rac and Rho This interaction is dependent on the presence of the G protein binding domain Cellular expression of epitope tagged WASP produces clusters of", "mention_data": [{"mention": "WAS", "kb_id": "D014923", "start": 43, "end": 45}]}
{"text": "coexpression with dominant negative CDC42Hs N17 but not with dominant negative forms of Rac or Rho Thus WASP provides a novel link between CDC42Hs and the actin cytoskeleton which suggests a molecular mechanism for many of the cellular abnormalities in [E1] WAS [/E1] The WASP sequence contains two novel domains that are homologous to other proteins involved in action organization", "mention_data": [{"mention": "WAS", "kb_id": "D014923", "start": 146, "end": 148}]}
{"text": "[E1] Adult onset globoid cell leukodystrophy [/E1] Krabbe disease analysis of galactosylceramidase cDNA from four Japanese patients We examined galactosylceramidase GALC cDNA in four Japanese patients with adult onset globoid cell leukodystrophy Krabbe disease AO GLD by polymerase chain reaction/single strand conformation polymorphism PCR SSCP analysis", "mention_data": [{"mention": "Adult onset globoid cell leukodystrophy", "kb_id": "D007965", "start": 0, "end": 6}]}
{"text": "Adult onset globoid cell leukodystrophy [E1] Krabbe disease [/E1] analysis of galactosylceramidase cDNA from four Japanese patients We examined galactosylceramidase GALC cDNA in four Japanese patients with adult onset globoid cell leukodystrophy Krabbe disease AO GLD by polymerase chain reaction/single strand conformation polymorphism PCR SSCP analysis subsequent sequence", "mention_data": [{"mention": "Krabbe disease", "kb_id": "245200", "start": 5, "end": 8}]}
{"text": "Adult onset globoid cell leukodystrophy Krabbe disease analysis of galactosylceramidase cDNA from four Japanese patients We examined galactosylceramidase GALC cDNA in four Japanese patients with [E1] adult onset globoid cell leukodystrophy [/E1] Krabbe disease AO GLD by polymerase chain reaction/single strand conformation polymorphism PCR SSCP analysis subsequent sequence determination and restriction enzyme digestion of PCR products initial symptoms were the onset of slowly progressive spastic paraplegia from the middle of the", "mention_data": [{"mention": "adult onset globoid cell leukodystrophy", "kb_id": "D007965", "start": 25, "end": 31}]}
{"text": "Adult onset globoid cell leukodystrophy Krabbe disease analysis of galactosylceramidase cDNA from four Japanese patients We examined galactosylceramidase GALC cDNA in four Japanese patients with adult onset globoid cell leukodystrophy [E1] Krabbe disease [/E1] AO GLD by polymerase chain reaction/single strand conformation polymorphism PCR SSCP analysis subsequent sequence determination and restriction enzyme digestion of PCR products initial symptoms were the onset of slowly progressive spastic paraplegia from the middle of the second decade", "mention_data": [{"mention": "Krabbe disease", "kb_id": "245200", "start": 30, "end": 33}]}
{"text": "Adult onset globoid cell leukodystrophy Krabbe disease analysis of galactosylceramidase cDNA from four Japanese patients We examined galactosylceramidase GALC cDNA in four Japanese patients with adult onset globoid cell leukodystrophy Krabbe disease [E1] AO GLD [/E1] by polymerase chain reaction/single strand conformation polymorphism PCR SSCP analysis subsequent sequence determination and restriction enzyme digestion of PCR products initial symptoms were the onset of slowly progressive spastic paraplegia from the middle of the second decade and all", "mention_data": [{"mention": "AO GLD", "kb_id": "D007965", "start": 32, "end": 35}]}
{"text": "Japanese patients with adult onset globoid cell leukodystrophy Krabbe disease AO GLD by polymerase chain reaction/single strand conformation polymorphism PCR SSCP analysis subsequent sequence determination and restriction enzyme digestion of PCR products initial symptoms were the onset of slowly progressive [E1] spastic paraplegia [/E1] from the middle of the second decade and all patients had diminished GALC activity in their leukocytes We identified three missense mutations I66M G270D L618S and one exon 6 skipping 535 573del Two of the patients had only the", "mention_data": [{"mention": "spastic paraplegia", "kb_id": "D010264", "start": 62, "end": 65}]}
{"text": "polymerase chain reaction/single strand conformation polymorphism PCR SSCP analysis subsequent sequence determination and restriction enzyme digestion of PCR products initial symptoms were the onset of slowly progressive spastic paraplegia from the middle of the second decade and all patients had [E1] diminished GALC activity [/E1] in their leukocytes We identified three missense mutations I66M G270D L618S and one exon 6 skipping 535 573del Two of the patients had only the I66M mutant mRNA and one only the G27OD mutant mRNA The fourth patient carried", "mention_data": [{"mention": "diminished GALC activity", "kb_id": "C538554", "start": 75, "end": 79}]}
{"text": "heterozygous mutation of 535 573del and L618S To determine the enzymatic activities produced by these mutations we constructed mutated GALC cDNAs and expressed them in COS 1 cells Three mutations viz G270D L618S and exon 6 skipping 535 573del produced [E1] diminished GALC activity [/E1] as expected The I66M mutation in the wild type GALC cDNA I289 had normal activity but when this mutation and the V289 polymorphism were introduced into the same allele it had decreased activity Thus the combination of a unique", "mention_data": [{"mention": "diminished GALC activity", "kb_id": "C538554", "start": 159, "end": 163}]}
{"text": "activity but when this mutation and the V289 polymorphism were introduced into the same allele it had decreased activity Thus the combination of a unique mutation and polymorphism causes conformational change in the GALC enzyme resulting in low enzymatic activity [E1] AO GLD [/E1] mutations including those found here are located in the N terminus I66M G270D 535 573del or C terminus L618S of the GALC enzyme whereas the reported mutations in the infantile form IF GLD are in the central domain This", "mention_data": [{"mention": "AO GLD", "kb_id": "D007965", "start": 216, "end": 219}]}
{"text": "GALC enzyme resulting in low enzymatic activity AO GLD mutations including those found here are located in the N terminus I66M G270D 535 573del or C terminus L618S of the GALC enzyme whereas the reported mutations in the infantile form [E1] IF GLD [/E1] are in the central domain This difference in mutation sites may affect the clinical features of GLD", "mention_data": [{"mention": "IF GLD", "kb_id": "D007965", "start": 249, "end": 252}]}
{"text": "N terminus I66M G270D 535 573del or C terminus L618S of the GALC enzyme whereas the reported mutations in the infantile form IF GLD are in the central domain This difference in mutation sites may affect the clinical features of [E1] GLD [/E1]", "mention_data": [{"mention": "GLD", "kb_id": "D007965", "start": 267, "end": 269}]}
{"text": "BRCA1 is secreted and exhibits properties of a granin Germline mutations in BRCA1 are responsible for most cases of [E1] inherited breast and ovarian cancer [/E1] However the function of the BRCA1 protein has remained elusive We now show that BRCA1 encodes a 190 kD protein with sequence homology and biochemical analogy to the granin protein family Interestingly BRCA2 also includes a motif similar to", "mention_data": [{"mention": "inherited breast and ovarian cancer", "kb_id": "D061325", "start": 19, "end": 25}]}
{"text": "Both BRCA1 and the granins localize to secretory vesicles are secreted by a regulated pathway are post translationally glycosylated and are responsive to hormones As a regulated secretory protein BRCA1 appears to function by a mechanism not previously described for [E1] tumour [/E1] suppressor gene products", "mention_data": [{"mention": "tumour", "kb_id": "D009369", "start": 113, "end": 115}]}
{"text": "Insulin gene region contributes to genetic susceptibility to but may not to low incidence of [E1] insulin dependent diabetes mellitus [/E1] in Japanese In the Caucasian population it has been demonstrated that the insulin gene INS region contains the insulin dependent diabetes mellitus locus IDDM2 In the Japanese population however there has been no report demonstrating the contribution of IDDM2", "mention_data": [{"mention": "insulin dependent diabetes mellitus", "kb_id": "125852", "start": 15, "end": 20}]}
{"text": "Insulin gene region contributes to genetic susceptibility to but may not to low incidence of insulin dependent diabetes mellitus in Japanese In the Caucasian population it has been demonstrated that the insulin gene INS region contains the [E1] insulin dependent diabetes mellitus [/E1] locus IDDM2 In the Japanese population however there has been no report demonstrating the contribution of IDDM2 to the pathogenesis of IDDM We conducted an association study of IDDM in a large number of Japanese subjects with multiple polymorphisms", "mention_data": [{"mention": "insulin dependent diabetes mellitus", "kb_id": "125852", "start": 37, "end": 42}]}
{"text": "the Caucasian population it has been demonstrated that the insulin gene INS region contains the insulin dependent diabetes mellitus locus IDDM2 In the Japanese population however there has been no report demonstrating the contribution of IDDM2 to the pathogenesis of [E1] IDDM [/E1] We conducted an association study of IDDM in a large number of Japanese subjects with multiple polymorphisms in INS region We found a significant association of the INS region with IDDM Alleles positively associated with IDDM in INS region", "mention_data": [{"mention": "IDDM", "kb_id": "D003922", "start": 62, "end": 64}]}
{"text": "that the insulin gene INS region contains the insulin dependent diabetes mellitus locus IDDM2 In the Japanese population however there has been no report demonstrating the contribution of IDDM2 to the pathogenesis of IDDM We conducted an association study of [E1] IDDM [/E1] in a large number of Japanese subjects with multiple polymorphisms in INS region We found a significant association of the INS region with IDDM Alleles positively associated with IDDM in INS region were the same as those positively associated", "mention_data": [{"mention": "IDDM", "kb_id": "D003922", "start": 69, "end": 71}]}
{"text": "demonstrating the contribution of IDDM2 to the pathogenesis of IDDM We conducted an association study of IDDM in a large number of Japanese subjects with multiple polymorphisms in INS region We found a significant association of the INS region with [E1] IDDM [/E1] Alleles positively associated with IDDM in INS region were the same as those positively associated with IDDM in Caucasian population although positively associated alleles are very common allele frequencies 0 9 in the Japanese general population These data suggest", "mention_data": [{"mention": "IDDM", "kb_id": "D003922", "start": 93, "end": 95}]}
{"text": "to the pathogenesis of IDDM We conducted an association study of IDDM in a large number of Japanese subjects with multiple polymorphisms in INS region We found a significant association of the INS region with IDDM Alleles positively associated with [E1] IDDM [/E1] in INS region were the same as those positively associated with IDDM in Caucasian population although positively associated alleles are very common allele frequencies 0 9 in the Japanese general population These data suggest that IDDM2 is involved in", "mention_data": [{"mention": "IDDM", "kb_id": "D003922", "start": 98, "end": 100}]}
{"text": "in a large number of Japanese subjects with multiple polymorphisms in INS region We found a significant association of the INS region with IDDM Alleles positively associated with IDDM in INS region were the same as those positively associated with [E1] IDDM [/E1] in Caucasian population although positively associated alleles are very common allele frequencies 0 9 in the Japanese general population These data suggest that IDDM2 is involved in the genetic susceptibility to IDDM in Japanese The high frequencies of disease", "mention_data": [{"mention": "IDDM", "kb_id": "D003922", "start": 110, "end": 112}]}
{"text": "were the same as those positively associated with IDDM in Caucasian population although positively associated alleles are very common allele frequencies 0 9 in the Japanese general population These data suggest that IDDM2 is involved in the genetic susceptibility to [E1] IDDM [/E1] in Japanese The high frequencies of disease associated alleles in the general population suggest that IDDM2 locus is not responsible for the low incidence of IDDM in Japanese", "mention_data": [{"mention": "IDDM", "kb_id": "D003922", "start": 142, "end": 144}]}
{"text": "general population These data suggest that IDDM2 is involved in the genetic susceptibility to IDDM in Japanese The high frequencies of disease associated alleles in the general population suggest that IDDM2 locus is not responsible for the low incidence of [E1] IDDM [/E1] in Japanese", "mention_data": [{"mention": "IDDM", "kb_id": "D003922", "start": 168, "end": 170}]}
{"text": "Association of [E1] anxiety related traits [/E1] with a polymorphism in the serotonin transporter gene regulatory region Transporter facilitated uptake of serotonin 5 hydroxytryptamine or 5 HT has been implicated in anxiety in humans and animal models and is the site of action of widely used", "mention_data": [{"mention": "anxiety related traits", "kb_id": "607834", "start": 2, "end": 6}]}
{"text": "Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region Transporter facilitated uptake of serotonin 5 hydroxytryptamine or 5 HT has been implicated in [E1] anxiety [/E1] in humans and animal models and is the site of action of widely used uptake inhibiting antidepressant and antianxiety drugs Human 5 HT transporter 5 HTT gene transcription is modulated by a common polymorphism in its upstream regulatory region", "mention_data": [{"mention": "anxiety", "kb_id": "D001008", "start": 29, "end": 31}]}
{"text": "expression and 5 HT uptake in lymphoblasts Association studies in two independent samples totaling 505 individuals revealed that the 5 HTT polymorphism accounts for 3 to 4 percent of total variation and 7 to 9 percent of inherited variance in [E1] anxiety related personality traits [/E1] in individuals as well as sibships", "mention_data": [{"mention": "anxiety related personality traits", "kb_id": "607834", "start": 130, "end": 135}]}
{"text": "tissue specific distribution of VLCAD mRNA and protein in several human tissues we showed that VLCAD is most abundant in heart and skeletal muscle This agrees well with the fact that cardiac and muscle symptoms are characteristic for patients with [E1] VLCAD deficiency [/E1] Northern blot analysis and sequencing of cloned PCR amplified VLCAD cDNA from four unrelated patients with VLCAD deficiency showed that VLCAD mRNA was undetectable in one patient and that the other three have mutations in both VLCAD alleles Western", "mention_data": [{"mention": "VLCAD deficiency", "kb_id": "C536353", "start": 207, "end": 210}]}
{"text": "abundant in heart and skeletal muscle This agrees well with the fact that cardiac and muscle symptoms are characteristic for patients with VLCAD deficiency Northern blot analysis and sequencing of cloned PCR amplified VLCAD cDNA from four unrelated patients with [E1] VLCAD deficiency [/E1] showed that VLCAD mRNA was undetectable in one patient and that the other three have mutations in both VLCAD alleles Western blot analysis of patient fibroblasts showed that the identified mutations result in severely reduced amounts of VLCAD protein", "mention_data": [{"mention": "VLCAD deficiency", "kb_id": "C536353", "start": 225, "end": 228}]}
{"text": "Genetic bases of human [E1] complement C7 deficiency [/E1] Complement C7 deficiency C7D is associated frequently with recurrent bacterial infections especially meningitis caused by Neisseria meningitidis We report in this work the molecular bases of C7D in two unrelated Japanese males We used exon specific PCR/single strand conformation", "mention_data": [{"mention": "complement C7 deficiency", "kb_id": "610102", "start": 4, "end": 8}]}
{"text": "Genetic bases of human complement C7 deficiency [E1] Complement C7 deficiency [/E1] C7D is associated frequently with recurrent bacterial infections especially meningitis caused by Neisseria meningitidis We report in this work the molecular bases of C7D in two unrelated Japanese males We used exon specific PCR/single strand conformation polymorphism analysis as", "mention_data": [{"mention": "Complement C7 deficiency", "kb_id": "610102", "start": 7, "end": 11}]}
{"text": "Genetic bases of human complement C7 deficiency Complement C7 deficiency [E1] C7D [/E1] is associated frequently with recurrent bacterial infections especially meningitis caused by Neisseria meningitidis We report in this work the molecular bases of C7D in two unrelated Japanese males We used exon specific PCR/single strand conformation polymorphism analysis as a", "mention_data": [{"mention": "C7D", "kb_id": "610102", "start": 10, "end": 12}]}
{"text": "Genetic bases of human complement C7 deficiency Complement C7 deficiency C7D is associated frequently with recurrent [E1] bacterial infections [/E1] especially meningitis caused by Neisseria meningitidis We report in this work the molecular bases of C7D in two unrelated Japanese males We used exon specific PCR/single strand conformation polymorphism analysis as a screening step for mutations Subsequent direct sequencing", "mention_data": [{"mention": "bacterial infections", "kb_id": "D001424", "start": 16, "end": 19}]}
{"text": "Genetic bases of human complement C7 deficiency Complement C7 deficiency C7D is associated frequently with recurrent bacterial infections especially [E1] meningitis [/E1] caused by Neisseria meningitidis We report in this work the molecular bases of C7D in two unrelated Japanese males We used exon specific PCR/single strand conformation polymorphism analysis as a screening step for mutations Subsequent direct sequencing of the", "mention_data": [{"mention": "meningitis", "kb_id": "D008581", "start": 19, "end": 21}]}
{"text": "Genetic bases of human complement C7 deficiency Complement C7 deficiency C7D is associated frequently with recurrent bacterial infections especially meningitis caused by [E1] Neisseria meningitidis [/E1] We report in this work the molecular bases of C7D in two unrelated Japanese males We used exon specific PCR/single strand conformation polymorphism analysis as a screening step for mutations Subsequent direct sequencing of the target exons identified homozygous", "mention_data": [{"mention": "Neisseria meningitidis", "kb_id": "D008589", "start": 22, "end": 25}]}
{"text": "Genetic bases of human complement C7 deficiency Complement C7 deficiency C7D is associated frequently with recurrent bacterial infections especially meningitis caused by Neisseria meningitidis We report in this work the molecular bases of [E1] C7D [/E1] in two unrelated Japanese males We used exon specific PCR/single strand conformation polymorphism analysis as a screening step for mutations Subsequent direct sequencing of the target exons identified homozygous mutations in exon 16 of case 1 and in exon", "mention_data": [{"mention": "C7D", "kb_id": "610102", "start": 33, "end": 35}]}
{"text": "generating a premature termination codon 4 to 6 nucleotides downstream Family study in case 1 confirmed the genetic nature of the defect Moreover we detected a novel polymorphism in intron 11 that presumably is linked to the mutation responsible for [E1] C7D [/E1] in case 1 Our results indicate that the pathogenesis of C7D is heterogeneous like most of the other deficiencies of complement components", "mention_data": [{"mention": "C7D", "kb_id": "610102", "start": 160, "end": 162}]}
{"text": "study in case 1 confirmed the genetic nature of the defect Moreover we detected a novel polymorphism in intron 11 that presumably is linked to the mutation responsible for C7D in case 1 Our results indicate that the pathogenesis of [E1] C7D [/E1] is heterogeneous like most of the other deficiencies of complement components", "mention_data": [{"mention": "C7D", "kb_id": "610102", "start": 171, "end": 173}]}
{"text": "of the defect Moreover we detected a novel polymorphism in intron 11 that presumably is linked to the mutation responsible for C7D in case 1 Our results indicate that the pathogenesis of C7D is heterogeneous like most of the other [E1] deficiencies of complement components [/E1]", "mention_data": [{"mention": "deficiencies of complement components", "kb_id": "D007153", "start": 179, "end": 184}]}
{"text": "Defective dimerization of [E1] von Willebrand [/E1] factor subunits due to a Cys Arg mutation in type IID von Willebrand disease The same heterozygous T C transition at nt 8567 of the von Willebrand factor vWF transcript was found in two unrelated patients with type IID", "mention_data": [{"mention": "von Willebrand", "kb_id": "D014842", "start": 3, "end": 6}]}
{"text": "Defective dimerization of von Willebrand factor subunits due to a Cys Arg mutation in [E1] type IID von Willebrand disease [/E1] The same heterozygous T C transition at nt 8567 of the von Willebrand factor vWF transcript was found in two unrelated patients with type IID von Willebrand disease with no other apparent abnormality In one family both alleles were", "mention_data": [{"mention": "type IID von Willebrand disease", "kb_id": "D056728", "start": 14, "end": 20}]}
{"text": "Defective dimerization of von Willebrand factor subunits due to a Cys Arg mutation in type IID von Willebrand disease The same heterozygous T C transition at nt 8567 of the [E1] von Willebrand [/E1] factor vWF transcript was found in two unrelated patients with type IID von Willebrand disease with no other apparent abnormality In one family both alleles were normal in the parents and one sister thus the mutation originated de novo", "mention_data": [{"mention": "von Willebrand", "kb_id": "D014842", "start": 30, "end": 33}]}
{"text": "of von Willebrand factor subunits due to a Cys Arg mutation in type IID von Willebrand disease The same heterozygous T C transition at nt 8567 of the von Willebrand factor vWF transcript was found in two unrelated patients with [E1] type IID von Willebrand disease [/E1] with no other apparent abnormality In one family both alleles were normal in the parents and one sister thus the mutation originated de novo in the proposita The second patient also had asymptomatic parents who however were not available", "mention_data": [{"mention": "type IID von Willebrand disease", "kb_id": "D056728", "start": 42, "end": 48}]}
{"text": "which remained unchanged after reduction We conclude that CyS2010 is essential for normal dimerization of vWF subunits through disulfide bonding of carboxyl terminal domains and that a heterozygous mutation in the corresponding codon is responsible for defective multimer formation in [E1] type IID von Willebrand disease [/E1]", "mention_data": [{"mention": "type IID von Willebrand disease", "kb_id": "D056728", "start": 210, "end": 216}]}
{"text": "[E1] Ataxia telangiectasia [/E1] founder effect among north African Jews The ATM gene is responsible for the autosomal recessive disorder ataxia telangiectasia A T characterized by cerebellar degeneration immunodeficiency and cancer predisposition A T carriers were reported to be moderately cancer prone A", "mention_data": [{"mention": "Ataxia telangiectasia", "kb_id": "D001260", "start": 0, "end": 3}]}
{"text": "Ataxia telangiectasia founder effect among north African Jews The ATM gene is responsible for the [E1] autosomal recessive disorder [/E1] ataxia telangiectasia A T characterized by cerebellar degeneration immunodeficiency and cancer predisposition A T carriers were reported to be moderately cancer prone A wide variety of A T mutations most of which are unique to single families were identified", "mention_data": [{"mention": "autosomal recessive disorder", "kb_id": "D030342", "start": 15, "end": 19}]}
{"text": "Ataxia telangiectasia founder effect among north African Jews The ATM gene is responsible for the autosomal recessive disorder [E1] ataxia telangiectasia [/E1] A T characterized by cerebellar degeneration immunodeficiency and cancer predisposition A T carriers were reported to be moderately cancer prone A wide variety of A T mutations most of which are unique to single families were identified in various", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 18, "end": 21}]}
{"text": "Ataxia telangiectasia founder effect among north African Jews The ATM gene is responsible for the autosomal recessive disorder ataxia telangiectasia [E1] A T [/E1] characterized by cerebellar degeneration immunodeficiency and cancer predisposition A T carriers were reported to be moderately cancer prone A wide variety of A T mutations most of which are unique to single families were identified in various ethnic groups", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 20, "end": 23}]}
{"text": "Ataxia telangiectasia founder effect among north African Jews The ATM gene is responsible for the autosomal recessive disorder ataxia telangiectasia A T characterized by [E1] cerebellar degeneration [/E1] immunodeficiency and cancer predisposition A T carriers were reported to be moderately cancer prone A wide variety of A T mutations most of which are unique to single families were identified in various ethnic groups precluding carrier screening with", "mention_data": [{"mention": "cerebellar degeneration", "kb_id": "D013132", "start": 24, "end": 27}]}
{"text": "Ataxia telangiectasia founder effect among north African Jews The ATM gene is responsible for the autosomal recessive disorder ataxia telangiectasia A T characterized by cerebellar degeneration [E1] immunodeficiency [/E1] and cancer predisposition A T carriers were reported to be moderately cancer prone A wide variety of A T mutations most of which are unique to single families were identified in various ethnic groups precluding carrier screening with mutation", "mention_data": [{"mention": "immunodeficiency", "kb_id": "D007153", "start": 26, "end": 28}]}
{"text": "Ataxia telangiectasia founder effect among north African Jews The ATM gene is responsible for the autosomal recessive disorder ataxia telangiectasia A T characterized by cerebellar degeneration immunodeficiency and [E1] cancer predisposition [/E1] A T carriers were reported to be moderately cancer prone A wide variety of A T mutations most of which are unique to single families were identified in various ethnic groups precluding carrier screening with mutation specific assays However", "mention_data": [{"mention": "cancer predisposition", "kb_id": "D009369", "start": 28, "end": 31}]}
{"text": "Ataxia telangiectasia founder effect among north African Jews The ATM gene is responsible for the autosomal recessive disorder ataxia telangiectasia A T characterized by cerebellar degeneration immunodeficiency and cancer predisposition [E1] A T [/E1] carriers were reported to be moderately cancer prone A wide variety of A T mutations most of which are unique to single families were identified in various ethnic groups precluding carrier screening with mutation specific assays However a single", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 30, "end": 33}]}
{"text": "Ataxia telangiectasia founder effect among north African Jews The ATM gene is responsible for the autosomal recessive disorder ataxia telangiectasia A T characterized by cerebellar degeneration immunodeficiency and cancer predisposition A T carriers were reported to be moderately [E1] cancer prone [/E1] A wide variety of A T mutations most of which are unique to single families were identified in various ethnic groups precluding carrier screening with mutation specific assays However a single mutation was observed in 32/33 defective ATM alleles", "mention_data": [{"mention": "cancer prone", "kb_id": "D009369", "start": 38, "end": 41}]}
{"text": "among north African Jews The ATM gene is responsible for the autosomal recessive disorder ataxia telangiectasia A T characterized by cerebellar degeneration immunodeficiency and cancer predisposition A T carriers were reported to be moderately cancer prone A wide variety of [E1] A T [/E1] mutations most of which are unique to single families were identified in various ethnic groups precluding carrier screening with mutation specific assays However a single mutation was observed in 32/33 defective ATM alleles in Jewish A T families of", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 44, "end": 47}]}
{"text": "wide variety of A T mutations most of which are unique to single families were identified in various ethnic groups precluding carrier screening with mutation specific assays However a single mutation was observed in 32/33 defective ATM alleles in Jewish [E1] A T [/E1] families of North African origin coming from various regions of Morocco and Tunisia This mutation 103C T results in a stop codon at position 35 of the ATM protein In keeping with the nature of this mutation various antibodies", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 81, "end": 84}]}
{"text": "to defect this protein in patient cells A rapid carrier detection assay detected this mutation in three out of 488 ATM alleles of Jewish Moroccan or Tunisian origin This founder effect provides a unique opportunity for population based screening for [E1] A T [/E1] carriers in a large Jewish community", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 168, "end": 171}]}
{"text": "Mutations associated with variant phenotypes in [E1] ataxia telangiectasia [/E1] We have identified 14 families with ataxia telangiectasia A T in which mutation of the ATM gene is associated with a less severe clinical and cellular phenotype approximately 10 15 of A T families identified in the United Kingdom", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 6, "end": 9}]}
{"text": "Mutations associated with variant phenotypes in ataxia telangiectasia We have identified 14 families with [E1] ataxia telangiectasia [/E1] A T in which mutation of the ATM gene is associated with a less severe clinical and cellular phenotype approximately 10 15 of A T families identified in the United Kingdom In 10 of these families all the homozygotes", "mention_data": [{"mention": "ataxia telangiectasia", "kb_id": "D001260", "start": 14, "end": 17}]}
{"text": "Mutations associated with variant phenotypes in ataxia telangiectasia We have identified 14 families with ataxia telangiectasia [E1] A T [/E1] in which mutation of the ATM gene is associated with a less severe clinical and cellular phenotype approximately 10 15 of A T families identified in the United Kingdom In 10 of these families all the homozygotes have a", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 16, "end": 19}]}
{"text": "Mutations associated with variant phenotypes in ataxia telangiectasia We have identified 14 families with ataxia telangiectasia A T in which mutation of the ATM gene is associated with a less severe clinical and cellular phenotype approximately 10 15 of [E1] A T [/E1] families identified in the United Kingdom In 10 of these families all the homozygotes have a 137 bp insertion in their cDNA caused by a point mutation in a sequence resembling a splice donor site The second A T", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 39, "end": 42}]}
{"text": "of A T families identified in the United Kingdom In 10 of these families all the homozygotes have a 137 bp insertion in their cDNA caused by a point mutation in a sequence resembling a splice donor site The second [E1] A T [/E1] allele has a different mutation in each patient We show that the less severe phenotype in these patients is caused by some degree of normal splicing which occurs as an alternative product from the insertion containing allele The level", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 78, "end": 81}]}
{"text": "caused by some degree of normal splicing which occurs as an alternative product from the insertion containing allele The level of the 137 bp PCR product containing the insertion was lowest in two patients who showed a later onset of [E1] cerebellar ataxia [/E1] A further four families who do not have this insertion have been identified Mutations detected in two of four of these are missense mutations normally rare in A T patients The demonstration of mutations giving rise to a slightly", "mention_data": [{"mention": "cerebellar ataxia", "kb_id": "D002524", "start": 139, "end": 142}]}
{"text": "was lowest in two patients who showed a later onset of cerebellar ataxia A further four families who do not have this insertion have been identified Mutations detected in two of four of these are missense mutations normally rare in [E1] A T [/E1] patients The demonstration of mutations giving rise to a slightly milder phenotype in A T raises the interesting question of what range of phenotypes might occur in individuals in whom both mutations are milder One possibility might be that", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 168, "end": 171}]}
{"text": "four families who do not have this insertion have been identified Mutations detected in two of four of these are missense mutations normally rare in A T patients The demonstration of mutations giving rise to a slightly milder phenotype in [E1] A T [/E1] raises the interesting question of what range of phenotypes might occur in individuals in whom both mutations are milder One possibility might be that individuals who are compound heterozygotes for ATM mutations are more common than we realize", "mention_data": [{"mention": "A T", "kb_id": "D001260", "start": 183, "end": 186}]}
{"text": "Cleavage of huntingtin by apopain a proapoptotic cysteine protease is modulated by the polyglutamine tract Apoptosis has recently been recognized as a mode of cell death in [E1] Huntington disease [/E1] HD Apopain a human counterpart of the nematode cysteine protease death gene product CED 3 has a key role in proteolytic events leading to apoptosis Here we show that apoptotic extracts and apopain itself specifically cleave the HD gene", "mention_data": [{"mention": "Huntington disease", "kb_id": "D006816", "start": 27, "end": 30}]}
{"text": "Cleavage of huntingtin by apopain a proapoptotic cysteine protease is modulated by the polyglutamine tract Apoptosis has recently been recognized as a mode of cell death in Huntington disease [E1] HD [/E1] Apopain a human counterpart of the nematode cysteine protease death gene product CED 3 has a key role in proteolytic events leading to apoptosis Here we show that apoptotic extracts and apopain itself specifically cleave the HD gene product", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 29, "end": 31}]}
{"text": "in Huntington disease HD Apopain a human counterpart of the nematode cysteine protease death gene product CED 3 has a key role in proteolytic events leading to apoptosis Here we show that apoptotic extracts and apopain itself specifically cleave the [E1] HD [/E1] gene product huntingtin The rate of cleavage increases with the length of the huntingtin polyglutamine tract providing an explanation for the gain of function associated with CAG expansion Our results show that huntingtin is cleaved by cysteine proteases and", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 66, "end": 68}]}
{"text": "product huntingtin The rate of cleavage increases with the length of the huntingtin polyglutamine tract providing an explanation for the gain of function associated with CAG expansion Our results show that huntingtin is cleaved by cysteine proteases and suggest that [E1] HD [/E1] might be a disorder of inappropriate apoptosis", "mention_data": [{"mention": "HD", "kb_id": "D006816", "start": 108, "end": 110}]}
{"text": "of cleavage increases with the length of the huntingtin polyglutamine tract providing an explanation for the gain of function associated with CAG expansion Our results show that huntingtin is cleaved by cysteine proteases and suggest that HD might be a [E1] disorder of inappropriate apoptosis [/E1]", "mention_data": [{"mention": "disorder of inappropriate apoptosis", "kb_id": "D004194", "start": 112, "end": 117}]}
